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Abstract 
 
Proteins have been extensively studied over the last decade as comprehensive 
understanding of the proteome can definitely lead to the discovery of novel biomarkers, 
early-stage disease diagnoses and the development of diagnostic tools and novel drug 
therapies. One of the crucial and fundamental processes in protein analysis is protein 
separation, which is usually performed as multidimensional separations to achieve high 
resolution and high peak capacity. However, high performance analyses are difficult to 
achieve due to the challenges involved in efficiently integrating different dimensions.  
   
In this work, we present the development of a microfluidic device for the effective 
transfer of protein droplets into the second separation dimension. Consequently, the 
device provides a stable, reproducible, easy to operate, portable and flexible system to 
connect a first dimension separation to the downstream second dimension analysis via 
droplets. The droplets act to preserve the resolution during transfer between separation 
techniques.  
 
In summary, a fluorescently labeled protein ladder serving as a representative of proteins 
separated from the first dimension is compartmentalized into droplets using the robotic 
droplet generator. These protein droplets are then transferred via the interfacing 
microdevice into the second dimension where the released proteins are further separated 
using capillary gel electrophoresis. Herein, several designs of interfacing microdevices 
were evaluated for the successful transfer of droplet contents (droplet injection) into the 
second dimension. The buffer for capillary gel electrophoresis was developed to achieve 
high-speed and high-resolution separations of proteins in droplet-based injection format. 
Several fluorescent dyes were also examined for protein labeling to achieve high 
fluorescent intensities necessary when using this droplet format. Successful droplet-based 
separation of proteins necessitates the seamless integration of all the developed 
components. This has been demonstrated here.  
 
This interface automates the oil depletion process, minimizes dead volume, prevents 
dispersion of analyte bands and reduces sample loss at the interface between separation 
  5 
dimensions. Furthermore, optimization of the entire system used in conjunction with the 
interfacing microdevice provided for ease of operation and more efficient droplet 
injections. Moreover, droplet injection into parallel separation channels was achieved, 
highlighting the interfaces capacity for high-throughput analyses.  
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end. This process is repeated as the RNA polymerase moves along the template strand 
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(b) adapted from reference 1. 
 
Figure 1.5: (a) Parallel compartmentalization using a well plate; (b) Serial 
compartmentalization using flow injection analysis. Images reproduced from reference 
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Figure 1.6: Microdroplet formation using a T-junction. In this case, an aqueous phase 
(i.e. water) is injected into a continuous oil phase. Image reproduced from reference 54. 
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the oil phase. Image reproduced from reference 53.  
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reproduced from reference 55.  
 
Figure 1.9: (a) Mixing in droplets flowing in a straight channel (b) Mixing in droplets 
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Figure 1.10: Droplet manipulations (a) Passive merging of two adjacent droplets60 (b) 
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arrays63  
 
Figure 1.11: Schematics of (a) Differential centrifugation and (b) Isopycnic 
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density. Images reproduced from reference 2.  
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dialysis bag or tube, while proteins are retained inside the dialysis bag or tube. Image 
reproduced from reference 66. 
 
Figure 1.13: (a) Ion-exchange chromatography (b) Size-exclusion chromatography (c) 
Affinity chromatography. Images reproduced from reference 25. 
 
Figure 1.14: Slab gel electrophoresis. Smaller proteins can pass through the pores of a 
gel with ease and will, therefore, elute faster than larger proteins. Image reproduced from 
reference 25.  
 
Figure 1.15: Instrumental setup of a standard capillary electrophoresis system consists of 
a capillary connecting two buffer reservoirs, a sample reservoir which can be replaced 
with one of the buffer reservoirs, two electrodes placed at each buffer reservoir to apply 
an electric field across the capillary using a high-voltage power supply, and a detector. 
 
Figure 1.16: Schematics of a cross-piece microchip with normal injection mode (a) 
During loading step; (b) During separation step  
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Figure 1.17: (a) Sample loading during pinched injection; (b) Sample dispensing during 
pinched injection; (c) Gated injection (i) Applied voltage for sample (S) = 700 V, buffer 
(B) = 1000 V, sample waste (SW) and buffer waste (BW) = 0 V, (ii) prior to injection: S 
= 700 V, B, BW and SW = 0 V, (iii) sample dispensing: voltages were shifted back to the 
same as those of (i). Image (a) and (b) reproduced from reference 108, while image (c) 
reproduced from reference 34.  
 
Figure 1.18: Two-dimensional gel electrophoresis. Proteins are separated by isoelectric 
focusing in the first dimension and by SDS gel electrophoresis in the second dimension. 
Image reproduced from reference 124. 
 
Figure 1.19: Images of microchips containing two intersecting channels as valves (V1 
and V2) for the 2D separation of (a) a tryptic digest of BSA having MEKC as the first 
dimension and CZE as the second dimension, and (b) a tryptic digest of β-casein having 
OCEC coupled with CZE. Both microchips consist of a sample reservoir (S), two sample 
waste reservoirs (SW1 and SW2), two buffer reservoirs (B1 and B2) and one buffer waste 
reservoir (BW). The separated analytes are detected at the point D illustrated in Figure 
1.18a and at the points x and y as shown in Figure 1.18b. Image (a) is reproduced from 
reference 119 and image (b) is reproduced from reference 120.  
 
Figure 1.20: An image of a PMMA microchip with intersecting channel geometries as 
interfaces between CGE (1st dimension) and MEEKC (2nd dimension) for the separation 
of cytosolic proteins of E. coli. The reservoirs shown in the image are sample reservoir 
(A), sample waste reservoir (B), CGE buffer reservoir (C), CGE sample waste reservoir 
(D), MEEKC buffer reservoir (E) and MEEKC buffer waste reservoir (F). Detection is 
performed at the point d1 as shown in the image. Image reproduced from reference 139.  
 
Figure 1.21: Schematics of simple cross-intersection geometries for protein separations 
by IEF coupled with CZE. A sample is first separated by IEF and when the analyte bands 
reach the intersection, they are then separated by CZE. The direction of IEF in the first 
dimension separation is from reservoir A to reservoir C in (a) and from reservoir 1 to 
reservoir 2 in (b). The direction of CZE is from reservoir B (buffer) to reservoir W 
(waste) in (a) and from reservoir 3 to reservoir 4 in (b). The dashed box D in part (a) 
shows the detection area. Schematics (a) and (b) reproduced from references 140 and 141, 
respectively.  
 
Figure 1.22: IEF coupled with CGE using a variety of interfaces between the two 
separation dimensions. (a) A 2D-separation microchip incorporating a PDMS membrane 
as an interface (i) A protein mixture is first separated in a composite PDMS membrane 
serving as an IEF channel (red line). The composite PDMS membrane is then assembled 
to the other two PDMS pieces: parallel green lines represent the channels in the top 
PDMS piece and parallel blue lines represent the channels in the bottom PDMS piece. 
Together they form a single PDMS device for CGE. The separated analytes from the IEF 
channel are transferred to parallel vertical channels to perform CGE in the second 
dimension, (ii) The separated fluorescein-conjugated bovine serum albumin (BSAF) and 
Texas-red-conjugated ovalbumin (OvTR) bands are obtained using different filters for the 
detection of fluorescein and Texas Red. (b) A staggered-channel network within a planar 
PC microchip for 2D separations (i) A schematic of the microchip shows a horizontal 
channel for IEF separation traversing vertical channels for performing CGE, (ii) Shows 
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IEF focusing of a protein mixture, (iii) The focused proteins are transferred 
electrokinetically to the second dimension, (iv) CGE is then performed in the vertical 
channels. (c) Schematics of 2D separation processes utilizing microvalves as interfaces 
between IEF and CGE separations (i) During CGE buffer loading, right valves connected 
to an IEF channel are closed, (ii) IEF buffer loading, left valves connected to a CGE 
channel are closed, (iii) All valves are closed after IEF focusing, (iv) Left valves are 
opened again for CGE separation. (d) An IEF-CGE microchip employing in situ 
polymerized gel as valves (i) A micrograph of the stained polymerized gel within vertical 
channels, (ii) The enlargement of (i) shows an IEF channel and an array of CGE channels 
containing polymerized gel. Image (a) reproduced from reference 142, image (b) 
reproduced from reference 143, image (c) reproduced from reference 144 and image (d) 
reproduced from reference 146. 
 
Figure 1.23: (a) A schematic of a microchip for IEF coupled with µ-RPLC using 
microvalves as interfaces. The microvalves are manually turned off after separation in an 
IEF channel. The analytes are then further separated using µ-RPLC. (b) 2D separation by 
IEF coupled with DIGE (i) An illustration of a microchip having an IEF channel laying 
across an array of DIGE channels, (ii) The connection between the IEF channel 
(horizontal channel) and DIGE channels (vertical channels) using very small channels 
that prevent gel buffer from dispersing into the IEF channel during the focusing 
operation, (iii) The gel buffer fills all channels, (iv) The IEF channel is cleared by 
applying a vacuum at one end and water at the other end, (v) IEF buffer is then 
introduced into the clean IEF channel. (c) Illustrations of GEMBE coupled with CZE 
separation. The microdevice consists of a sample reservoir, a CZE buffer reservoir, a 
buffer waste reservoir, a GEMBE channel connected to a CZE channel via an intersection 
geometry. By varying the bulk solution counterflow velocity in GEMBE, analytes are 
allowed to enter the channel at different times. The analyte bands from GEMBE are 
periodically injected into a CZE channel for further separation by turning on/off a 
computer-controlled relay. Image (a) reproduced from reference 150, image (b) 
reproduced from reference 151, image (c) reproduced from reference 122.  
 
Chapter II 
 
Figure 2.1: A schematic illustrating the process of chromium mask fabrication consisting 
of four steps. The pattern on a film mask is transferred to a chromium coated glass wafer 
by exposure to the UV light. The exposed photoresist and the chromium layer are then 
removed to reveal the pattern on the chromium mask. 
 
Figure 2.2: A chemical structure of Bisphenol A Novolak epoxy oligomer containing 8 
epoxy groups provide for high degree of cross-linking after photoactivation. Image 
reproduced from reference 5. 
 
Figure 2.3: Flow chart showing the process of SU-8 master fabrication and surface 
treatment by silanization. 
 
Figure 2.4: An image and schematics of a robotic droplet generator (a) An image 
showing the entire system of the robotic droplet generator consisting of a PTFE tube 
inserted into a metal hook, an oil-filled carousel, a camera, a glass syringe and a syringe 
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pump; (b) An enlargement of the oil-filled carousel part showing the carousel that can 
move forward and backward as illustrated by the arrows and the hook that can be in the 
“up” and “down” position under the control of a solenoid. Fifteen samples can be held by 
holes on a metal ring for this model of the robotic droplet generator; (c) A schematic 
illustrating droplet generation from two samples using the robotic droplet generator (i) 
The carousel moves until the tip of the hook is in the oil phase beneath the first sample 
(red), (ii) The hook is in the “up” position and withdraws the sample (red), (iii) The hook 
is in the “down” position and withdraws the oil, (iv) The carousel moves again towards 
the second sample (blue) until the tip of the hook is underneath the sample, (v) The same 
process as that of (ii) occurs to achieve a droplet of the second sample (blue), (vi) The 
process in (iii) is repeated. Image (b) and (c) reproduced from reference 9.                
 
Figure 2.5: Schematics illustrating overall instrumentation of Peregrine (a) Outside of the 
machine showing main cover, status panel and carousel cover; (b) Inside the machine 
showing main cover interlock, lamp cover and main electrophoresis compartment/ optical 
rail components inside the main cover, carousel cover interlock inside the carousel cover 
and power switch at the side of the machine. Images reproduced from reference 10. 
 
Figure 2.6: Schematic depicting the components inside the main cover of Peregrine. 
Image reproduced from reference 10.                                                                      
Figure 2.7: Schematics illustrating outside and inside of the capillary block used with 
Peregrine machine (a) Overview of the capillary block; (b) Capillary track (red line) of 
20.2 cm input capillary length; (c) Illustrating a fused silica capillary with 1.25 cm 
detection window. Images reproduced from reference 10. 
 
Figure 2.8: An example of (a) raw data obtained from 1-pixel detector showing 
transmittance vs. time (scan count) and (b) GST processed electropherogram in which the 
axes are absorbance vs. time (min). 
 
Figure 2.9: Equiphase map (a) An example of equiphase map; (b) Schematic illustrating 
how the equiphase map is generated. Image (a) reproduced from reference 10 and (b) 
adapted from reference 12. 
 
Chapter III 
Figure 3.1: Diagram showing the process of buffer development for protein separations. 
 
Figure 3.2: Microfluidic devices used to perform protein gel electrophoresis (a) A cross-
piece PDMS microdevice; (b) A cross-piece PDMS microdevice with an enlarged 
channel for the insertion of a glass capillary; (c) Aluminium platform for holding either a 
cross-piece PDMS microdevice or a cross-piece PDMS microdevice coupled to a glass 
capillary. S = sample reservoir, SW = sample waste reservoir, B = buffer reservoir and 
BW = buffer waste reservoir. 
 
Figure 3.3: The separation of a 3-protein mixture in Beckman buffer using the CE 
machine (a) GST processed electropherograms of lysozyme (1), CA (2), BSA (3) and a 
mixture of these proteins performed in Beckman buffer using a 34 cm long capillary 
having an effective length of 20 cm, at 25°C and using electric field strength of 441.18 
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V/cm (Note: Y-axes are offset due to overlaying). All samples were prepared in Beckman 
sample buffer with the addition of 2-mercaptoethanol (BME); (b) An equiphase map 
obtained from the separation of the mixture. 
 
Figure 3.4: The separation of a 3-protein mixture in Beckman buffer in which samples 
were prepared in (a) 10 mM TRIS-HCl, 0.1% SDS, pH 6.6; (b) 5 mM SDS, 5 mM 
sodium tetraborate buffer, pH 8.5; (c) 5 mM SDS, 5 mM sodium tetraborate buffer, pH 
8.8. For (a), (b) and (c), (i) Showing GST processed electropherograms of lysozyme (1), 
CA (2), BSA (3) and a mixture of these proteins performed in Beckman buffer using the 
CE machine that employed a 34 cm long capillary having an effective length of 20 cm, at 
25°C (Note: Y-axes are offset due to overlaying), (ii) Showing the equiphase map from 
the separation of the mixture. The electric field strength used in (a) was 300 V/cm and 
used in (b) and (c) was 450 V/cm. 
 
Figure 3.5: Effect of pH of samples on protein separation. (a) A plot of mobility versus 
molecular weight of proteins; (b) A plot of resolution versus molecular weight. Two sets 
of a 3-protein mixture (lysozyme, CA and BSA) prepared in 5 mM borate buffer, 5 mM 
SDS at pH 8.5 and pH 8.8 were separated in Beckman buffer using	the	CE	machine	that	employed	a 34 cm long capillary having an effective length of 20 cm, at 25°C and using 
separation field strength of 450 V/cm. 
 
Figure 3.6: The separation of a 3-protein mixture in an 80/20 mixture of Beckman buffer 
and 5 mM SDS in 5 mM sodium tetraborate buffer, pH 9.0 using the CE machine (a) GST 
processed electropherograms of lysozyme (1), CA (2), BSA (3) and a mixture of these 
proteins performed using a 34 cm long capillary having an effective length of 20 cm, at 
25°C and using electric field strength of 462.4 V/cm. Thiourea peaks (4) are also 
observed in these electropherograms (Note: Y-axes are offset due to overlaying); (b) The 
equiphase map from the separation of the mixture.  
 
Figure 3.7: Electropherogram of a fluorescently labeled protein ladder (20-200 kDa 
fluorescent molecular weight marker, Sigma Aldrich, UK) performed in Beckman buffer 
solution in a cross-piece PDMS microdevice using electric field strength of 135 V/cm. 
Detection was done at 0.5 cm from the intersection. Note: The injection time was at 120 
seconds according to the electropherogram. 
 
Figure 3.8: Electrophoresis of BSA and thiourea in various concentrations of diluted 
Beckman buffer using the CE machine. (a) GST processed electropherograms of BSA 
and thiourea performed in Beckman diluted in DI water at concentrations of 0.2x (green 
line), 0.25x (pink line), 0.33x (blue line) and 0.5x (red line) using a 34 cm long capillary 
having an effective length of 20 cm, at 25°C and using electric field strength of 441.18 
V/cm. The peaks shown in these electropherograms are thiourea injected from the 
opposite end of the capillary to BSA, which is not observed (Note: Y-axes are offset due 
to overlaying); (b) An equiphase map shows the opposite direction of migration of 
thiourea due to high EOF.   
 
Figure 3.9: Electropherograms of protein ladder (20-200 kDa fluorescent molecular 
weight marker, Sigma Aldrich, UK) performed in 0.2x Beckman mixed with EOTrol 
buffer on a cross-piece PDMS microdevice using electric field strength of 121.67 V/cm. 
The separations were observed at two detection points: 0.5 cm (black line) and 1.0 cm 
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(blue line) measured from the intersection. Note: The actual injection time was not 
recorded and y-axes are offset due to overlaying. 
 
Figure 3.10: An electropherogram of protein ladder (20-200 kDa fluorescent molecular 
weight marker, Sigma Aldrich, UK) electrophoresed in dialysed Beckman against DI 
water on a cross-piece PDMS microdevice coupled to a glass capillary using electric field 
strength of 88.75 V/cm. The cross-piece PDMS microdevice contained 0.1x TBE 
solution, while the 7-cm glass capillary contained dialysed Beckman buffer. Note: The 
actual injection time was not recorded. 
 
Figure 3.11: Electropherograms of protein ladder (20-200 kDa fluorescent molecular 
weight marker, Sigma Aldrich, UK) performed in (a) dialysed Beckman against 0.1x TBE 
and (b) dialysed Beckman against 0.1x TBE added 0.5% SDS on a cross-piece PDMS 
microdevice coupled to a glass capillary using electric field strength of 88.75 V/cm. The 
cross-piece PDMS microdevice contained 0.1x TBE mixed with EOTrol solution, while 
the 7-cm glass capillary contained dialysed Beckman buffer. Note: Time shown in the 
electropherograms was not the actual time from the injection. 
 
Figure 3.12: Electropherograms of fluorescein (1 and 2) and BSA-FITC (3) separated in 
(a) 1.5% PDMA in 0.085 M, 0.1% SDS, pH 9.3 using separation field strength of 133 
V/cm (detection at 0.5 cm) and (b) 3% PDMA in 0.085 M, 0.1% SDS, pH 9.3 using 
separation field strength of 200 V/cm (detection at 2 cm). The sample was prepared in 
0.2% SDS. 
 
Figure 3.13: Possible existing structures of fluorescein. Image reproduced from reference 
49. 
 
Figure 3.14: Effect of polymer concentration and effect of adding glycerol in running 
buffer. (a) Electropherograms of a protein mixture separated in 3% PEO 100 kDa (green 
line) and 5% PEO 100 kDa (pink line) in 0.1 M TRIS-CHES, 0.1% SDS, pH 8.7 and 3% 
PEO 100 kDa (blue line) and 5% PEO 100 kDa (red line) in 0.1 M TRIS-CHES, 0.1% 
SDS, 5% glycerol, pH 8.7 (Note: Y-axes are offset due to overlaying); (b) Plot of 
mobility vs. molecular weight; (c) Plot of resolution vs. molecular weight. The 
separations of a protein mixture (lysozyme (1), CA (2) and BSA (3)) were performed 
using a 34 cm long capillary having an effective length of 20 cm, at 25°C and using 
electric field strength of 441.18 V/cm. All samples were prepared in 1x TBE buffer, 0.1% 
SDS, pH 7.56. Note: CA peak (2) in 5% PEO 100 kDa buffer containing 5% glycerol (red 
line) is indistinguishable. Therefore, mobility for CA and resolution results for this buffer 
are not available. 
 
Figure 3.15: Effect of polymer concentration of mixed polymer molecular weight. (a) 
Electropherograms of a protein mixture separated in 3% PEO 100 kDa mixed with 2% 
PEO 200 kDa (green line), 5% PEO 100 kDa mixed with 1.5% PEO 200 kDa (pink line), 
and 6% PEO 100 kDa mixed with 0.5% PEO 200 kDa (red line) in 0.1 M TRIS-CHES, 
0.1% SDS, 2% glycerol, pH 8.5 (Note: Y-axes are offset due to overlaying); (b) Plot of 
mobility vs. molecular weight; (c) Plot of resolution vs. molecular weight. The 
separations of a protein mixture (lysozyme (1), CA (2) and BSA (3)) were performed 
using a 34 cm long capillary having an effective length of 20 cm, at 25°C and using 
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electric field strength of 441.18 V/cm. All samples were prepared in 1x TBE buffer, 0.1% 
SDS, pH 7.56. Note: Lysozyme peak (1) is not shown in 3% PEO 100 kDa mixed with 
2% PEO 200 kDa buffer. Therefore, mobility for lysozyme and resolution between 
lysozyme and CA are not available. 
 
Figure 3.16: Effect of buffer pH. (a) Electropherograms of a protein mixture separated in 
3% PEO 100 kDa mixed with 2% PEO 200 kDa in 0.1 M TRIS-CHES, 0.1% SDS, 2% 
glycerol, pH 8.3 (red line) and pH 8.5 (green line) (Note: Y-axes are offset due to 
overlaying); (b) Plot of mobility vs. molecular weight; (c) Plot of resolution vs. molecular 
weight. The separations of a protein mixture (lysozyme (1), CA (2) and BSA (3)) were 
performed using a 34 cm long capillary having an effective length of 20 cm, at 25°C and 
using electric field strength of 441.18 V/cm. All samples were prepared in 1x TBE buffer, 
0.1% SDS, pH 7.56. Note: Lysozyme peak (1) is not shown in buffer pH 8.5. Therefore, 
mobility for lysozyme and resolution between lysozyme and CA are not available.  
 
Figure 3.17: Comparison of the current during electrophoresis in 3% PEO 100 kDa 
mixed with 2% PEO 200 kDa in 0.1 M TRIS-CHES, 0.1% SDS, 2% glycerol, pH 8.3 and 
pH 8.5. (a) Plots between current and voltage of buffer pH 8.3 (red line) and buffer pH 
8.5 (black line). Plots of current and time during separation in (b) buffer pH 8.3 and (c) 
buffer pH 8.5. 
 
Figure 3.18: Electrophoretic separation of a fluorescently labeled protein ladder (11-155 
kDa Benchmark fluorescent protein standard) performed in a cross-piece PDMS 
microdevice. (a) An electropherogram showing the fluorescein peak in the front followed 
by 7 protein bands of protein ladder separated in 5% PEO (100 kDa) in 0.05 M TRIS-
CHES 0.1% SDS, pH 8.5 using electric field strength of 208.33 V/cm. Detection was 
done at 1.3 cm from the intersection; (b) A plot of mobility versus molecular weight of 
11-155 kDa protein ladder; (c) A plot of resolution versus molecular weight. Note: The 
injection time was at 80 seconds according to the electropherogram. 
 
Figure 3.19: Electrophoretic separation of a fluorescently labeled protein ladder (11-155 
kDa Benchmark fluorescent protein standard) performed in a cross-piece PDMS 
microdevice. (a) An electropherogram showing the fluorescein peak in the front followed 
by 7 protein bands of protein ladder separated in 6% PEO (100 kDa) in 0.05 M TRIS-
CHES 0.1% SDS, pH 8.5 using electric field strength of 167.5 V/cm. Detection was done 
at 1.0 cm from the intersection; (b) Showing three repetitions of protein separations; (c) A 
plot of mobility versus molecular weight; (d) A plot of resolution versus molecular 
weight. Note: The injection time was at 120 seconds according to the electropherogram. 
 
Figure 3.20: Electropherograms comparing between BSA peak in fluorescently labeled 
protein ladder (11-155 kDa Benchmark fluorescent protein standard) and the injected 
BSA-FITC. The separations were performed in a cross-piece PDMS microdevice using 
6% PEO (100 kDa) in 0.05 M TRIS-CHES, 0.1% SDS, pH 8.5 at separation field strength 
of 167.5 V/cm and were detected at 1.0 cm from the injection point (Note: Y-axes are 
offset due to overlaying). 
 
Figure 3.21: Electrophoretic separation of a fluorescently labeled protein ladder (11-155 
kDa Benchmark fluorescent protein standard) performed in a cross-piece PDMS 
microdevice coupled to a glass capillary. (a) An electropherogram showing the 
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fluorescein peak in the front followed by 7 protein bands of protein ladder separated in 
6% PEO (100 kDa) in 0.05 M TRIS-CHES 0.1% SDS, pH 8.5 using electric field strength 
of 188 V/cm. Detection was done at 2.0 cm from the intersection; (b) A plot of mobility 
versus molecular weight; (d) A plot of resolution versus molecular weight. Note: The 
injection time was at 120 seconds according to the electropherogram. 
 
Chapter IV 
Figure 4.1:  The reaction of protein conjugated with FITC. 
 
Figure 4.2:  The reaction of protein conjugated with NHS-Fluorescein. 
 
Figure 4.3:  Absorption spectra of (a) lysozyme conjugated FITC and (b) BSA 
conjugated FITC. Both protein conjugates were prepared in DI water. 
 
Figure 4.4: Electrophoresis performed in 6% PEO 100 kDa in 0.05 M TRIS-CHES, 0.1% 
SDS, pH 8.5 using a cross-piece PDMS microdevice. The electric field was applied at 
~168 V/cm and the detection was made at 1 cm. The electropherograms of (a) lysozyme-
FITC prepared in 0.1% SDS buffer and heated at 95 °C for 5 min and (b) 38.5 µM FITC 
dissolved in DI water. 
 
Figure 4.5: Possible forms of FITC in an aqueous solution (a) neutral species (p-
quinoid); (b) neutral species (lactone); (c) neutral species (zwitterion); (d) cation; (e) 
anion (carboxylate); (f) anion (phenolate) and (g) dianion 
 
Figure 4.6: The reaction of free FITC with TRIS containing in 6% PEO buffer. 
 
Figure 4.7:  Absorption spectra of (a) lysozyme conjugated NHS-Fluorescein and (b) 
BSA conjugated NHS-Fluorescein. Both protein conjugates were prepared in DI water. 
 
Figure 4.8:  The electropherogram of NHS-Fluorescein performed in 6% PEO 100 kDa 
in 0.05 M TRIS-CHES, 0.1% SDS, pH 8.5 using a cross-piece PDMS microdevice. The 
electric field was applied at ~168 V/cm and the detection was made at 1 cm. 0.5 mM 
NHS-Fluorescein was prepared in 0.1x TBE buffer 
 
Figure 4.9:  The reaction of NHS-Fluorescein in 6% PEO buffer (a) The hydrolysis of 
NHS-Fluorescein and (b) The reaction between NHS-Fluorescein and TRIS. 
 
Figure 4.10:  The electropherograms of lysozyme-NHS-Fluorescein electrophoresed in 
6% PEO 100 kDa in 0.05 M TRIS-CHES, 0.1% SDS, pH 8.5 using a cross-piece PDMS 
microdevice (a) First injection of lysozyme-NHS-Fluorescein; (b) Second injection of 
lysozyme-NHS-Fluorescein; (c) First addition of 4 µl 0.1 mM NHS-Fluorescein to the 
depleted lysozyme-NHS-Fluorescein and (d) Second addition of 4 µl 0.1 mM NHS-
Fluorescein to the depleted lysozyme-NHS-Fluorescein. The electric field was applied at 
~168 V/cm and the detection was made at 1 cm. Lysozyme-NHS-Fluorescein was 
prepared in 0.1% SDS buffer and heated at 95 °C for 5 min, while 0.1 mM NHS-
Fluorescein was prepared in 0.1x TBE buffer. 
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Figure 4.11: Effect of SDS concentration on the fluorescence intensity of protein 
conjugated NanoOrange. (a) The background intensity of 0.05 M TRIS-CHES, pH 8.5 
buffer containing various concentrations of SDS (i) 0% SDS, (ii) 0.01% SDS and (iii) 
0.1% SDS; (b) 10 µl of 0.01 mg/ml lysozyme conjugated 1x NanoOrange was added to 
0.05 M TRIS-CHES, pH 8.5 buffer containing (i) 0% SDS, (ii) 0.01% SDS and (iii) 0.1% 
SDS; (c) A graph translating the fluorescence intensity from the images in Figure 4.11a 
and Figure 4.11b into the values in which the blue columns show the intensity of the 
background buffer containing 0-0.1% SDS and the red columns show the intensity of the 
buffer added 10 µl of 0.01 mg/ml lysozyme conjugated NanoOrange. 
 
Figure 4.12: Fluorescence intensity of protein conjugated NanoOrange. (a) Lysozyme 
conjugated NanoOrange droplet and (b) BSA conjugated NanoOrange droplet. The 
concentration of the proteins conjugated dye used to generate droplets were 0.5 mg/ml. 
 
Figure 4.13: An electropherogram of BSA conjugated NanoOrange obtained from the 
injections of five droplets into 6% PEO 100 kDa in 0.05 M TRIS-CHES, 0.1% SDS, pH 
8.5 using the interfacing droplet-based microdevice “Design 6”. The electrophoresis was 
performed at the electric field strength of ~ 333 V/cm and detected at 1.0 cm. 
 
Chapter V 
Figure 5.1:  Compartmentalization of analyte bands into droplets (a) A schematic 
showing separated analyte bands from a first dimension being compartmentalized into 
droplets that are transferred downstream for further analysis; (b) A mixture of fluorescent 
dyes was injected at the cross-channel part of a microdevice shown in the inset (color 
images). The mixture was separated using CGE and the separated bands moved along the 
straight channel to a T-junction where droplets could be generated. Schematics are 
reproduced from reference 34 and 35. 
 
Figure 5.2: Droplet-based interfacing microdevices employing surface modification. (a) 
A droplet generated at a hydrophobic T-junction channel moves towards a hydrophilic 
separation channel where it fuses with an immiscible boundary allowing the droplet 
contents to be injected into the separation channel; (b) A schematic showing a sample 
plug moving along a segmented flow channel prior to merging with a virtual wall at a K-
shaped interface. Here, only small amount of the sample is injected into the separation 
channel; (c) A parallel electrophoretic analysis on a microdevice employing K-shaped 
interfaces for the transfer of sample plugs; (d) A schematic and images showing the 
transfer of sample plugs obtained from a microdialysis probe (not shown) into a 
separation channel using a hydrophilic extraction bridge. Schematics and images 
reproduced from reference 36, 37, 38 and 39, respectively. 
 
Figure 5.3: Droplet-based interfacing microdevices coupled to mass spectrometry 
analysis (a) A micrograph showing an analyte plug being transferred into an aqueous 
stream employing an array of apertures as an interface for pressure control; (b) An 
integrated platform for protein analysis consisting of a droplet generation part, which 
compartmentalizes eluted bands from HPLC, and an electrospray ionization emitter for 
mass spectrometry analysis of proteins in droplets. Schematics and image reproduced 
from reference 40 and 41, respectively. 
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Figure 5.4: Droplet-based interfacing microdevices developed by Niu and co-workers (a) 
A schematic showing the compartmentalization of eluted bands from the first separation 
dimension into droplets (left) and droplet injection into the second dimension employing 
a pillar-structured microdevice to eliminate oil surrounding droplets (right); (b) 
Schematics of the Nano LC-MALDI-MS droplet-based interfacing microdevice (i) 
Separated analyte bands from Nano-LC are compartmentalized into droplets, (ii) Droplet 
contents are collected at the tip of the probe prior to the deposition onto the MALDI 
stage, whilst oil is absorbed into an oleophilic film; (c) Schematics illustrating the 
interfacing microdevices utilizing an oleophilic membrane as an oil depletion unit (i) An 
entire microdevice made of PDMS (left) and a PDMS microdevice coupled to a glass 
capillary (right), (ii) A schematic depicting the injection of a droplet through an open 
channel, while oil is depleted via the oleophilic membrane. Schematics reproduced from 
reference 31, 32 and 33, respectively. 
 
Figure 5.5: Schematics and an image illustrating the structure of the initial interface 
design used to perform single or multiple separations (a) A schematic of the entire 
microdevice consisting of a top layer (black solid lines) and a bottom layer (black and red 
dashed lines) of PDMS. The top PDMS layer contains two parallel separation channels 
with reservoirs at each end (the left reservoir is the “buffer reservoir” and the right 
reservoir is the “buffer waste reservoir”), two channels with enlarged ends to allow 
insertion of the droplet delivery tubes and four oil depletion units (with a pillar in each 
unit). The bottom PDMS layer consists of four open circles at the same positions as the 
oil depletion units in the top layer; (b) An enlargement of the oil depletion units.  
 
Figure 5.6:  (a) A schematic showing the separated top and bottom PDMS layers: (i) Top 
layer, (ii) Bottom layer; (b) An image showing a separation channel connected to two 
sides of pillar-structured oil depletion units and a channel for delivering droplets. 
 
Figure 5.7: A top view schematic of the microdevice during droplet injection experiment. 
One end of the droplet delivery tube is inserted into a side channel of the microdevice, 
while the other end is connected to the syringe pump to drive droplets towards a 
separation channel. An electric field is applied across the separation channel by placing a 
cathode in the buffer reservoir and an anode in the buffer waste reservoir. 
 
Figure 5.8: Illustration of the droplet injection process. (a) The injection of a mixture of a 
fluorescent dye and a food dye. (i) The microdevice prior to injection at t = 0 s, (ii) The 
first sample plug is injected into the separation channel (t = 50 s) and moves towards the 
anode, (iii) The first sample plug stops being injected at t = 53 s, (iv) The next sample 
plug is injected at t = 54 s (v) A sample plug is injected at t = 63 s, whilst the previous 
one is still being injected. Buffer solution leakage can be observed at the right oil 
depletion unit in each image; (b) A dead volume exists at the connection between the 
droplet delivery tube and the droplet delivery channel. Oil surrounding the droplets is 
thus accumulated and causes droplets merge prior to injection; (c) Diffusion of the sample 
into the oil depletion units. Experiments were performed at an infusing flow rate of 0.12 
µl/min and an electric field strength of 85.7 V/cm. 
 
Figure 5.9: Schematics illustrating the structure of “Design 2” for single or multiple 
separations (a) A schematic of the entire microdevice consisting of a top layer (solid 
lines) and a bottom layer (dashed lines) in PDMS. The top PDMS layer consists of two 
  29 
parallel separation channels with reservoirs at each end (the left reservoir is the “buffer 
reservoir” and the right reservoir is the “buffer waste reservoir”). The bottom PDMS 
layer is cut into two pieces and placed 2-3 mm apart beneath the top layer; (b) Schematics 
showing the separated top and bottom PDMS layers: (i) Top layer, (ii) Bottom layer 
before being cut and (iii) Bottom layer cut after oxygen plasma treatment. 
 
Figure 5.10: Schematics showing the experimental setup used for droplet injection using 
the interfacing microdevice “Design 2”. (a) The interfacing microdevice placed on 
droplet delivery tubes. Both tubes are on a PTFE membrane. The open channels are 
aligned to the mouths of the two droplet delivery tubes cut at 30° to the edge. The other 
ends of the tubes are connected to precision syringe pumps; (b) A platform to hold the 
microdevice during the experiments consists of two acrylic plates: a top plate and a 
bottom plate. The microdevice along with the tubes and the PTFE membrane is placed on 
the bottom plate of the platform, whilst the top plate is put on the microdevice to secure 
everything in place. There is a square cavity on the top plate at the position of the buffer 
reservoir so that a Pt electrode can be immersed into the buffer reservoir through the 
cavity. 
 
Figure 5.11: Droplet injections in parallel channels. (a) The injection of an analyte 
mixture droplet into the upper separation channel. (i) The droplet prior to injection at t = 0 
s, (ii) The droplet is injected at t = 1 s, (iii) The whole droplet is successfully injected and 
moves along the separation channel towards the anode at t = 2 s; (b) The injection of the 
analyte mixture droplet into the lower separation channel. (i) The droplet prior to 
injection at t = 107 s, (ii) The droplet is injected at t = 110 s, (iii) The whole droplet is 
successfully injected into the separation channel at t = 111 s. Some of the analyte mixture 
moves towards the anode (right arrow) but some moves in the opposite direction towards 
the cathode (left arrow). The arrows indicate the direction of the analyte mixture 
movement; (c) Droplet injection in the lower channel (right), while a droplet in the other 
tubing (left) moves towards the upper channel. 
 
Figure 5.12: Schematics illustrating the third generation interfacing microdevice with 
two open-channel structures. (a) Separated top layer and bottom PDMS layers (i) Top 
layer consisting of a T-junction droplet delivery channel with an expansion at the left and 
right sides to allow insertion of droplet delivery tube and a glass capillary, respectively. A 
buffer reservoir is placed at one end of the channel, whilst a buffer waste reservoir (not 
shown) is placed at the end of the capillary, (ii) Initial design of the bottom layer. A flat 
PDMS layer is cut and placed 2-3 mm separately after oxygen plasma treatment, (iii) 
Second design of the bottom layer. A rectangular, thin PDMS layer is removed after 
oxygen plasma treatment; (b) Entire microdevices after bonding the top and bottom layers 
(i) The top layer of microdevice bonded with the first design of the bottom layer “Design 
3.1”, (ii) The top layer of microdevice bonded with the second design of the bottom layer 
“Design 3.2”. 
 
Figure 5.13: Schematics illustrating the experimental set up used for droplet injection 
using the third generation interfacing microdevices. (a) “Design 3.1” with the separated 
bottom layer; (b) “Design 3.2” with the open, rectangular bottom layer. Both 
microdevices are configured in the same manner, i.e. droplet delivery tube and a glass 
capillary are inserted into the left and the right enlarged channels, respectively, and the 
open channel is placed on a PTFE membrane for oil depletion. A cathode is placed at a 
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buffer reservoir, while an anode is placed at a buffer waste reservoir for application of an 
electric field.  
 
Figure 5.14: Images showing the injection of droplets and the migration of droplet 
content towards the separation channel performed in microdevice “Design 3.1”. (a) A 
droplet leaves the mouth of the droplet delivery tube and moves into the droplet delivery 
channel; (b) The droplet content is accumulated at the mouth of the tube and its 
movement ceases; (c) After a period of time, the droplet contents start moving again. 
 
Figure 5.15: Schematics illustrating the fourth interfacing microdevices containing two 
similar open-channel designs. (a) Separated top and bottom PDMS layers: (i) Top layer of 
“Design 4.1” consisting of a round U-shaped droplet delivery channel, (ii) Top layer of 
“Design 4.2” consisting of a square U-shaped droplet delivery channel. Both designs 
consist of an enlarged channel in the middle of the U-shaped channel for insertion of 
droplet delivery tube, a buffer reservoir and the other enlarged channel for the insertion of 
a glass capillary at each end of the U-shaped channel, (iii) Bottom layer of both “Design 
4.1” and “Design 4.2” consisting of a rectangular open space on a PDMS sheet, which is 
cut after oxygen plasma treatment; (b) The entire microdevices after bonding: (i) “Design 
4.1”, (ii) “Design 4.2”. 
 
Figure 5.16: Schematics illustrating the process of droplet injection using the fourth 
generation of interfacing microdevices. (a) “Design 4.1” with a round U-shaped PDMS 
channel; (b) “Design 4.2” with a square U-shaped PDMS channel. Both microdevices are 
operated in the same manner. A droplet delivery tube is inserted into the enlarged channel 
at the middle of the U-shaped channel, while a glass capillary is inserted into the other 
enlarged channel. The entire microdevice is placed on a PTFE membrane, which serves 
as an oil depletion unit. A cathode is placed at a buffer reservoir, while an anode is placed 
at a buffer waste reservoir. 
 
Figure 5.17: Images showing the injection of a droplet in “Design 4.1”. The red dashed 
lines indicate the open PDMS channel of the microdevice. (a) A droplet moves towards 
the mouth of the droplet delivery tube; (b) The droplet contents form a spherical plug 
when the droplet reaches the open PDMS channel, while the oil is absorbed into the 
PTFE membrane underneath; (c) The droplet content migrates towards a glass capillary 
placed downstream (the movement direction indicated by a yellow arrow). 
 
Figure 5.18: An electropherogram of fluorescein obtained from droplet injections 
performed in the microdevice “Design 4.1”. Three fluorescein droplets were injected and 
detected inside a glass capillary. Each droplet was injected as single injection. The 
electric field used in this experiment was ~ 253 V/cm. 
 
Figure 5.19: Images showing the injection of a droplet performed using “Design 4.2”. 
The red dashed lines indicate the open PDMS channel of the microdevice. (a) A droplet 
enters the PDMS channel of the microdevice; (b) The droplet contents form a spherical 
plug; (c) The droplet content migrates along the PDMS channel and then into a glass 
capillary (with movement direction indicated by a yellow arrow). 
 
Figure 5.20: Images showing multiple injection of a droplet performed using Design 4.2. 
The red dashed lines indicate the open PDMS channel of the microdevice. (a) A part of a 
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droplet is injected into the PDMS channel; (b) The injected droplet content migrates 
along the PDMS channel, with material being left at the mouth of the tube; (c) Most of 
the droplet content migrates towards a glass capillary (the movement direction indicated 
by a yellow arrow), while a small portion of the droplet diffuses at the top and the bottom 
edges of the tube (blue arrows). 
 
Figure 5.21: An electropherogram of fluorescein obtained from droplet injections 
performed in a “Design 4.2” microdevice. Five fluorescein droplets were injected and 
detected inside a glass capillary. Each droplet was injected as multiple injections. 
 
Figure 5.22: Schematics and images depicting the structure of the fifth generation 
interfacing microdevices made of acrylonitrile butadiene styrene or ABS (a) Separated 
top and bottom layer: (i) Modified top layer from “Design 4.2” with four holes, (ii) 
Bottom layer with four post, (iii) A photograph showing the back of the top layer of the 
3D-printed microdevice, (iv) A photograph of the front of the top layer showing a 4 mm 
I.D. buffer reservoir, (v) A photograph of the bottom layer; (b) The entire microdevice 
after assembling: (i) A schematic showing inside the microdevice, (ii) A photograph of 
the assembled microdevice showing the buffer reservoir and the side channel for the 
insertion of a droplet delivery tube, (iii) A photograph of the assembled microdevice 
showing the buffer reservoir and the side channel for the insertion of glass capillary. 
 
Figure 5.23: A schematic showing the experimental set up of droplet injection using the 
fifth generation interfacing microdevice developed from “Design 4.2”. A PTFE 
membrane is cut into a small piece, folded and placed into the square hole of the bottom 
layer prior to being assembled with the top layer. Droplet delivery tube is inserted into the 
enlarged channel at the middle of the U-shaped channel, while a glass capillary is inserted 
into the other enlarged channel. A cathode is placed at a buffer reservoir, while an anode 
is placed at a buffer waste reservoir, which is a microcentrifuge tube (not shown) for the 
application of an electric field. 
 
Figure 5.24: Images showing hydrophilic testing on the surface of 3D-printed pieces of 
microdevices (a) Red food dye was dropped onto the surface of each 3D-printed piece. 
Before (right) and after (left) surface treatment with 10% SDS at 70°C for 2 hours; (b) 
Red food dye filled up the entire channel of the microdevice. 
 
Figure 5.25: Schematics depicting the structure of the sixth design of interfacing 
microdevices. (a) A schematic of the entire microdevice consisting of a top (solid lines) 
and a bottom (dashed lines) layer of PDMS; (b) Schematics showing the separated top 
and bottom PDMS layers: (i) The top layer consisting of a straight channel connected to a 
buffer reservoir at one end and an enlarged channel for the insertion of a glass capillary at 
the other end, (ii) The 2-3 mm separated PDMS bottom layer after plasma treatment. 
 
Figure 5.26: Schematics showing the experimental setup of droplet injection experiment 
using the sixth design of the interfacing microdevices. (a) A droplet delivery tube cut a 
30° angle at one end was placed onto a PTFE membrane, while the other end of the tube 
was connected to a syringe pump. The microdevice with an inserted glass capillary was 
then placed on the tube by aligning the PDMS channel onto the mouth of the tube; (b) An 
acrylic platform used to hold the microdevice consisting of two plates. The microdevice 
along with the tube, the glass capillary and the PTFE membrane is placed on the bottom 
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plate of the platform. The top plate is then put on the microdevice to secure everything in 
place. One Pt electrode is immersed into a buffer reservoir through a square cavity on the 
top acrylic plate, while the other Pt electrode is immersed into a buffer waste reservoir (a 
microcentrifuge tube which is not shown) placed at the end of the capillary. 
 
Figure 5.27: Images showing the injection of a fluorescein droplet. (a) A fluorescein 
droplet moves towards the mouth of the tube at the flow rate of 0.3 µl/min; (b) The oil 
surrounding the droplet is absorbed into a PTFE membrane, whilst fluorescein released 
from the droplet forms a spherical shape at the mouth of the tube; (c) Fluorescein is 
successfully injected into the PDMS channel (red dashed lines) and migrates under an 
electric field (333.33 V/cm) towards an anode. 
 
Chapter VI 
 
Figure 6.1: Illustrations of (a) one-piece and (b) two-piece droplet delivery tube. 
Figure 6.2: A photograph showing the assembly of the interfacing droplet-based 
microdevice on the old platform. 
 
Figure 6.3: Diagram showing the problems occurred in each part of the experiment. 
 
Figure 6.4: Images showing the leakage of a droplet due to the imperfect joining of two 
tubes (a) The leakage of a whole droplet (i) A droplet reaches the connection between two 
tubes, (ii) The droplet starts to leak into the sleeve, (iii) The rest of the droplet is leaking 
out; (b) The leakage of a part of a droplet. The droplet designated as “1” has the normal 
shape, while the shape of droplets designated as “2” and “3” is deformed after they pass 
the connection between two tubes. 
 
Figure 6.5: The injection of nine fluorescein droplets using “Design 6” interfacing 
microdevice. (a) An electropherogram of nine injected fluorescein droplets (designated 
from 1 to 9). In this experiment, the droplets were delivered to the mouth of the tube at 
the flow rate of 0.3 µl/min and injected to the open channel containing 0.1% SDS. 
Fluorescein released from droplets migrated into the 5-cm long glass capillary containing 
6% PEO 100 kDa in 0.05 M TRIS-CHES, 0.1% SDS, pH 8.5. The applied electric field 
during this experiment was 333.33 V/cm. The detection was performed at 1 cm from the 
injection point; (b) A scatterplot between the droplet volume and the fluorescence 
intensity of nine injected droplets with the correlation coefficient (r) of 0.9752 and the p-
value of 7.7×10-6. 
 
Figure 6.6: An electropherogram obtained from the injection of BSA-FITC droplets 
using “Design 6” interfacing microdevice. In this experiment, the droplets were delivered 
to the mouth of the tube at the flow rate of 0.3 µl/min and injected to the open channel 
containing 0.005 M TRIS-CHES, 0.1% SDS, pH 8.5. BSA-FITC released from droplets 
migrated into the 5-cm long glass capillary containing 6% PEO 100 kDa in 0.05 M TRIS-
CHES, 0.1% SDS, pH 8.5. The applied electric field during this experiment was 333.33 
V/cm. The detection was performed at 1 cm from the injection point. 
 
Figure 6.7: Electropherograms showing fluorescent protein standard (11-155 kDa) mixed 
with 0.18 µM fluorescein separated in 6% PEO 100 kDa in 0.05 M TRIS-CHES, 0.1% 
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SDS, pH 8.5 using the interfacing droplet-based microdevice “Design 6”. The droplets 
were delivered to the interfacing PDMS microdevice containing 0.005 M TRIS-CHES, 
0.1% SDS, pH 8.5 at the flow rate of 0.08 µl/min. The detection was around 2.5 cm from 
the injection point, while the total length of the system was 8.0 cm. The applied 
separation fields were (a) 81.25 V/cm; (b) 118.75 V/cm; (c) 125 V/cm and (d) 150 V/cm. 
Fluorescein peak was designated as (1) and protein ladder was designated as (2).  
 
Figure 6.8: A photograph showing the new platform to facilitate the assembly of 
interfacing droplet-based separation unit. Note: the PDMS microdevice shown in the 
photo was not the actual size used in the experiment. 
 
Figure 6.9: The overlay of electropherograms of fluorescein droplets injected in parallel 
channels of the interfacing droplet-based microdevice “Design 6”. Fluorescein peaks 
obtained from the above channel and from the below channel were illustrated as black 
line and red line, respectively. The droplets were delivered to the interfacing PDMS 
microdevice containing 0.005 M TRIS-CHES, 0.1% SDS, pH 8.5 at the flow rate of 0.1 
µl/min. The detection was around 1.3 cm from the injection point, while the total length 
of the system was 6.0 cm. The applied electric field was ~ 217 V/cm. The detection was 
performed at 1.3 cm from the injection point. 
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1.1 Importance of studying cells and cellular contents (i.e. proteins) 
All living organisms can be categorized as being either unicellular (single-celled) or 
multicellular. Unicellular organisms are the simplest organisms consisting of only one 
cell (e.g. bacteria and protozoa), while multicellular organisms (e.g. plants and animals) 
are far more complex1,2. A typical human, for example, contains around 37 trillion cells 
that work in a concerted manner to support life3. All biological processes in both 
unicellular and multicellular organisms are known to occur at the cellular level1. By 
differentiating between cell types and understanding how cells work and respond to 
different environments, advanced biological sciences that accelerate medical diagnoses 
and improve medical therapies can be more easily developed4. Studies of both cells and 
their contents are therefore important in providing a more comprehensive understanding 
of biological functions and mechanisms occurring throughout an organism.  
 
 
Table 1.1: Estimated gross molecular contents of a typical 20-micron human cell5 
 
Molecule Mass % MW 
(daltons) 
Number of 
Molecules 
Molecule % Number of 
Molecular Types 
Water 65% 18 1.74 x 1014 98.73% 1 
Other Inorganic 1.5% 55 1.31 x 1012 0.74% 20 
Lipid 12% 700 8.4 x 1011 0.48% 50 
Other Organic 0.4% 250 7.7 x 1010 0.04% ~200 
Protein 20% 50,000 1.9 x 1010 0.01% ~5,000 
RNA 1% 1 x 106 5.0 x 107 3 x 10-5 % ---- 
DNA 0.1% 1 x 1011 46 3 x 10-11 % ---- 
TOTALS 100% ---- 1.76 x 1014 100% ---- 
 
 
A generic human cell (a few tens of microns in diameter) consists of water (98.73%), 
other inorganics (0.74%), lipid molecules (0.48), organics (0.04%), proteins (0.01%), 
RNA (3x10-5%) and DNA (3x10-11%)5. Of all the cell components, proteins exhibit the 
widest variety in their molecular identity (Table 1.1) despite only comprising 0.01% of 
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the total molecular composition. Such a large diversity of protein types suggests the 
distinct and varied functions they play. The importance of proteins in cells can also be 
confirmed by inspection of the system interaction map between proteins in a fruit fly cell 
(Figure 1.1)1. This map pictorially shows how each protein relates or interacts with other 
cellular proteins and how a change in one protein affects others.  
 
 
 
 
 
 
 
 
 
 
Figure 1.1: A system map illustrating the interactions between proteins in a fruit fly cell constructed from 
databases of known proteins and their interactions. The map shows 3,500 proteins (dots) located at different 
cellular positions with their interaction network (lines). Image reproduced from reference 1. 
 
 
Proteins are widely recognized as one of the most important classes of biomarkers for 
many diseases including bladder cancer6, breast cancer7,8, colorectal cancer8, esophageal 
cancer8,9, liver cancer10, lung cancer8,11, leukemia8, kidney cancer12, ovarian cancer13, 
prostate cancer8,14, pancreatic cancer13, cardiovascular disease15, Alzheimer’s disease16, 
tuberculosis17 and severe acute respiratory syndrome (SARS)17. Variations in the amount, 
structure and function of proteins associated with a disease can be used to discriminate 
between healthy and diseased individuals and may be effective at identifying the presence 
of the disease at an early stage18,19. Moreover, studies of proteins can be used to elucidate 
disease mechanisms and predict the response of patients to treatments or side effects that 
might occur13. In recent years, proteins have also become central figures in the process of 
drug development by serving as therapeutic targets used to monitor the efficacy of 
medical treatments20. Accordingly, the study of proteins expressed in cells, tissues or 
organisms (proteomics) has attracted increasing attention in recent years since a 
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comprehensive understanding of proteomes (the entire protein compliment in a cell, 
tissue or organism expressed by a genome21) will almost certainly lead to the discovery of 
novel biomarkers and the development of diagnostic tools and novel drug therapies22, 23,24.  
 
1.2 Proteins  
Proteins are biological macromolecules found in every cell in a living organism. 
Thousands of different proteins have been identified and characterized. They range from 
low to high molecular weight and exhibit a diversity of biological functions. These 
include catalytic proteins (or enzymes), regulatory proteins (or hormones), antibodies, 
structural proteins (such as muscle fibres, hair, horn, wool, nails and feathers) and 
proteins involved in cell-cell recognition etc1,2,18 (Figure 1.2a). Proteins are polymeric 
molecules formed from a linear chain of amino acid residues. Standard amino acids can 
be categorized into five groups based on their chemical properties. Members of the first 
group contain a nonpolar, uncharged aliphatic R group and consist of glycine, alanine, 
proline, valine, leucine, isoleucine and methionine. Members of the second group possess 
an aromatic R group and consist of phenylalanine, tyrosine and tryptophan. Molecules in 
the third contain a polar, uncharged R group and consist of serine, threonine, cysteine, 
asparagine and glutamine. The fourth group consists of lysine, arginine and histidine, 
where each contains a basic polar and positively charged R group, whereas the final group 
consisting of aspartate and glutamate contains a negatively charged R group2.  
 
Proteins normally exhibit four distinct aspects of structure, termed primary structure, 
secondary structure, tertiary structure, and quaternary structure (Figure 1.2b). The 
primary structure of a protein consisting of a linear polypeptide chain simply refers to the 
linear sequence of amino acids in the chain. The secondary structure of a protein is 
established by the formation of hydrogen bonds between amino groups (NH) and 
carbonyl groups (CO) on the same polypeptide chain (yielding an alpha helix or a rod-
like structure) or on different polypeptide chains (yielding a beta sheet structure). In an 
aqueous system, when an alpha helix or a beta sheet polypeptide chain arranges itself so 
that its hydrophobic side chains point inside to form a non-polar core and its hydrophilic 
side chains point outside towards the solution, a tertiary structure (a globular compact 
three-dimensional structure) forms. In addition to the tertiary, multiple-subunit proteins 
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possess a quaternary structure. A dimer consisting of two identical subunits is the 
simplest form of quaternary structure25. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2: (a) Examples of proteins as functional components in nature; (b) Hierarchy of protein structure 
from the most complicated to the simplest structures (i) Quaternary structure consisting of 4 subunits called 
a tetramer, (ii) Tertiary structure defining the compact globular structure of a protein, (iii) An alpha helix 
describing secondary structure of a protein, (iv) Primary structure defined by the sequence of a linear 
polypeptide chain. Image (b) adapted from reference 2. 
 
 
Figure 1.3: (a) General structure of an amino acid; (b) Formation of a peptide bond between two amino 
acids (i.e. alanine and serine). Images reproduced from reference 18.  
 
 
Two amino acid residues (Figure 1.3a) can be covalently joined via a peptide bond 
(between a carboxylate group on one amino acid and an amino group on the other amino 
acid) to form a dipeptide (Figure 1.3b)2,18. When a large number of amino acid residues 
are joined, a polymer chain of amino acids known as a polypeptide forms. Although 
(a) (b) 
(a) (b) i. ii. 
iii. 
iv. 
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proteins may consist of one or more polypeptides spontaneously folded into a specific 
conformation, only polypeptides having molecular weights of more than 10,000 are 
classified as proteins1,2.  
 
 
 
 
 
 
  
 
 
 
 
Figure 1.4: Protein synthesis (a) Transcription: A DNA double helix comprises a coding strand (read from 
the 5’ end to 3’ end) and a template strand (read from the 3’ end to 5’ end). During transcription, RNA 
polymerase finds a promoter sequence on the coding strand and attaches to the DNA. It then unwinds a 
short length of the double stranded DNA and separates the two DNA strands. The new RNA strand is then 
constructed by adding a new nucleotide that complements the nucleotide on the template strand at the 3’ 
end. This process is repeated as the RNA polymerase moves along the template strand and stops when the 
enzyme reaches a termination sequence. The generated mRNA then migrates to the cytoplasm26; (b) 
Translation: First, a small ribosomal subunit attaches to the mRNA at the 5’ end and then moves along the 
mRNA strand to find a start codon - a set of three bases. The first tRNA carrying the amino acid 
(methionine) with an anticodon pairs the anticodon with the start codon on the mRNA strand. In the 
meantime, a large ribosomal subunit joins the small ribosomal subunit and the first tRNA. Another tRNA 
molecule with an amino acid will bind its anticodon to the next matched codon inside the ribosome. When a 
peptide bond is formed between two amino acids, the first amino acid (methionine) leaves its attached 
tRNA. The process repeats again and again until the ribosome reaches a stop codon and the produced 
protein is then released27. Image (a) and (b) adapted from reference 1. 
(a) 
(b) 
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Each protein is constructed from a specific sequence of amino acids that is controlled by 
genetic information. Protein synthesis occurs via the processes of transcription and 
translation. During transcription, genetic information encoded from a template strand of 
deoxyribonucleic acid (DNA) is transferred to a messenger ribonucleic acid (mRNA). 
This process occurs in the nucleus of a cell (Figure 1.4a). The mRNA migrates from the 
nucleus into the cytoplasm where translation takes place. Protein translation involves four 
main components; mRNA, transfer RNA (tRNA), amino acids and ribosomes, that 
decode and translate the genetic information from the mRNA to a protein chain (Figure 
1.4b)26,27. 
 
1.3 Conventional methods for high-throughput biological analysis 
In biological research, the ability to assay or screen small volumes of analytes in an 
automated and rapid fashion is of critical importance. Conventionally, high-throughput 
analysis of biological samples is performed by parallel compartmentalization (e.g. using a 
well plate) or serial compartmentalization (e.g. by flow injection analysis).  
 
 
Figure 1.5: (a) Parallel compartmentalization using a well plate; (b) Serial compartmentalization using 
flow injection analysis. Images reproduced from reference 28.  
 
 
(a) 
(b) 
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In a well plate format, a sample is pipetted using a multichannel pipette into each well 
containing different reagents or different analytical conditions. Reaction products can be 
assayed using a plate reader in which an (optical) detector scans over or images (Figure 
1.5a)28. Commercially available well plates are normally limited to 3456 wells with a 
minimum volume of ~1 µl29,30. In flow injection analysis, the sample is introduced into 
different reagent plugs (separated by a buffer solution) as the reagent flows along a length 
of tube. Reaction products are assayed when they pass through a downstream detector 
and signals as a function of elution times are extracted (Figure 1.5b)28. The use of well 
plates requires precise control of both fluid handling and is limited by potential 
evaporation of sample when using small well volumes. On the other hand, flow injection 
analysis encounters different problems. For example, dispersion has the potential to cause 
cross contamination between adjacent reagent zones and also presents difficulties in 
controlling reaction times and sample dilution28. In addition, complete automation of the 
analytical process when operating at high-throughput is difficult to achieve when 
conventional compartmentalization is utilized. To address these problems, the use of 
microfluidic systems for these analyses has been increasingly investigated in recent years.  
 
1.4 Microfluidics:  a new tool for biological analysis  
Microfluidics defines the transportation and manipulation of ultra small volumes of fluid 
(typically between 10-9 to 10-15 litres)31 within closed conduits having cross-sectional 
dimensions most conveniently measured in microns31,32. Such closed channels are 
generally constructed in substrates such as silicon, quartz, glass, and polymers (e.g. 
polydimethylsiloxane or PDMS and poly (methyl methacrylate) or PMMA)33. When 
functional processes such as sample introduction, sample pre-treatment, chemical 
reaction, product separation, and detection are integrated within a single microfluidic 
device, a micro total analysis system (µTAS) or Lab-on-a-Chip (LOC) is formed34. The 
miniaturization and integration of such processes within a single device affords short 
analysis times32,35, portability34,35,36, system automation31,37, parallelization and high 
analytical throughput37,38, minimal usage of sample and reagents32,36, minimal waste 
generation31, superior heat and mass transfer32 and low-cost mass production39. Some of 
the key advantages of using microfluidic devices are a result of the vastly reduced 
diffusion lengths (and hence reduced mixing times when operating under laminar flow 
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conditions) and the huge increase in the reactor densities, which in turn increases the 
amount of chemical or biological information that can be extracted per unit time (Table 
1.2). 
 
 
Table 1.2: Some key device characteristics at three values of a characteristic length d 35 
 
Length d 1 mm 100 µm 10 µm 
Volume 10-6 L 10-9 L 10-12 L 
No. of molecules at 1 µM 6×1011 6×108 6×105 
Diffusion time 15 min 10 s 100 ms 
Arrangement 25 
volumes/cm2 
2500 
volumes/cm2 
25×105 
volumes/cm2 
Arbitrary information density 1.5 
values/mincm2 
250 
values/scm2 
2.5×106 
values/scm2 
 
 
Due to the advantages that microfluidic systems offer, an enormous number of 
applications ranging from chemical synthesis and analysis40,41, high-throughput 
screening42,43,44, clinical diagnostics41,45,46, DNA analysis41,47 and cell-based assays48,49 
have been reported over the past two decades. Although microfluidic systems offer 
significant advantages when compared to macroscale platforms, single phase flows are 
still limited in some respects, e.g. in terms of sample dilution, cross contamination of 
reagent zones, difficulty in controlling reaction times, adsorption of reagents onto channel 
walls28. To eliminate these problems and to increase the potential of microfluidic 
technology in biological analysis, the compartmentalization of reagents in droplets 
dispersed in an immiscible carrier fluid has recently been used to good effect28,39. 
 
1.5 Droplet-based microfluidics 
Droplets produced in microchannels, so-called microdroplets, typically have dimensions 
of a few microns39 and volumes ranging from femtolitres to nanolitres50. Microdroplets 
are formed within microfluidic channels when a continuous phase (which normally wets 
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the microchannel walls) encloses a dispersed and immiscible phase. Droplets can be 
generated by various means but the most common methods that allow production of 
highly monodisperse droplets (<1-3% dispersity)50 at high formation rates (up to several 
kHz)51 involve the use of T-junctions and flow-focusing geometries39,50. 
 
For a T-junction geometry (Figure 1.6), a dispersed phase (normally aqueous) is injected 
perpendicularly to a continuous immiscible phase resulting in droplet generation through 
shear force and interfacial tension at the interface between the two fluids28,39. By 
changing fluid flow rates, channel widths or the relative viscosity between the two fluids, 
the size of droplets can be controlled52.  
 
 
 
 
 
 
 
 
Figure 1.6: Microdroplet formation using a T-junction. In this case, an aqueous phase (i.e. water) is 
injected into a continuous oil phase. Image reproduced from reference 54. 
 
 
Varying droplet contents or achieving concentration gradients using T-junction 
geometries can be accomplished with some limitations. For example, concentration 
gradients obtained by varying flow rates of sample and diluent as shown in Figure 1.7 are 
limited by the need to adjust flow rates at each step to achieve serial concentration-
gradient droplets, which in turn significantly lengthens the entire process53.  
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Figure 1.7: A Schematic showing concentration-gradient droplets formed in a T-junction geometry by 
varying sample (red) and diluent (light grey) flow rates in which the magnitude of flow rates are indicated 
by the size of the arrows. The dark grey represents the oil phase. Image reproduced from reference 53.  
 
 
In the case of a flow-focusing geometry, a dispersed phase flows through a central 
channel that is sandwiched by a continuous phase flowing through two flanking channels. 
Both phases are then forced to flow through a small orifice, which is placed downstream 
as shown in Figure 1.8. The formation of droplets in or beyond the orifice occurs due to 
pressure and viscous stresses provided by the outer continuous phase28,39. Although the 
configuration of the flow-focusing is marginally more complicated than that of the T-
junction, it allows the production of small or viscous droplet populations exhibiting low 
size dispersions28,39.  
 
 
 
 
 
 
 
 
 
Figure 1.8: Microdroplet formation using a flow-focusing geometry (a) Water flows from the middle 
channel and is sandwiched by oil flowing from the two side channels into an orifice. Water-in-oil droplets 
are formed downstream of the orifice; (b) Droplets are generated when the aqueous and oil phases pass 
through the orifice. In the absence of surfactants, small droplets may merge and form larger droplets after 
generation. Image reproduced from reference 55.  
 (a) (b) 
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In a channel containing continuous and miscible microflows, liquid typically moves 
under laminar flow, which can be characterized by the dimensionless Reynolds number 
(Re). Re defines the ratio of inertial and viscous forces and can be calculated according to 
Equation 1.1 as 
 
     !" =  !"#!         (1.1) 
 
where ρ is the density of the fluid (kg/m3),  ν is the fluid velocity (m/s), d is characteristic 
dimension or tube diameter (m) and η is the dynamic viscosity of the fluid (kg/ms)40. 
 
Laminar flow normally occurs when Re values are significantly below 200056. Under 
laminar flow conditions, the mixing of reagents only occurs through diffusion of fluid 
elements orthogonal to the flow direction. On the other hand, reagent mixing within a 
segmented flow may be accelerated by chaotic advection28. Here, a droplet consisting of 
multiple reagents moving along a straight channel exhibits convection within each half of 
the droplet (two symmetrical halves form on the left and the right of the droplet with 
respect to the flow direction), with diffusion only occurring across the interface between 
the two halves (Figure 1.9a). However, the movement of a droplet along a winding 
channel allows for chaotic advection in which reorientation at the interface of the two 
halves as well as the stretching and folding of the contained striations leads to an 
exponential reduction in diffusional distances and thus mixing times (Figure 1.9b)28.  
 
 
 
Figure 1.9: (a) Mixing in droplets flowing in a straight channel (b) Mixing in droplets flowing in a winding 
channel. Images reproduced from reference 28.  
  
(a) (b) 
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Droplets formed within microchannels can be manipulated in many ways to fulfill a range 
of unit operations. Various concentration gradients in droplets can be achieved by 
controlling the flow rates of either the sample or reagent streams28,53. Importantly, to 
examine multiple reaction conditions against a single sample, a cartridge technique can be 
used, where the sample is introduced via a T-junction into pre-formed droplets containing 
various reagents28,53. Droplet contents can also be varied by directly introducing reagents 
to droplets via side channels28. Furthermore, serial dilution of droplet contents can be 
performed by adding diluent droplets to a large ‘mother droplet’ to generate diluted 
‘daughter’ droplets57. Different sample or reagent droplets can also be sequentially 
generated using automated droplet generators that provide for droplet-on-demand 
platforms53,58,59. Other droplet-based manipulations that enable complex chemical and 
biological experimentation include droplet merging, splitting, sorting, and trapping28,39,51. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Figure 1.10: Droplet manipulations (a) Passive merging of two adjacent droplets60 (b) Sequential splitting 
of droplets61 (c) Dielectrophoretic sorting62 (d) Droplet trapping arrays63  
 
(a) (b) 
(c) (d) 
100 µm  
50 µm  
75 µm  
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Droplet merging and splitting operations allow multi-step reactions to be performed with 
significant operational and configurational flexibility28 since the initiation and termination 
of reactions can be controlled with precision. For example, Figure 1.10a shows the 
passive merging of two adjacent droplets using a pillar-array device developed by Niu 
and co-workers60. In addition, Link and co-workers61 reported the use of a hierarchical T-
junction device to facilitate the sequential splitting of droplets, as shown in Figure 1.10b. 
Another key droplet manipulation operation is droplet sorting. This allows the separation 
of the droplet of interest from a larger droplet population52. Figure 1.10c shows droplet 
sorting by means of dielectrophoresis. In this case, droplets migrate into one of two 
branches depending on the electrode charge62. Moreover, droplet trapping is very useful 
for the investigation of chemical and biological experiments that need extended times to 
proceed, such as cell incubation and protein expression50. Figure 1.10d shows an 
example of droplet trapping in which each droplet is localized and stored inside a trap for 
further investigation prior to being released63. 
 
In conclusion, the utilization of droplet-based formats not only provides for the same 
advantages as continuous-flow microfluidic systems, but crucially prevents the dilution, 
dispersion and cross-contamination of the analytes. Furthermore, an extraordinary large 
number of different reaction conditions can be screened in ultra-short times. This 
provides for a novel and direct route to high-throughput screening of biological samples. 
 
1.6 Protein analysis  
Proteins represent only about 0.01% of the molecular population contained within a 
human cell, but can be categorized into approximate variants (Table 1.1)5. This means 
that most protein types are present in a cell at very low analytical concentrations. For this 
reason, proteins of interest normally must be separated and purified from cellular 
organelles and other proteins prior to analysis. Cells can be lysed by several methods 
(based on physical, chemical, optical, electrical and acoustic methods64,65) to release the 
contained materials into solution. Unfortunately, this almost always (on the macroscale) 
results in extreme dilution of the contained materials including proteins. The solution is 
then centrifuged to fractionate subcellular contents or organelles on the basis of size 
(Figure 1.11a). It is also possible to separate subcellular contents that differ in density by 
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means of isopycnic centrifugation in which subcellular contents migrate in a medium 
containing step gradients of density and stop when they reach a point where their density 
matches the density of the medium (Figure 1.11b).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.11: Schematics of (a) Differential centrifugation and (b) Isopycnic centrifugation. For differential 
centrifugation, subcellular contents are fractionated based on their sizes. At low speeds and shorter 
centrifugation times, larger particles are precipitated at the bottom of the tube, while smaller particles 
remain in a supernatant. Repeated centrifugations at higher speeds and for longer times allow fractionation 
of the remaining subcellular contents. For isopycnic centrifugation, subcellular contents are fractionated 
based on their densities. Components migrate along a sucrose density gradient and stop moving when they 
reach a location in the gradient that matches its density. Images reproduced from reference 2.  
(a) 
 
(b) 
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To extract proteins of interest from fractionated cellular components, salt (ammonium 
sulfate) is added to precipitate the proteins out of solution. The solution containing 
proteins of interest is then dialysed to remove other particulates (Figure 1.12). Proteins 
remaining in the dialysis bag or tube can then be further fractionated using column 
chromatography.  
 
  
 
  
 
 
 
 
 
Figure 1.12: Dialysis. Only small molecules can penetrate through a membrane of a dialysis bag or tube, 
while proteins are retained inside the dialysis bag or tube. Image reproduced from reference 66. 
 
 
The primary chromatographic methods used in protein separation are ion-exchange 
chromatography (Figure 1.13a), size-exclusion chromatography (Figure 1.13b) and 
affinity chromatography (Figure 1.13c). Ion-exchange chromatography is used to 
separate proteins based on differences in charge. In this method, a column is packed with 
charged polymer particles, called cation exchangers if polymer particles are negatively 
charged and anionic exchangers if polymer particles are positively charged. Figure 1.13a 
illustrates a column packed with negatively charged polymer beads. In this case, 
negatively charged proteins will migrate faster and elute earlier than positively charged 
proteins since the latter will bind with the negatively charged beads within the column, 
which in turn retards their migration rate. Size-exclusion chromatography separates 
proteins on the basis of their sizes. In this method, larger proteins elute faster than smaller 
ones because the smaller proteins are able to enter pores of polymer beads packed in a 
column (and thus spend some time in the pores prior to elution), whilst larger proteins 
cannot enter these pores and thus take less time to pass through the column as shown in 
Figure 1.13b. In affinity chromatography, the stationary phase consists of polymer beads 
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bound by a particular chemical group (or ligand). Proteins having a binding affinity for 
the ligand will bind to the polymer beads, while other proteins are washed out. The 
ligand-bound proteins are then eluted by adding ligand solution (Figure 1.13c)2. All the 
above methods separate proteins on the basis of differences in charge, size and binding 
affinity. Proteins can also be separated using electrophoresis2,25. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.13: (a) Ion-exchange chromatography (b) Size-exclusion chromatography (c) Affinity 
chromatography. Images reproduced from reference 25. 
 
1.7 Electrophoresis 
Electrophoresis is a well-established separation technique that provides for the rapid and 
efficient separation of charged species67. When charged species migrate under an applied 
electric field, they separate based on the differences in their electrophoretic mobilities, 
which are controlled by the charge-to-mass ratio68. In simple terms, an ion of small size 
and high charge will move faster than an ion of large size and low charge68. 
Electrophoresis can be broadly categorized into three major experimental formats: slab 
(a) (b) 
(c) 
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gel electrophoresis, capillary electrophoresis and microchip (or chip-based) capillary 
electrophoresis69. 
 
1.7.1 Slab Gel Electrophoresis (SGE) 
Slab gel electrophoresis involves the use of a gel layered into a flat sheet as a support 
medium for electrophoresis. SGE has commonly been used to perform DNA analysis 
(due to the fact that DNA fragments of varying size will have essentially the same charge-
to-mass ratio, and thus cannot be separated using free zone separations) and two-
dimensional separations of proteins70. In the common vernacular slab gel electrophoresis 
usually refers to the separation of molecules in a polymer-based sieving medium. 
Typically, the gel is made from a cross-linked polyacrylamide or cellulose matrix, which 
acts as a molecular sieve71. To perform a separation, proteins are firstly linearized (or 
denatured) by heating in the presence of excess sodium dodecyl sulfate (SDS) and a 
reducing agent (such as β-mercaptoethanol or dithiothreitol)71,72. SDS hydrophobically 
and uniformly binds to linearized proteins. This binding interaction results in SDS-protein 
complexes with a net negative charge and with the charge-to-mass ratio of each SDS-
protein complex being similar. SDS-protein complexes will, therefore, move under an 
applied electric field through a sieving matrix at a velocity defined by their molecular 
weight or size (Figure 1.14). For instance, a smaller protein will move more easily and 
more quickly through a sieving matrix than a larger one. Finally, separated proteins are 
stained with a dye such as Coomassie blue for visualization2,72. 
 
 
 
 
 
 
 
 
 
Figure 1.14: Slab gel electrophoresis. Smaller proteins can pass through the pores of a gel with ease and 
will, therefore, elute faster than larger proteins. Image reproduced from reference 25.  
 Chapter I  
 
 53 
Another form of slab gel electrophoresis used in protein analysis is isoelectric focusing 
(IEF). Isoelectric focusing is a variant of electrophoresis utilized to separate amphoteric 
molecules containing both positively and negatively charged groups73. Amphoteric 
molecules, e.g. peptides and proteins, can exhibit a net positive or negative charge 
depending on the pH of the surrounding environment74. At a specific pH where positive 
and negative charges in an amphoteric molecule are balanced, an amphoteric molecule 
will be neutral; the specific pH being defined as the isoelectric point (pI) of the 
molecule73,74.  
In order to perform IEF, a mixture of carrier ampholytes (amphoteric molecules that are 
aliphatic, oligo-amino, oligo-carboxylic acid molecules75,76 of varying length and 
branching and having molecular weight of around 200 to 100074,77) is combined with an 
anti-convective polymer (e.g. polyacrylamide) and placed on a glass or plastic plate. This 
plate is placed between two electrodes, which are in contact with electrolyte solutions: an 
anode immersed in an anolyte (a low pH electrolyte solution) and a cathode immersed in 
a catholyte (a high pH electrolyte solution)74. When an electric field is applied, each 
ampholyte starts to move toward an appropriate electrode and will stop when a zero net 
charge is achieved (i.e. when the pH equals the pI). More acidic carrier ampholytes will 
migrate towards the anode, while more basic carrier ampholytes will migrate towards the 
cathode. When the system is in equilibrium and all ampholytes have stopped, the pH 
gradient (the arrangement of carrier ampholytes according to their pI) is established73,74,78. 
Subsequently, a protein mixture is added to the stable pH gradient gel. Proteins will 
migrate under the influence of an electric field until they reach a location where pH is 
equivalent to their pI and the separated zones visualized using dyes or stains after 
focusing2,74. 
Although both of the slab gel electrophoresis embodiments can be employed to separate 
proteins successfully, they are laborious, complex and time-consuming. Moreover, low 
voltages can only be used since heat dissipation in large volume systems is poor. 
Improvements in slab gel IEF have been realized by replacing the slab gel with an 
immobilized pH gradient (IPG) strip24,79. However, automatic operation and data 
acquisition are still difficult to achieve. Therefore, “capillary” electrophoresis formats 
have been introduced to solve these problems74.	  
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1.7.2 Capillary Electrophoresis (CE)  
Capillary electrophoresis (CE) takes place in narrow-bore capillary tubes normally having 
an inner diameter (I.D.) between 20 and 100 µm73. Over the past 30 years, CE has 
emerged as a useful separation tool in chemical, biochemical and pharmaceutical 
applications due to distinct advantages over the conventional slab gel format19,20. For 
example, CE can provide for highly automated, rapid, and high-efficiency separations of 
either charged or neutral molecules using minute amounts of sample. In addition, heat 
dissipation in small-bore capillaries is far more efficient than in slab gel electrophoresis 
because of the significantly higher surface-to-volume ratios. This allows high applied 
potentials to be used, leading to faster and more efficient separations19,67. 
The evolution of capillary electrophoresis began in the late 19th century67. However, it 
was defined as free solution electrophoresis in capillaries in 1967 when Hjertén80 
performed the first free solution capillary electrophoresis in a tube having inner diameter 
of 3 mm. Later in 1979, Mikkers et al.81 reported the use of polymer capillaries having 
inner diameters of 200 µm. In 1981, Jorgenson and Lukacs82 introduced the standard 
theory and practical embodiment of glass capillary electrophoresis with capillary 
diameters less than 100 µm. Since then a wide range of applications that utilize CE as an 
analysis tool has been developed and reported67.  
 
1.7.2.1 Capillary electrophoresis formats  
Capillary electrophoresis can be operated in various modes including capillary zone 
electrophoresis (CZE), capillary gel electrophoresis (CGE), capillary isoelectric focusing 
(cIEF), micellar electrokinetic capillary electrophoresis (MEKC), capillary 
isotachophoresis (cITP), and capillary electrochromatography (CEC)67,73. These modes 
are commonly used for the separation of biomolecules such as DNA, proteins, peptides 
and amino acids19,20,83 and will therefore be introduced briefly. 
Capillary zone electrophoresis (CZE), also known as free-solution capillary 
electrophoresis (FSCE)84, is the simplest and most widely used form of CE used to 
separate charged molecules. Separation is simply based on differences in electrophoretic 
mobilities, which are governed by molecular size and charge. The velocity of charged 
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molecules travelling along a capillary filled with a conductive buffer solution and with an 
applied voltage across a channel is also defined in large part by electroosmotic flow or 
EOF67,85.  
Capillary gel electrophoresis (CGE) is a common mode of CE directly related to 
conventional slab gel electrophoresis. It makes use of a molecular sieving matrix, and 
results in the separation of compounds based on their molecular sizes. In simple terms, 
larger molecules can pass through the pores of the gel matrix less easily than smaller 
ones. As a result, larger molecules take more time to migrate to the detector. The 
molecular sieving matrix also helps to reduce broadening of analyte bands that occurs as 
a result of solute diffusion and convection currents caused by temperature gradients 
during electrophoresis67,84. The presence of a molecular sieving matrix has also been 
shown to minimize electroosmotic flow and to prevent the adsorption of solute onto 
capillary walls67. As mentioned in Section 1.7.1, slab gel and capillary gel electrophoresis 
have been extensively used in DNA sequencing86,87. For protein separations, Karger et al. 
introduced the use of cross-linked polyacrylamide gels containing SDS as a sieving 
medium for high-efficiency separation of proteins88. This technique is called capillary 
sodium dodecyl sulfate - polyacrylamide gel electrophoresis or capillary SDS-PAGE, and 
provides significant advantage in DNA, protein and polynucleotide analysis72.  
Due to the problems associated with conventional slab gel IEF described earlier, Hjertén 
and Zhu89 first proposed the IEF separation of proteins in 200 µm I.D. glass capillaries. 
The separation principle in cIEF is similar to IEF. However, after focusing, separated 
zones can be removed from a capillary by establishment of a pressurized flow or by 
adding salt to the anolyte or catholyte. The latter results in a pH imbalance gradient that 
makes the focused analyte zones migrate. The utilization of cIEF allows for the use of 
high voltages, which in turn increases both resolution and decreases separation speed67. 
 
Micellar electrokinetic capillary electrophoresis or MEKC is one of the most useful CE 
modes for neutral biomolecular separations and was introduced by Terabe and co-
workers90 in 1984. This mode involves the addition of an ionic surfactant above its 
critical micelle concentration (CMC) into a buffer solution to form micelles that serve as 
a pseudostationary phase91, while EOF acts as a mobile phase92. Commonly, SDS is used 
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as the surfactant since it forms anionic micelles with hydrophobic tails pointing into the 
centre of the micelles and hydrophilic heads pointing outwards into the buffer solution. 
The anionic SDS micelles are negatively charged on the surface and hence, they tend to 
move towards the anode. However, in a bare fused silica capillary at neutral or basic pH, 
the flow of EOF toward the cathode is much greater than the electrophoretic migration of 
the SDS micelles. Consequently, SDS micelles migrate towards the cathode at a slower 
velocity than the bulk solution. For example, when neutral molecules are separated by 
MEKC, each neutral molecule will interact differently with micelles depending on its 
hydrophobicity. In other words, highly hydrophobic, neutral molecules will spend more 
time inside the micelles and will migrate at the same rate, whereas highly hydrophilic, 
neutral molecules stay in a bulk solution and will migrate at the bulk solution flow rate. 
Thus, MEKC makes the separation of neutral molecules possible67. 
 
Capillary isotachophoresis (cITP) is an electrophoresis mode established through use of a 
discontinuous buffer system and separates ionic species based on differences in their 
electrophoretic mobilities67. An isotachophoretic separation has a leading electrolyte (LE) 
and a terminating electrolyte (TE) placed at different sides of the capillary. In this format 
the sample ions are placed between the LE and TE. The LE contains “leading ions” with 
the same charge as the sample ions but higher mobility, while the TE contains 
“terminating ions” of the same charge as the sample but lower mobility than all the 
sample ions93,94. During separation, a mixture of analytes is injected between the LE and 
TE and a constant electric field is applied. The polarity of the electric field is chosen 
depending on the charge of the leading ion. Application of the field will result in a low 
potential drop across the LE zone and a high potential drop in the TE zone. Analytes will 
migrate slowly in the LE zone and faster than the TE co-ions in the TE zone, resulting in 
a focusing of the analyte ions. The process of isotachophoresis, like IEF, can be divided 
into two steps. The first step involves the separation of the ions and the migration velocity 
of the individual ions in the mixed zones is different. In the second part a steady state is 
achieved, the ions have already separated from one other and all move with the same 
velocity. Consequently, once steady state is reached, the mixed zone disappears and the 
analyte components are completely separated between the LE and TE zones. Other buffer 
elements include counter ions, which aid in buffering and imaging (i.e. counter ions 
absorb more UV light compared to the sample ions enabling their detection). Detection is 
 Chapter I  
 
 57 
performed downstream of separation and the length of each analyte band/zone can then 
be measured for quantitative analysis93,94,95. 
 
Capillary electrochromatography (CEC) is based on the marriage of capillary 
electrophoresis (CE) and high-performance liquid chromatography (HPLC). Here 
separation occurs in a small bore capillary packed with a particulate stationary phase, 
employing EOF to drive the mobile phase through the packed capillary. The order of 
elution depends on both the interaction of analytes with the stationary phase and 
electrokinetic migration velocities. Significantly, solute band dispersion is dramatically 
reduced in CEC, due to the plug flow profile, thus providing for exceptional separation 
efficiencies and peak resolution when compared to HPLC96,97.  
 
CE has been utilized in a wide range of applications over the past 30 years. For example, 
CZE, cIEF, MEKC and CEC (often coupled with mass spectrometry) have been used to 
determine a range of metal species such as selenium, arsenic, chromium, iron, mercury, 
aluminum, and zinc in biological and environmental systems98. In forensics, CE is 
commonly employed for illicit drug screening, the analysis of poisonous species in 
human fluid samples, toxicological analysis, the characterization of explosives and 
gunshot residues, and forensic investigations of DNA fingerprints99. Various modes of 
CE are used in food industries (e.g. cereals, fruit-based products, milk and dairy products, 
meat and fish products, soft drink, tea, alcoholic drink, vegetables, oils and sauces) for 
establishing food authenticity or adulteration, the analysis of nutrients in food, monitoring 
food processing and storage100,101,102. CE separations of a wide variety of mixtures such as 
organic compounds86, inorganic ions80,86, bases80, nucleosides80, nucleotides80, nucleic 
acids80,86, viruses, cells80, subcellular particles80, native and denatured DNA80, DNA 
sequencing86, amino acids86, peptides86 and proteins80,86 are of critical importance in 
medical and pharmaceutical research86,103,104. 
 
1.7.2.2 Principle of separation in typical free zone CE 
Figure 1.15 shows the basic instrumental setup used in capillary electrophoresis. The 
system consists of a capillary with both ends immersed in two buffer reservoirs, a 
cathode, an anode, a high-voltage supply, and a detector. The capillary is filled with 
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buffer solution prior to the introduction of a sample at one end of the capillary using 
either hydrodynamic or electrokinetic injection. A high voltage is then applied across the 
capillary causing two main phenomena: electrophoretic migration of analytes and 
electroosmosis (discussed in Section 1.7.2.2).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.15: Instrumental setup of a standard capillary electrophoresis system consists of a capillary 
connecting two buffer reservoirs, a sample reservoir which can be replaced with one of the buffer 
reservoirs, two electrodes placed at each buffer reservoir to apply an electric field across the capillary using 
a high-voltage power supply, and a detector. 
 
 
Analytes migrate based on their electrophoretic mobilities and on the magnitude and 
direction of electroosmotic flow and finally pass through the detector67,68. Various types 
of detectors can be used with CE such as UV-Visible absorbance detection, fluorescence 
detection, refractive index detection, surface-plasmon resonance detection, 
electrochemical detection and mass spectrometry detection34. The signal trace obtained 
from a fixed detector versus time is called an electropherogram68. Analytes separated in 
CE due to the differences in their electrophoretic velocities, νep (ms-1), are present as peaks 
in an electropherogram. The electrophoretic velocity is defined as 
 
      !!" =  !!"!         (1.2) 
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where µep is the electrophoretic mobility of an analyte (m2s-1V-1) and E is the electric field 
strength (Vm-1)67. Besides the electrophoretic mobility, the migration of analytes also 
depends on electroosmotic flow, which describes the flow of a bulk solution in the 
presence of an applied electric field85. In a glass capillary at neutral or high pH, silanol 
groups on the capillary wall are deprotonated; thus, leaving an excess of negative charges 
on the wall. The negative charges are balanced to some extent by positive species from 
the bulk solution, and form an immobilized layer of ions. A second layer adjacent to the 
immobilized layer is termed the diffuse double layer, where positive charges accumulate 
but are still mobile105. When an electric field is applied, these mobile positive charges 
along with water molecules solvating them migrate toward a cathode. This causes a bulk 
electroosmotic flow with a velocity, νeo, defined as 
 !!" = !!"!         (1.3)  
 
                !!" = !"!          (1.4) 
 
Here µeo is the electroosmotic mobility (m2s-1V-1), ε is the dielectric constant of the 
electrolyte, ζ is the zeta potential (V), and η is the viscosity (kgm-1s-1). Accordingly, the 
electroosmotic velocity can be defined using the Smoluchowski equation as 
 
      !!" = !"! !         (1.5) 
 
According to the Equation 1.5, the electroosmotic flow velocity is directly proportional 
to the dielectric constant of the electrolyte, the zeta potential (defined as the potential 
gradient over the diffuse double layer106) and the electric field, while it is inversely 
proportional to the viscosity of the electrolyte solution. When the concentration of 
electrolyte increases, the zeta potential decreases due to compaction of the double layer106 
and the EOF decreases. 
 
The total migration velocity of the analyte can then be defined as 
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       ! =  !!" + !!"              (1.6) 
 
Accordingly,                                                 ! = !!" + !!" ! = (!!" + !!") !!!                 (1.7) 
 
where V is the voltage applied across the channel, and Lc is the capillary length. The total 
mobility can also be determined by experimental measurement, i.e. 
 
   ! =  !!!!!"                 (1.8) 
 
where Ls is the separation length, and t is the migration time. The migration time is 
defined as the time that the analyte takes to travel from one end of the capillary to the 
other. 
         ! = !!! = !!!!!!"+!!" ! 	 	 	 	 					(1.9) 
 
The efficiency of separation is reduced by band broadening, which is caused by numerous 
factors including the finite injection volume (σ2inj), the detection volume (σ2det), 
adsorption of analytes on the capillary wall (σ2ads), longitudinal diffusion of analyte 
molecules (σ2diff), capillary temperature variations (σ2T), pressure drops (σ2P), and 
variations in the geometry of the channel (σ2G). In an ideal case, only longitudinal 
diffusion is appreciable. The longitudinal diffusion band variance is given by 
    !!"##! = 2!!!!                   (1.10) 
 
where D is the molecular diffusion coefficient of the solute (m2s-1). The efficiency of a 
separation is described in simple terms by the theoretical plate number, N 
 
          ! = !!!                   (1.11) 
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where H is the plate height and defined by 
  ! = !!"##!!! = 2!!!"+!!" !                  (1.12) 
 
The efficiency of the separation is thus given by 
 ! = !!!!!"##! = !!"+!!" !!! 2!!!                             (1.13)     
 
The resolution of the separation defines the ability to separate two adjacent peaks and is 
defined in the term of peak width and migration time as  
 
   ! = 2(!!−!!)!!+!!                              (1.14)   
 
where t1 and t2  are the migration time of two adjacent separated peaks, w1 and w2 are the 
width at the base of each peak.  
 
The relationship between resolution and efficiency is given by 
 
     ! =  14 Δ!!"!!"+!!" !                 (1.15) 
 
where Δµep is the difference in electrophoretic mobility between the two species and µep is 
the mean electrophoretic mobility. According to Equation 1.15, resolution is directly 
proportional to the square root of theoretical plate number107.  
 
Inspection of Equation 1.11 demonstrates that the separation efficiency can be increased 
by reducing the plate height, which can be achieved by increasing the electric field 
strength as shown in Equation 1.12. However, increasing the applied potential to 
increase the separation efficiency is limited due to Joule heating caused by current flow 
through the solution. Joule heating results in a rise in the buffer temperature, which in 
turn causes band broadening and hence decreases the separation efficiency. To overcome 
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such a limitation, microfluidic devices can be used to dramatically increase surface area-
to-volume ratios and thus enhance heat dissipation. 
 
1.7.3 Chip-based capillary electrophoresis 
Capillary electrophoresis has been performed in chip-based platforms since the early 
1990s due to its ability to manipulate small sample volumes, excellent heat dissipation 
characteristics, high-throughput operation and ability to produce high-resolution 
separations85. Various CE modes can be performed efficiently in chip-based platforms. 
The principles and operation of chip-based capillary electrophoresis are similar to the 
conventional CE, but include significant and additional advantages. 
 
  
  
Figure 1.16: Schematics of a cross-piece microdevice with normal injection mode (a) During loading step; 
(b) During separation step  
 
 
The simplest structure of a planar electrophoresis chip incorporates a cross-channel 
injection geometry as illustrated in Figure 1.16. The device consists of four reservoirs (a 
buffer, a buffer waste, a sample and a sample waste reservoir) located at each end of the 
channels. In the normal mode of injection, a voltage is applied between the sample and 
the sample waste reservoir to draw the sample towards the channel intersection in the 
loading step. The voltage is then switched and applied between the buffer and the buffer 
waste reservoir during the separation step. This mode of injection is simple but does not 
provide control over the injected sample volume due to two issues. The first is diffusion 
(b) (a) 
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of sample into the separation channel during sample loading and the second is sample 
leakage from the sample loading channel during separation. These issues can potentially 
cause peak broadening and increased background noise108. 
 
 
 
Figure 1.17: (a) Sample loading during pinched injection; (b) Sample dispensing during pinched injection; 
(c) Gated injection (i) Applied voltage for sample (S) = 700 V, buffer (B) = 1000 V, sample waste (SW) 
and buffer waste (BW) = 0 V, (ii) prior to injection: S = 700 V, B, BW and SW = 0 V, (iii) sample 
dispensing: voltages were shifted back to the same as those of (i). Image (a) and (b) reproduced from 
reference 108, while image (c) reproduced from reference 34.  
 
 
To address these eventualities, “pinched” and “gated” injection schemes are commonly 
used to introduce samples. In pinched injection, a voltage (in addition to the voltage 
applied between the sample reservoir and sample waste reservoir) is also applied across a 
separation channel during the loading step to prevent sample from dispersing into a 
separation channel (Figure 1.17a). During separation, a small “push-back” voltage is also 
applied across the sample and the sample waste reservoirs to avoid sample leakage into 
the separation channel (Figure 1.17b). For gated injection, a sample migrates continually 
(a)                                             (b)                                             
(c)                                             
i ii iii 
S
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along the flow of a buffer solution toward a sample waste reservoir. When the flow of the 
buffer stops (when the voltage is switched off), the sample is injected into a separation 
channel (Figure 1.17c)34,85,108. Use of either of these injection modes prevents dispersion 
of sample into a separation channel during the loading step and also leakage of the sample 
into a separation channel during the separation step. Furthermore, the amount of sample 
introduced can be controlled more precisely than when using normal injection modes. 
 
Three types of materials are most commonly used to fabricate CE microdevices. These 
are glass or fused silica, polydimethylsiloxane (PDMS), and other plastics108. The 
adoption of glass (or silica-based materials), provides several advantages, including well-
established microfabrication processes adapted from the semiconductor industry33,85, 
excellent optical transparency over a wide range of wavelengths85, well-understood 
surface chemistries, high EOF generation109, low thermal expansion33, good heat transfer 
(thermal conductivity ~1.4 W m-1K-1)110 and low cost. However, the use of glass raises 
some problems including the need for time-consuming and complicated fabrication 
methods, high real costs of produced devices, device fragility and adsorption of 
biomolecules to the negatively charged channel surfaces109. To overcome these problems, 
alternative materials based on polymers have been investigated. 
 
The major advantages associated with polymer-based microfluidic devices lie in the 
ability to mass produce devices at low unit cost using accessible fabrication methods such 
as hot embossing, injection molding, laser ablation, polymer casting34,36 and 3D 
printing111. Moreover, polymer-based microfluidic devices are biocompatible and 
frequently more flexible than glass112. Commonly used polymers include 
polydimethylsiloxane (PDMS), poly methyl methacrylate (PMMA), polycarbonate (PC), 
poly ethylene terephthalate (PET), polystyrene (PS), cellulose acetate and 
polyvinylchloride (PVC).36,51,108,109,47 Of these, PDMS has been the most popular 
substrate used to fabricate microfluidic devices112.  
 
PDMS is widely used in the fabrication of microfluidic devices because of the ease of 
device fabrication using soft photolithography that allows fast prototyping of complex 
designs108,112. PDMS is also optically transparent over a wide range of wavelengths33, 
non-toxic, gas-permeable33, elastomeric51 and electrically insulating51. However, the 
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absorption of organic solvents, biopolymers, and small hydrophobic molecules can be a 
serious problem when using PDMS108. Native PDMS is hydrophobic, but still exhibits 
EOF113. EOF in PDMS microchannels is often found to be spatially inconsistent. 
Therefore, several methods have been employed for the modification of PDMS channels. 
These include dynamic and static wall coatings and oxygen plasma treatment114,102. For 
oxygen plasma treatment, oxygen radicals substitute the methyl group (Si-CH3) with 
silanol groups (Si-OH). This renders the surface chemistry of the PDMS hydrophilic and 
broadly similar to glass. The surface can then be temporarily kept hydrophilic in a polar 
solvent. When a PDMS surface is in contact with an aqueous solution at pHs above 3, the 
silanol groups dissociate into SiO- and H+. Consequently, a negative surface charge is 
established. Since the hydrophilicity of a PDMS surface after oxygen plasma treatment is 
not permanent, hydrophilicity can be recovered by treating the channel with a strong base 
such as 1M NaOH34. 
 
1.8 Two-dimensional (2D) separation of proteins and problems with interfaces 
between two separation dimensions 
In conventional protein and amino acid separations, two-dimensional gel electrophoresis 
is employed to achieve high peak capacities and high peak resolution115. The peak 
capacity defines the maximum number of peaks that can be resolved in separation 
space116,117,118. For two-dimensional separations, the total peak capacity is the product of 
peak capacities of the two orthogonal separation dimensions115,119,120. A two-dimensional 
separation is characterized as orthogonal if the separation mechanisms of the two 
dimensions are distinct. In other words, analytes are separated based on different 
physicochemical properties in each dimension120. For instance, 2D polyacrylamide gel 
electrophoresis (2D-PAGE) for protein analysis121 employs IEF for the first dimension 
and SDS-PAGE for the second dimension (Figure 1.18). Although conventional 2D-
PAGE provides peak capacities of 5000 or higher, it is slow, laborious and difficult to 
directly couple to mass spectrometry (MS) 86,122,123.  
 
Two-dimensional capillary electrophoresis or column chromatography methods such as 
2D-liquid chromatography (LC-LC), liquid chromatography-capillary electrophoresis 
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(LC-CE) and 2D-CE (CE-CE) are employed to provide higher speeds, easier automation 
and access to a broader range of biomolecules than conventional 2D-PAGE115. Several 
modes of CE (such as CZE, CGE, MEKC, cIEF and cITP) located either in the first or the 
second dimension are coupled to another LC or CE mode in an offline or online manner 
to provide 2D separations123.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.18: Two-dimensional gel electrophoresis. Proteins are separated by isoelectric focusing in the first 
dimension and by SDS gel electrophoresis in the second dimension. Image reproduced from reference 124. 
 
 
In offline 2D systems, analytes are collected in several fractions after separation in a first 
dimension. The collected fractions are then treated prior to injection into the second 
dimension. Unfortunately, offline modes cannot provide for automated analysis, are time-
consuming and plagued by sample dilution123.  
 
Online 2D separations can be categorized into three broad groupings: i) 2D separations in 
a single capillary, ii) coupling two separation techniques using an interface, and iii) 
coupling two separation techniques using mechanical valves123. 2D separations in a single 
capillary are achieved by performing one CE mode in the first dimension. Subsequently, 
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separated analytes remain in the capillary during the exchange of a buffer solution for a 
second CE separation. Chiral separations of amino acids, for example, can be performed 
using single-capillary 2D separations125,126. For hyphenated 2D separations, many 
interface systems have been employed. These include dialysis interfaces127, porous 
junction interfaces128,129, tee-union interfaces130, flow gating interfaces131, microreactor 
interfaces132, nicked-sleeve interfaces133 and hydrodynamic interfaces134. It is noted that 
six-port valves have usually been used as a mechanical valves for coupling two separation 
systems as reviewed in elsewhere123. 
 
Although the use of capillary electrophoresis or column chromatography for 2D 
separations is more convenient than that of 2D-PAGE, these techniques still exhibit some 
flaws. For instance, high analytical performance is difficult to achieve due to the 
inconvenient integration of different separation dimensions135. This also causes high 
dispersion at an interface between the two separation dimensions. Accordingly, much 
effort has been focused on the development of new techniques for protein separations 
based on two-dimensional microfluidic formats.  
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Table 1.3: Summary of two-dimensional protein separation within microfluidic platforms 
 
First 
Dimension 
Second 
Dimension 
Chip 
Material 
Interface Detection Peak 
Capacity 
Analysis 
time (min) 
Samples Ref. 
MEKC CZE Glass Intersecting channels Fluorescence 500-1000 < 10 Tryptic peptides from 136 
       cytochrome c  
MEKC CZE Glass Intersecting channels Fluorescence 4200 < 15 Tryptic digest of BSA 119 
CGE MEKC PMMA Intersecting channels Fluorescence 1000 12 10-Protein mixture 137 
CGE MEKC PMMA Intersecting channels Fluorescence 2600 < 30 Fetal calf serum (FCS) 138 
       proteins  
CGE MEEKC PMMA Intersecting channels Fluorescence 481 3.7 Cytosolic proteins of 139 
       E.coli  
IEF CZE PMMA Intersecting channels Fluorescence 1300 < 5 Standard proteins 140 
IEF CZE Glass Intersecting channels Fluorescence 540 50 Digest of BSA and 141 
       protein extracted from 
E.coli 
 
IEF CGE PDMS PDMS membrane Fluorescence - - Standard proteins 142 
IEF CGE PC Staggered Fluorescence 1700 < 10 Standard proteins 143 
   configuration      
IEF CGE/CZE PDMS Microvalve Fluorescence - 10 Standard proteins 144 
IEF CGE Cyclic olefin Gel pseudovalves Fluorescence - 10 Standard proteins 145 
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First 
Dimension 
Second 
Dimension 
Chip 
Material 
Interface Detection Peak 
Capacity 
Analysis 
time (min) 
Samples Ref. 
IEF  Cyclic olefin Gel pseudovalves Fluorescence - - GFP and 146 
       R-phycoerythrin  
IEF CGE PMMA Gel pseudovalves Fluorescence 2880 - E.coli lysate 147 
IEF CGE PMMA Gel pseudovalves Fluorescence - < 10 E.coli lysate 148 
IEF CGE PMMA Open channels Fluorescence - - Myoglobin 149 
IEF µ-RPLC Cyclic olefin Microvalves Fluorescence 215 - Angiotensin, BSA 150 
       and cytochrome c  
IEF DIGE Glass Smaller channels Fluorescence - - E.coli lysate 151 
OCEC CZE Glass Intersecting channels Fluorescence 150 13 Tryptic digest of 120 
       β-casein  
GEMBE CZE Glass Intersecting channels Fluorescence 35 210-240 Chiral amino acids 122 
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Recently, two-dimensional protein separations within microfluidic platforms based on 
MEKC-CZE, IEF-CGE and IEF-CZE have been reported in glass, PDMS and other 
polymer-based microfluidic devices108 and are summarized in Table 1.3. Ramsey et al. 
used MEKC coupled with CZE to separate tryptic digests of BSA (Figure 1.19a)119 and 
to separate tryptic peptides from cytochrome c136 within a glass microchip using 
intersecting channels and gated injection of samples. The peak capacities and analysis 
times for the separation of a tryptic digest of BSA and for the separation of tryptic 
peptides from cytochrome c were 4200, < 15 minutes119 and 500-1000, <10 minutes136, 
respectively. Another report from this group120 also used a glass microchip to separate 
tryptic digested proteins from β-casein (Figure 1.19b) within 13 minutes by coupling 
open channel electrochromatography (OCEC) with CZE, and yielding a total peak 
capacity of 150. 
 
 
 
 
 
 
 
 
 
Figure 1.19: Images of microchips containing two intersecting channels as valves (V1 and V2) for the 2D 
separation of (a) a tryptic digest of BSA having MEKC as the first dimension and CZE as the second 
dimension, and (b) a tryptic digest of β-casein having OCEC coupled with CZE. Both microchips consist of 
a sample reservoir (S), two sample waste reservoirs (SW1 and SW2), two buffer reservoirs (B1 and B2) and 
one buffer waste reservoir (BW). The separated analytes are detected at the point D illustrated in Figure 
1.18a and at the points x and y as shown in Figure 1.18b. Image (a) is reproduced from reference 119 and 
image (b) is reproduced from reference 120. 
 
 
Soper and co-workers reported the coupling of CGE and MEKC within PMMA 
microchips to separate a 10-protein mixture with a peak capacity of 1000 in 12 
minutes137, and to separate fetal calf serum (FCS) proteins with a peak capacity of 2600 
in less than 30 minutes138. The same group also reported the 2D separation of cytosolic 
(a) (b) 
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proteins of E.coli employing CGE as the first dimension and microemulsion 
electrokinetic chromatography (MEEKC) as the second dimension139. The separation was 
completed within 4 minutes with a peak capacity of 481 (Figure 1.20). All of these 
separations employed intersecting geometries as an interface between the two separation 
dimensions. 
 
 
 
 
 
 
 
 
Figure 1.20: An image of a PMMA microchip with intersecting channel geometries as interfaces between 
CGE (1st dimension) and MEEKC (2nd dimension) for the separation of cytosolic proteins of E. coli. The 
reservoirs shown in the image are sample reservoir (A), sample waste reservoir (B), CGE buffer reservoir 
(C), CGE sample waste reservoir (D), MEEKC buffer reservoir (E) and MEEKC buffer waste reservoir (F). 
Detection is performed at the point d1 as shown in the image. Image reproduced from reference 139.  
 
 
2D protein separations achieved by coupling IEF and CZE using a simple cross-
intersection PMMA microchip and glass microchip have been reported by Herr et al. 
(Figure 1.21a)140 and Cong et al. (Figure 1.21b)141 respectively.  
 
 
 
 
 
 
 
 
Figure 1.21: Schematics of simple cross-intersection geometries for protein separations by IEF coupled 
with CZE. A sample is first separated by IEF and when the analyte bands reach the intersection, they are 
then separated by CZE. The direction of IEF in the first dimension separation is from reservoir A to 
reservoir C in (a) and from reservoir 1 to reservoir 2 in (b). The direction of CZE is from reservoir B 
(buffer) to reservoir W (waste) in (a) and from reservoir 3 to reservoir 4 in (b). The dashed box D in part (a) 
shows the detection area. Schematics (a) and (b) reproduced from references 140 and 141, respectively.  
(a) (b) 
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Figure 1.22: IEF coupled with CGE using a variety of interfaces between the two separation dimensions. 
(a) A 2D-separation microchip incorporating a PDMS membrane as an interface (i) A protein mixture is 
first separated in a composite PDMS membrane serving as an IEF channel (red line). The composite PDMS 
membrane is then assembled to the other two PDMS pieces: parallel green lines represent the channels in 
the top PDMS piece and parallel blue lines represent the channels in the bottom PDMS piece. Together they 
form a single PDMS device for CGE. The separated analytes from the IEF channel are transferred to 
parallel vertical channels to perform CGE in the second dimension, (ii) The separated fluorescein-
conjugated bovine serum albumin (BSAF) and Texas-red-conjugated ovalbumin (OvTR) bands are obtained 
using different filters for the detection of fluorescein and Texas Red. (b) A staggered-channel network 
within a planar PC microchip for 2D separations (i) A schematic of the microchip shows a horizontal 
channel for IEF separation traversing vertical channels for performing CGE, (ii) Shows IEF focusing of a 
protein mixture, (iii) The focused proteins are transferred electrokinetically to the second dimension, (iv) 
CGE is then performed in the vertical channels. (c) Schematics of 2D separation processes utilizing 
microvalves as interfaces between IEF and CGE separations (i) During CGE buffer loading, right valves 
connected to an IEF channel are closed, (ii) IEF buffer loading, left valves connected to a CGE channel are 
closed, (iii) All valves are closed after IEF focusing, (iv) Left valves are opened again for CGE separation. 
(d) An IEF-CGE microchip employing in situ polymerized gel as valves (i) A micrograph of the stained 
polymerized gel within vertical channels, (ii) The enlargement of (i) shows an IEF channel and an array of 
CGE channels containing polymerized gel. Image (a) reproduced from reference 142, image (b) reproduced 
from reference 143, image (c) reproduced from reference 144 and image (d) reproduced from reference 
146. 
i 
ii 
(a) 
i ii 
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Several groups have also reported the separation of proteins on microfluidic devices 
utilizing IEF as the first dimension and CGE as the second dimension142-151. For example, 
Whitesides and co-workers142 fabricated a prototype 2D-CE device on a PDMS substrate 
in which the two dimensions were performed separately on different microfabricated 
devices, with separated proteins from the first dimension being transferred to the second 
via PDMS membranes, which could be assembled or disassembled (Figure 1.22a). Li et 
al.143 reported the IEF-CGE separation of a five-protein sample in a polycarbonate 
microfluidic device in which the two dimensions were connected via a staggered 
configuration of channels as illustrated in Figure 1.22b. The analysis time was 10 
minutes with a peak capacity of 1700. In addition, Wang and co-workers144 introduced a 
PDMS microchip with microvalves to prevent mixing of separation buffers (Figure 
1.22c). In this study, a four-protein mixture was separated by IEF and CGE within 10 
minutes. Das et al.145,146 and Yang et al.147,148 also reported IEF coupled CGE separations 
of protein mixtures in plastic microchips incorporating photopolymerized gel plugs as 
pseudovalves to prevent cross-contamination between the two separation systems as 
demonstrated in Figure 1.22d. Finally, Griebel et al.149 demonstrated a small open 
channel as an interface between IEF and CGE separation of myoglobin on a PMMA 
microchip. 
 
Other modes of two-dimensional protein separations with various types of interfaces have 
also been proposed. For instance, IEF was coupled to micro reverse phase liquid 
chromatography (µ-RPLC) by a microvalve interface to separate Angiotensin, BSA and 
cytochrome c (Figure 1.23a)150. Proteins from E.coli lysate were separated by IEF-DIGE 
(differential gel electrophoresis) utilizing shallow and narrow channels as interfaces 
(Figure 1.23b)151, and gradient elution moving boundary electrophoresis (GEMBE) 
coupled to CZE to separate chiral amino acids on a glass microchip (Figure 1.23c)122. 
 
In addition, MCE is also easily combined with mass spectrometry (MS) to perform 
protein and peptide analysis152. Li et al.153 successfully sequenced 88.5% of a peptide 
mixture obtained from a proteolytic digest of cytochrome c using CE connected to low-
sheath flow ESI via a connecting capillary. Ramsey et al.154 proposed the coupling of CE-
ESI-MS in which ESI was directly performed from a rectangular glass microchip and 
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coupled with MS without the use of an external pressure source. In this case, the 
separation of a peptide mixture was fully resolved in less than 30 seconds. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.23: (a) A schematic of a microchip for IEF coupled with µ-RPLC using microvalves as interfaces. 
The microvalves are manually turned off after separation in an IEF channel. The analytes are then further 
separated using µ-RPLC. (b) 2D separation by IEF coupled with DIGE (i) An illustration of a microchip 
having an IEF channel laying across an array of DIGE channels, (ii) The connection between the IEF 
channel (horizontal channel) and DIGE channels (vertical channels) using very small channels that prevent 
gel buffer from dispersing into the IEF channel during the focusing operation, (iii) The gel buffer fills all 
channels, (iv) The IEF channel is cleared by applying a vacuum at one end and water at the other end, (v) 
IEF buffer is then introduced into the clean IEF channel. (c) Illustrations of GEMBE coupled with CZE 
separation. The microdevice consists of a sample reservoir, a CZE buffer reservoir, a buffer waste reservoir, 
a GEMBE channel connected to a CZE channel via an intersection geometry. By varying the bulk solution 
counterflow velocity in GEMBE, analytes are allowed to enter the channel at different times. The analyte 
bands from GEMBE are periodically injected into a CZE channel for further separation by turning on/off a 
computer-controlled relay. Image (a) reproduced from reference 150, image (b) reproduced from reference 
151, image (c) reproduced from reference 122.  
i. ii. iii. 
iv. 
v. 
(a) (b) 
 (c) 
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1.9 Project outline 
Since the study of proteomics has received enormous attention in biological, medical and 
pharmaceutical science, the need for high-throughput, high-resolution and completely 
automated analysis of proteins is of undoubted importance. To achieve these goals, two-
dimensional separation of proteins was first introduced in the form of 2D-PAGE. This 
was found to be slow, complex and laborious. 2D-PAGE was then transferred into 2D 
columns or capillary separations and later followed by 2D separations within microfluidic 
formats (to provide for higher resolution, improved automation, and faster analysis 
times). However, all multidimensional separations face one unavoidable problem; that is 
the difficulty in selecting an appropriate interface between each dimension to reduce dead 
volumes, minimize dispersion at the interface and limit resolution losses122,135. To this 
end, the compartmentalization of separated bands into droplets can be used as an interface 
between each dimension of the separation process155,156. 
 
In the current work, we present the development of a microfluidic interface that can be 
used to transfer analyte microdroplets into a second separation dimension or distinct 
analytical process. Herein we use a fluorescently labeled protein mixture as a 
representative of proteins separated from the first dimension. This protein mixture is 
segmented into droplets using a robotic droplet generator. These droplets can then be 
transferred through a novel microfluidic interface into the second separation dimension. 
For the second separation dimension, CGE is employed because of its suitability for 
protein separations and its ease of operation. For this reason, an appropriate buffer system 
that can provide not only for high-resolution and rapid separation but also compatibility 
with the materials used in this experiment was developed (Chapter 3). In addition, 
several fluorescent dyes for labeling proteins were assayed so as to achieve high 
fluorescence intensities appropriate for use with the developed droplet platform (Chapter 
4). The interfacing of the droplet-based microfluidic device was then established in 
Chapter 5. Issues relating to previous designs are addressed and novel microfluidic 
interfaces were designed and evaluated. By integrating all the components developed in 
Chapters 3-5 (i.e. the appropriate interfacing chip design, the gel buffer solution, and the 
fluorescently labeled proteins), droplet-based separations of proteins are reported in 
Chapter 6. The developed interface device prevents dispersion of analyte bands and 
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sample loss at an interface between the two separation dimensions. The interface also 
provides for rapid separations, ease of operation and automation of complete oil 
depletion. All of these features are expected to enhance the separation performance of 
protein analysis in proteomic research. 
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2.1 Microfluidic device fabrication 
Among the materials that can be used to fabricate microfluidic devices (i.e. silicon, 
quartz, glass, polymers)1, PDMS is one of the most widely used materials due to several 
inherent advantages. Using soft photolithography, PDMS can be rapidly and simply 
fabricated into complicated designs2,3. The transparency of PDMS allows optical 
detection at wide range of wavelengths. It is also biocompatible being both non-toxic and 
gas-permeable, which permits biomolecular or cellular analysis within PDMS 
microdevices1. In addition, the flexibility and robustness are the advantages of PDMS 
over glass. PDMS is thus used to fabricate most of the designs in this work.  
 
Recently, the fabrication of microdevices using 3D printing technology has attracted 
much attention from researchers. This is due to some significant advantages in the 
fabrication process over the conventional soft photolithography. 3D printing is found to 
be much simpler in fabrication since there is no need to fabricate molds prior to achieving 
microdevices. The layout of microdevices can be directly transferred from the software 
(e.g. CAD) to material via a 3D printer to create the desired microdevices. By using 3D 
printing, it is foreseen that more rapid and automated fabrication processes between 
laboratories can be achieved with greater levels of standardisation4. Therefore, some 
microdevices used in this work were fabricated using the 3D printing technique. 
  
2.1.1 PDMS microdevice fabrication 
Typically, many processes are involved in the fabrication of PDMS microdevices. First, a 
design of a microdevice is transferred to a photomask that can be used to create an SU-8 
master. However, in practice the pattern on the photomask is usually transferred onto a 
more durable material, often a chromium mask, to prolong the photomask usage. The 
patterned chromium mask is then used to create an SU-8 master using the 
photolithography technique. Finally, a PDMS replica is casted from the fabricated SU-8 
master, This SU-8 master may be used to replicate microdevices several times. 
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2.1.1.1 Fabrication of chromium masks 
Prior to the fabrication of a chromium mask, a microdevice design is created using 
AutoCAD (Autodesk, USA) and printed onto a polyester-based film mask (Micro 
Lithography Services Ltd, UK), which is a darkfield film mask (i.e. translucent channels 
printed on an opaque dark field).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1: A schematic illustrating the process of chromium mask fabrication consisting of four steps. The 
pattern on a film mask is transferred to a chromium coated glass wafer by exposure to the UV light. The 
exposed photoresist and the chromium layer are then removed to reveal the pattern on the chromium mask. 
 
 
The chromium mask is then fabricated as illustrated in Figure 2.1. The first step, the 
printed darkfield film mask serving as a primary mask is placed onto a glass wafer coated 
with chromium and positive photoresist (AZ1518, 5300 Å, Soda Lime, Nanofilm, USA). 
The pattern is transferred to the coated glass wafer by exposure to the UV light (Model 
30, Optical Associates Inc., USA) through the film mask. The glass wafer is then 
immersed into a mixture of Microposit 351 Developer (Shipley Europe Limited, 
Coventry, UK) and deionized (DI) water (at 1:5 volume ratio) for 2 minutes to develop 
the positive photoresist and hence reveal the transferred pattern. After that the glass wafer 
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is rinsed with DI water and blown dry with nitrogen gas before it is immersed into a 
chromium etchant standard solution (Aldrich, UK) for 2 minutes to remove the exposed 
chromium layer. Subsequently, the glass wafer is rinsed with DI water, blown dry and 
sonicated in acetone (5-10 minutes) to remove the rest of the photoresist in the unexposed 
area. 
 
2.1.1.2 Fabrication of SU-8 masters 
SU-8 is a negative photoresist containing a Bisphenol A Novolak epoxy oligomer 
(Figure 2.2) and up to 10% triarylsulfonium hexafluroantimonate salt photoacid 
generator.  
 
 
 
 
  
  
 
 
Figure 2.2: A chemical structure of Bisphenol A Novolak epoxy oligomer containing 8 epoxy groups 
provide for high degree of cross-linking after photoactivation. Image reproduced from reference 5. 
 
 
The photoacid generator is firstly activated by irradiation. It transforms into an acid, 
which then protonates the epoxides on the oligomer. After heat application, the 
protonated epoxy groups react with neutral epoxides yielding the cross-linked SU-8  
structure5. An SU-8 master is employed as a mold for casting PDMS microdevices. The 
fabrication process of a SU-8 master is illustrated in Figure 2.3. There are five main steps 
in the fabrication process: spin coat, soft bake, expose, post exposure bake and develop6. 
The first process is spin coating of SU-8 photoresist onto a silicon wafer. The appropriate 
SU-8 photoresist and spin conditions are selected to achieve the required thickness of the 
SU-8 layer. This in turn will determine the depth of the channels. In this work, channels 
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with 100 µm diameter are required. Approximately 4 ml of SU-8 100 (MicroChem, USA) 
is gently poured onto a 4-inch silicon wafer, 100 mm N <100> with a resistivity of 1-10 
Ωcm and a thickness of 525 µm (IDB Technologies Ltd, UK). The silicon wafer is then 
placed inside a spin coater (Laurell Technologies Corporation, USA). The first cycle is to 
cover the entire wafer with the resist by ramping the speed up to 500 rpm at 100 
rpm/second acceleration and holding at this speed for 10 seconds. Next, the speed is 
ramped to 3000 rpm at an acceleration rate of 300 rpm/second and held for 30 seconds in 
order to achieve the photoresist thickness of 100 µm. The speed of the spin coater is then 
decreased to 0 rpm within 10 seconds at the acceleration rate of 408 rpm/second.  
 
 
 
 
 
 
 
  
 
Figure 2.3: Flow chart showing the process of SU-8 master fabrication and surface treatment by 
silanization. 
 
After spin coating of the silicon wafer is completed, it is soft baked to evaporate the 
solvent. It is pre-baked on a hot plate at the temperature of 65 °C for 10 minutes and then 
soft baked at 95 °C for 30 minutes. This condition is for spin coating the silicon wafer 
with SU-8 100 at 100 µm thickness. Subsequently, the silicon wafer is removed from the 
hot plate and left to gradually cool prior to the exposure step. 
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The patterned chromium mask (described in Section 2.1.1.1) is placed onto the coated 
silicon wafer after it is cool. Both silicon wafer and chromium mask are then irradiated 
with UV light (Model 30, Optical Associates Inc., USA) for 30 seconds. The irradiation 
initiates the polymerization of SU-8 100. The silicon wafer is then post exposure baked 
(PEB). This is achieved in two steps to minimize stress and photoresist cracking. The first 
PEB baked is at 65 °C for 1 minute and the second step is at 95 °C for 10 minutes. 
A developer solvent consisting of 2-methoxy-1-methylethyl acetate (Microposit EC 
Solvent, Chestech Ltd, UK) is used to remove unexposed SU-8 on the silicon wafer. The 
PEB silicon wafer is then immersed into the developer solvent and strongly agitated for 
10 minutes. It is then rinsed with isopropanol and blown dry with nitrogen gas. 
Another important process after the fabrication of SU-8 master is the silanization of the 
master to prevent cured PDMS from adhering to the master. The master is exposed to 
vaporised silane (Trichloro (1H, 1H, 2H, 2H-perfluorooctyl) silane, Sigma Aldrich) under 
vacuum for 2 hours. The master is now ready for PDMS casting. 
 
2.1.1.3 PDMS casting 
After the fabrication of an SU-8 master, PDMS microdevices are cast by pouring a 
mixture of a base (tetra (trimethylsiloxy) silane) and a curing agent 
(tetramethyltetravinylcyclote-trasiloxane), in a SYLGARD 184 Silicone Elastomer Kit 
(Dow Corning Ltd, UK) at the weight ratio of 10:1 onto the SU-8 master7. This mixture is 
first thoroughly mixed and then applied to the mold. Following this the mold is degassed 
and heated in an oven at 65 °C for 2-4 hours prior to assembly. 
 
2.1.1.4 Microdevice assembly 
 After PDMS casting, both top and bottom pieces of PDMS are cut and peeled off the 
mold. Holes are punched on the top piece of PDMS to create reservoirs using a biopsy 
punch (1, 2 or 4 mm I.D. biopsy punch, Kai Medical, Japan). Both top and bottom pieces 
of PDMS are sonicated in DI water for 5 minutes and blown dry with nitrogen gas. 
Following this cleaning stage, they are placed inside the oxygen plasma oven (Harrick 
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Plasma, USA) for 1 minute. The plasma-treated PDMS pieces are then aligned and placed 
under pressure to bond. 
 
2.1.2 3D-printed microdevice 
3D-printed microdevices used in this work were designed using AutoCAD 2013 
(Autodesk, USA) and were printed using a ProJet® 3510 HD (3D systems GmbH, 
Germany)8. The material used to fabricate the 3D-printed microdevices was UV curable 
acrylonitrile butadiene styrene (ABS) resin. The ABS resin was jetted through a printhead 
to print layer by layer onto a platform; meanwhile, the wax support material was jetted 
through the other printhead to fill voids. The plastic part was then cured by UV light. The 
support wax was then melted away. Owing to the small dimension of channels in the 
microdevices (~ 200 µm), further treatment to completely wash out the wax was 
performed by sonicating the microdevice in 10% SDS at 70°C for 2 hours. The 
microdevices were then rinsed with water and placed in an oven at 70°C for 30 minutes. 
 
2.2 Droplet-based microchip platform fabrication 
A droplet-based microchip platform was designed using AutoCAD 2013 (Autodesk, 
USA) and was fabricated using a laser engraving and cutting machine (Laserscript 
LS3040 LSRCUT, HPC Laser Ltd.). Briefly, an acrylic plate was cut according to the 
design using a CO2 laser, which emits infrared radiation (wavelength 10.6 µm). After the 
fabrication, the acrylic platform could be used immediately without other modification or 
treatment. 
 
2.3 Robotic droplet generator 
 The droplets used in the experiments were predominantly generated using the robotic 
droplet generator (Figure 2.4) developed by Gielen and co-workers9. The entire system 
consists of three main parts that are a robotic droplet generator, a syringe pump and a 
computer.  
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Figure 2.4: An image and schematics of a robotic droplet generator (a) An image showing the entire system 
of the robotic droplet generator consisting of a PTFE tube inserted into a metal hook, an oil-filled carousel, 
a camera, a glass syringe and a syringe pump; (b) An enlargement of the oil-filled carousel part showing the 
carousel that can move forward and backward as illustrated by the arrows and the hook that can be in the 
“up” and “down” position under the control of a solenoid. Fifteen samples can be held by holes on a metal 
ring for this model of the robotic droplet generator; (c) A schematic illustrating droplet generation from two 
samples using the robotic droplet generator (i) The carousel moves until the tip of the hook is in the oil 
phase beneath the first sample (red), (ii) The hook is in the “up” position and withdraws the sample (red), 
(iii) The hook is in the “down” position and withdraws the oil, (iv) The carousel moves again towards the 
second sample (blue) until the tip of the hook is underneath the sample, (v) The same process as that of (ii) 
occurs to achieve a droplet of the second sample (blue), (vi) The process in (iii) is repeated. Image (b) and 
(c) reproduced from reference 9. 
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64 signiﬁcantly lower throughput (1−10 Hz). The lower droplet
65 production rate presents an opportunity to exert full control
66 over the sequence and composition of each compartment.
67 Control over the compartment contents serves as an alternative
68 to encoding so that labeling steps become superﬂuous and can
69 be used for easy production of segmented concentration
70 gradients. Here, the conﬁdence in the data obtained from each
71 individual droplet is the crucial basis for the reduction of
72 droplet numbers (in turn enabling lower reagent consumption)
73 without loss in information quality.
74 Several COD platforms have been introduced in the past few
75 years and applied to combinatorial studies.19,20 On-chip
76 platforms based on valves21 or high-precision dosing pumps
77 that allow formation of droplets at the junction of multiple inlet
78 ports20 have been used to generate microliter droplets with
79 highly accurate reagent dispensing to generate concentration
80 gradients of analytes. Other platforms that generate droplets
81 directly from samples in titer plates in speciﬁc sequences use
82 valves to dispense these “droplet trains” for incubation, which
83 can be in tubing, or on- chip, and for further analysis.22
84 Continuous sampling of a PCR assay has been realized using an
85 automated platform for sample manipulation in which 500 nL
86 droplets were sequentially formed into a droplet train via a dual
87 aspirating valve unit for injection into tubing. Using a
88commercially available autosampler, kinetic analysis could be
89performed by drawing samples to form 5 μL droplets, which
90were then split into smaller droplets and mixed with other assay
91components to aﬀord ﬁnal assay droplet volumes of over 800
92nL.23 Such valve systems allow control over the sequence of
93droplets, but result in large plugs (assay volumes of 800 nL to 5
94μL), imply slow droplet generation (up to 30 s for one
95droplet), and incur a signiﬁcant risk of sample contamination
96within the valve itself.
97A few platforms generate droplets through the use of
98negative pressure. For example, the DropLab24,25 and a study
99by Wen et al.26 report the suction of aqueous and oil samples to
100create concentration gradients via the sequential uptake of the
101reagent droplets in the low nanoliter range. In the former work
102with DropLab, reagents are mixed by sucking varying ratios of
103liquid prior to ﬂow segmentation with oil, whereas the latter
104study uses merging elements to combine droplets. Although the
105use of negative pressure eliminates the need for valves and
106allows formation of much smaller droplets (20 pL to 3 nL),
107mixing aqueous solutions in the DropLab system leads to
108potential contamination and the initiation of reactions prior to
109droplet formation. Conversely, passive on-chip merging allows
110precise timing of the fusion event, for example, through pillar
Figure 1. (A) Schematic of the compartment-on-demand platform. Samples (in bottomless tubes) are supplied by rotating an oil-ﬁlled carousel.
Samples are withdrawn when a sample tube alig s to PTFE tubing located underneath. N g tive pressure is applied via a syringe pump operating in
continuous withdrawal mode, and droplet compartments are generated by moving the tubing up and down between the carrier phase and the
aqueous phase, as shown in (B). The residence time of the hooked end of the tubing in oil or aqueous phase determines the distance between
droplets and the droplet volume, r spectively. The absorbance of each microdroplet i read by passage between an LED source aligned with a
photodetector (PD). A typical data trace is shown in the top right (see Figure 2A) showing absorbance data for droplet sequences with diﬀerent
compounds (corresponding to diﬀerent colors) and concentration gradients (indicated by shading of each color). (B) Sequential operation of the
COD platform. During all steps of op ration, the tubing is aspirating liquid at a constan rate. (i) Th tip of the tubing is aligned with a given sample.
(ii) The tip is lifted so that it sits in the aqueous phase of sample 1 (red). (iii) The tip returns to the oil phase. The change from aqueous to oil phase
creates a microcompartment containing a controlled quantity of sample 1 (red). (iv) The tip is aligned below a second sample. (v) The tip is lifted
analogously to step (i), but now sample 2 (blu ) is taken up. (vi) The tip comes back to the carrier ﬂuid. As result of the process shown in (B), a
sequence of microdroplets with deﬁned contents (sample 1, red; sample 2, blue) emerges in the tubing in a preplanned order. Droplets can be
generated at a rate of 0.1−5 s per droplet. No further labeling is necessary as the sequence of sample compartmentalization can be programmed and
droplets appear in the tubing as plan ed. Contr l over compartment volume and the distance between compartments is exerted by variation of the
residence times of the tip in aqueous and oil phases.
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To set up the experiment for droplet generation, around 60 ml of FC-40 oil (Fluorinert, 
Acota, UK) was poured into an oil-filled carousel. An aqueous sample was pipetted into a 
bottomless PCR tube (0.2 ml PCR tube with ~ 0.2 cm of bottom cut out, VWR, USA) 
placed into one of 15 holes on a metal ring depicted in Figure 2.4b. A 30 cm long PTFE 
tube (Ultramicrobore 100 µm I.D., 400 µm O.D., Cole Parmer, London, UK) was inserted 
into a stainless steel hook, and was allowed to protrude about 3-4 mm from the mouth of 
the hook to ensure that the entrance of the tube reached an aqueous sample when the tube 
was moved to the upward position. Upstream from the hook, nearer the central section of 
the tube, a USB microscope (VMS-001, Veho Discovery, UK) was fixed and focused to 
observe the generated droplets. The terminal end of the tube was connected to a glass 
syringe (Gastight 100 µL, Model 1710 N SYR, Hamilton), which was secured on a 
syringe pump (PHD 2000, Harvard Apparatus).  
 
Prior to the droplet generation, the mouth of the tube was aligned to the middle of the 
bottomless PCR tube. A positive flow rate of 3.0 µl/min was applied for a while to 
eliminate any air bubbles remaining inside the tube. After that a negative flow rate set 
between 1.2 and 2.5 µl/min was exerted for 5-10 minutes to stabilize the pressure. 
Meanwhile, three parameters on a custom-written software (LabVIEW programme, 
National Instruments), used to control the robotic droplet generator were set. Normally, 
the frequency of droplet generation was set at 1 Hz. The retention times of the tube in the 
aqueous and the oil phase were 0.3 s and 0.7 s, respectively. The number of droplets to be 
generated was in the range of 100-150 droplets. These parameters could be varied to 
achieve the required droplet size and interdroplet spacing. When the pressure was stable, 
droplets were started generating at the set parameters.  
 
The droplet robot functioned in the following way - firstly, the carousel moved from the 
zero position to the first position where the sample was located (Figure 2.4ci). The hook 
controlled by a solenoid was then moved to the “up” position and the aqueous sample in 
the bottomless PCR tube was withdrawn into the tube for the determined period of time, 
i.e. the retention time of the tube in the aqueous phase (Figure 2.4cii). After that the hook 
was in the “down” position (Figure 2.4ciii) for a while (i.e. the retention time of the tube 
in the oil phase) before the carousel moved to the next sample (Figure 2.4civ) or moved 
back to the zero position in case only one sample was used. The process was repeated 
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until the required number of droplets was achieved. The pump was then stopped. The 
droplet delivery tube was detached from the robot when the pressure inside the tube was 
stabilized – this is determined to be when the droplets stop moving. The droplets 
collected in the tube were then ready for further analysis or were stored in the dark (for 
fluorescent dye or fluorescently labeled protein droplets) until they were used. 
 
2.4 Capillary electrophoresis operation 
2.4.1 Commercial capillary electrophoresis machine (Peregrine) 
The commercial capillary electrophoresis machine used in this work is called Peregrine 
(deltaDOT Ltd., UK). Peregrine is a High Performance Capillary Electrophoresis (HPCE) 
machine used to perform electrophoresis for label-free analytes using UV detection. The 
system instrumentation, operation and data analysis are described in detail in Section 
2.4.1.1- 2.4.1.3.  
 
2.4.1.1 Peregrine instrument  
The overview of the Peregrine machine is depicted in Figure 2.5a. The main 
electrophoresis compartment and optical components are situated under the main cover 
(Figure2.5b), whereas two carousels are located on the left and right side of Peregrine as 
shown in Figure 2.5a. The other components housed underneath the main cover are a 
deuterium lamp, a filter wheel (containing 214 nm, 254 nm and 280 nm filters), 
adjustable lens, a capillary block and a heat sink (for temperature control) and a 
photodiode array (PDA) detector as depicted in Figure 2.6. Each carousel contained 24 
vial holders (Figure 2.5b) for glass sample and reagent vials (SMI-LabHut Ltd, 
Gloucestershire, UK). In operation, Peregrine is connected to a nitrogen gas tank used as 
a pressure source for hydrodynamic actions (i.e. flushing or filling of buffer/reagents and 
sample injection). During the experiment, the machine is controlled by P3Controler 
software, while the collected data are analysed and compared by the software named 
P3EVA provided by deltaDOT. 
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The principle of this machine is briefly described here. Both sample and reagent are 
delivered from glass vials through a capillary housed in the capillary block. When 
analytes pass a detection window, they absorb UV light from the lamp. Samples that 
absorb UV light like proteins and DNA create a drop in light intensity. The UV light is 
converted into an electrical signal at the detector and is transformed into a trace called an 
electropherogram. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
Figure 2.5: Schematics illustrating overall instrumentation of Peregrine (a) Outside of the machine 
showing main cover, status panel and carousel cover; (b) Inside the machine showing main cover interlock, 
lamp cover and main electrophoresis compartment/ optical rail components inside the main cover, carousel 
cover interlock inside the carousel cover and power switch at the side of the machine. Images reproduced 
from reference 10. 
(a) 
  (b) 
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Figure 2.6: Schematic depicting the components inside the main cover of Peregrine. Image reproduced 
from reference 10. 
 
 
One of the important components of the CE machine is the capillary within which the 
analysis takes place. For Peregrine, the capillary is located inside the aluminium capillary 
block (Figure 2.7a) that has capillary tracks (10-70 cm long) carved into its surface 
(Figure 2.7b). The capillary can be placed into each pattern of the track according to its 
length; for example, a capillary with 20.2 cm separation length is situated in the capillary 
track as depicted in Figure 2.7b. The length of the capillary that can be fitted into the 
capillary track is determined as the separation length and the total length. The separation 
length of the capillary is defined as the length from the inlet end to the middle of the 
detection window Figure 2.7c and the total length is defined as the length from the inlet 
end to the outlet end. The separation length and the total length of the capillary fitted with 
the capillary track of Peregrine can be varied from 20 cm to 70 cm and from 34 cm to 82 
cm, respectively.  
 
For all experiments in this work performed using Peregrine, capillaries with a total length 
of 34 cm and a separation length of 20 cm (50 µm I.D., 375 µm O.D., Polymicro 
technologies, CM Scientific, UK) were employed. Capillaries were cut to the required 
length and were burned to remove polyimide coating to create 1.5 cm clear windows (the 
actual detection window is 1.25 cm) at the length of 20 cm. The burnt polyimide was 
wiped out using a fibre-free tissue soaked with ethanol. The capillaries were then placed 
into the track as illustrated in Figure 2.7b and were secured by the block cover and 
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several screws. After that the capillary block was placed into the block holder inside the 
main cover and was secured by two clamps. 
 
 
 
 
 
 
 
Figure 2.7: Schematics illustrating outside and inside of the capillary block used with Peregrine machine 
(a) Overview of the capillary block; (b) Capillary track (red line) of 20.2 cm input capillary length; (c) 
Illustrating a fused silica capillary with 1.25 cm detection window. Images reproduced from reference 10. 
 
2.4.1.2 Peregrine standard operating protocol 
In this work, the operating protocol of Peregrine was set for protein electrophoresis. The 
filter was set at 214 nm by adjusting the filter wheel. The temperature for electrophoresis 
was set at 25 °C. The reagent and sample vials were placed in their right carousel 
positions. Prior to the first protein electrophoresis, the capillary was conditioned 
according to Table 2.1. A sample was then electrokinetically injected at 5 kV for 20 
seconds and separated at 6-15 kV for 35 minutes. Between each run, the capillary was 
conditioned according to step 2 to step 4 in Table 2.1 prior to the next sample injection 
and separation. 
(a) 
 
(b) 
(c) 
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Table 2.1: Conditioning steps for new capillaries 
 
Step Condition Reagent Pressure (psi) Time (min) 
1 Flush 1 M HCl 20 20 
2 Flush DI water 20 2 
3 Flush 0.1 M HCl 30 3 
4 Flush Buffer solution 60 8 
 
2.4.1.3 Data analysis 
After the electrophoresis is completed, the collected data was processed and analysed 
using P3EVA software provided by deltaDOT. Two main analytical results obtained from 
P3EVA software and normally used in this work are GST processed electropherogram 
(Figure 2.8b) and Equiphase map (Figure 2.9a), which are discussed in detail in Section 
2.4.1.3.1 and 2.4.1.3.2. 
 
2.4.1.3.1 GST processed electropherogram 
The detection format used in the Peregrine instrument is UV based, which typically 
suffers from low sensitivity (i.e. low signal-to-noise ratio (S/N)) and poor limit of 
detection (10-5-10-6 M) for some analytes11. One of the methods to improve sensitivity 
and detection limits is to use multi-point detection (e.g. the use of photodiode array 
(PDA)) on a single run measurement.  
 
Peregrine employs a PDA as a detector. Herein, 512 diodes are placed in a linear array 
having 25 µm width and a total length of 1.28 cm. Each diode produces an 
electropherogram; hence, 512 diodes provide for 512 individual electropherograms. 
General separation transform (GST) is used to combine 512 individual electropherograms 
(Figure 2.8a) resulting in a single electropherogram (Figure 2.8b) retaining the same 
peak shape as the original electropherograms with significantly higher signal-to-noise 
ratio.  Consequently, by using multi-point detection, there is no need to modify the 
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capillary shape to achieve a longer path-length and several measurements are not required 
to achieve signal averaging in order to enhance the sensitivity and detection limits. 
 
 
 
Figure 2.8: An example of (a) raw data obtained from 1-pixel detector showing transmittance vs. time 
(scan count) and (b) GST processed electropherogram in which the axes are absorbance vs. time (min). 
 
2.4.1.3.2 Equiphase map 
An equiphase map is a 3D map showing the tracks of analytes passing through the 
detector (Figure 2.9a). The map consists of absorption, distance and time axes. Figure 
2.9b illustrates the generated tracks of analytes obtained from one of the 512 pixels of the 
detector. By dividing the distance (between pixel 1 and pixel 512) by the time the analyte 
passes the PDA, the velocity of the analyte, which depends on its intrinsic properties (e.g. 
overall charge and molecular mass) and an applied electric field, is obtained. The velocity 
is therefore equal to the slope of the track and the inclination of the slope indicates the 
magnitude of the velocity of the analyte (i.e. the steeper slope represents the higher 
velocity.)  
 
In addition, the track may be extrapolated back to the injection point so that any peaks 
being not related to the analytes and moving in the opposite direction will not be present 
in the processed signal. On the other hand, analytes moving from the outlet towards the 
detector can be observed by reversing the order of the pixels. This is useful for the 
determination of EOF during the performance of electrophoresis. The track may also be 
(a) (b) 
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extrapolated forward to predict the elution time of each analyte so that it can be 
selectively collected after separation. 
 
 
 
Figure 2.9: Equiphase map (a) An example of equiphase map; (b) Schematic illustrating how the equiphase 
map is generated. Image (a) reproduced from reference 10 and (b) adapted from reference 12. 
 
2.4.2 Microchip-based electrophoresis 
The setup for microchip-based electrophoresis consisted of a microdevice (i.e. cross-piece 
PDMS microdevice, cross-piece PDMS microdevice coupled to a fused-silica (glass) 
capillary and interfacing droplet-based microdevice), a platform for holding the 
microdevice, a high voltage power supply and a fluorescence detector. The cross-piece 
PDMS microdevice and the cross-piece PDMS microdevice coupled to the capillary are 
illustrated in Figure 3.2a and Figure 3.2b and described in detail in Chapter 3, while the 
interfacing droplet-based microdevices are depicted in Chapter 5. An aluminium 
platform was used to hold the cross-piece PDMS microdevice and the cross-piece PDMS 
microdevice coupled to the capillary (Figure 3.2c in Chapter 3), while either old (Figure 
5.25 in Chapter 5 and Figure 6.2 in Chapter 6) or new (Figure 6.8 in Chapter 6) 
acrylic platform was employed to hold the interfacing droplet-based microdevices. 
Illustrations of different types of microdevices and platforms are depicted with fully 
descriptive detail in different chapters where they are mentioned in the specific 
experimental setup. 
(a) (b) 
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2.4.2.1 Fluorescence detection 
Fluorescence detection in this work was performed using a Nikon Eclipse E400 (Nikon 
Ltd., Surrey, UK). The light from a 100 W mercury lamp (Nikon UK Ltd.) passed 
through a FITC filter cube (an excitation filter at 470-490 nm, a long pass emission filter 
at 510 nm cut-on, Nikon Instruments UK) and focused on the detection area on the 
microdevice through x4 or x10 objective lens. Fluorescence emission was detected by a 
CCD camera (C4742-96, Hamamatsu Photonic Systems, Bridgewater, NJ), which was 
controlled using Wasabi program version 2.0. The collected images were analysed with 
Image J software (NIH). The extracted data from images were used to create 
electropherograms.  
 
2.4.2.2 Microdevice-based instrument setup 
After the microdevice used to perform electrophoresis was filled with a buffer solution, 
the microdevice was then placed on a platform that was screwed to a motorized 
microscope stage (Optiscan, Prior Scientific Instruments Ltd., UK). A conductivity check 
was carried out by applying voltages through Pt electrodes across the separation channel 
prior to electrophoresis. After that, the electric field was applied in the injection and 
separation mode using a high voltage power supply (HVS448 3000V, Labsmith, CA, 
USA).  
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3.1 Introduction 
For many years, protein electrophoresis was performed in slab gel formats, employing 
polyacrylamide as a sieving matrix. Due to the long analysis times and laborious process 
of slab gel preparation, proteins separations were subsequently transferred to capillary-
based formats. However, gel shrinkage and the generation of bubbles inside capillaries 
often occur during in situ polymerization of polyacrylamide1,2. In addition, column 
stability is typically poor when cross-linked polyacrylamide is used3. Consequently, non-
crosslinked polymers, which are replaceable, have been proposed and used for a variety 
of protein separations using capillary electrophoresis. Significantly, due to their low 
viscosities, such polymer-based buffers may also be used in conjunction with 
microfluidic channels4.  
 
Examples of non-crosslinked polymers that have been used as sieving matrices for 
separations of SDS-protein complexes include linear polyacrylamide (LPA)1,2,3,5, 
polyethylene oxide (PEO)1,3,6,7, dextran1,3,7,8, pullulan1,4,9,10, polydimethylacrylamide 
(PDMA)4,11,12, and pluronic4,13. Many commercial buffers for SDS-protein capillary 
electrophoresis (including SDS-MW gel buffer from Beckman Coulter, ProSort SDS-
protein buffer from Applied Biosystems, SDS-protein calibration kit for CE from Sigma 
Aldrich and CE-SDS run buffer from Bio-Rad) also employ non-crosslinked polymers 
due to the ability to be easily replaced after each run. Unfortunately, some of these 
commercial buffers are no longer available, so they were not tested in this work. 
 
Of the non-crosslinked polymers described, PEO, dextran and PDMA have been widely 
used in the preparation of laboratory-made buffers and are assessed in the current work. 
PEO is a linear polymer that has been extensively studied as the functional component in 
sieving matrices. It provides several advantages, including low viscosity, minimal 
absorption in the UV region of the electromagnetic spectrum, utility as a dynamic surface 
coating, limited reactivity with fluorogenic labeling reagents and proteins and most 
importantly access to high resolution separations14. Owing to these properties, PEO has 
been used as a sieving matrix in commercial buffers14. Dextran is a hydrophilic-branched 
polymer, which has low viscosity and good transparency in the UV region of the 
electromagnetic spectrum. It also provides for high resolution separations of a wide range 
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of proteins and peptides14. For the background electrolytes, Tris (hydroxymethyl) 
aminomethane and N-Cyclohexyl-2-aminoethanesulfonic acid (TRIS-CHES) are 
compatible with PEO and 2-Amino-2-methyl-1,3-propanediol and cacodylic acid 
(AMPD-CACO) are compatible with dextran in terms of conductivity and UV absorption 
characteristics3. TRIS-CHES buffer also suppresses SDS adsorption to PEO15. PDMA is a 
low viscosity polymer with excellent sieving capabilities and a high surface coating 
capacity. It is employed as a sieving matrix in the Agilent Bioanalyzer 2100 running 
buffer14. Moreover, Tabuchi and co-workers11 have reported the use of PDMA in borate 
buffer as a sieving matrix for protein separations in microfluidic devices. 
 
Since the studies described in this thesis are focused on the rapid and high-resolution 
separation of proteins, an appropriate buffer system that is compatible with the droplet-
based microfluidic format is required. In addition, the developed buffer should be 
compatible with both PDMS and glass capillary systems that are used in this work. Both 
commercial and laboratory-made buffers were tested and optimized for protein 
separations using a commercial capillary electrophoresis system, a cross-piece PDMS 
microdevice and a cross-piece PDMS microdevice coupled to a glass capillary as 
illustrated in the diagram (Figure 3.1). The most appropriate buffer from the testing was 
then used for the droplet-based separation of proteins discussed in Chapter 6. 
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Figure 3.1: Diagram showing the process of buffer development for protein separations.
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3.2 Experimental 
3.2.1 Chemicals  
All chemicals used in the experiments discussed in this chapter are listed in Table 3.1. 
 
 
Table 3.1: Samples and chemicals used to perform protein electrophoresis in Chapter 3. 
 
No. Chemical Supplier 
1. 2-Amino-2-methyl-1,3-propanediol (AMPD) Sigma Aldrich, UK 
2.  2-(Cyclohexylamino)ethanesulfonic acid (CHES) Sigma Aldrich, UK 
3. β-Mercaptoethanol (BME) Sigma Aldrich, UK 
4. Albumin from bovine serum (BSA) Sigma Aldrich, UK 
5.  Albumin, Fluorescein isothiocyanate conjugate bovine  
(BSA-FITC) 
Sigma Aldrich, UK 
6. Ammonium peroxydisulfate (APS) Sigma Aldrich, UK 
7. Benchmark™ Fluorescent protein standard (11-155 kDa)  
in 0.45 M TRIS-HCl pH 8.5, 2% SDS, 12% glycerol,  
0.0025% Coomassie G-250 
Thermo Fisher 
Scientific, UK 
8. Cacodylic acid (CACO) Sigma Aldrich, UK 
9. Carbonic anhydrase from bovine erythrocytes (CA) Sigma Aldrich, UK 
10. Dextran from Leuconostoc spp. 70 kDa and 2 MDa Sigma Aldrich, UK 
11. EOTrol™ polymer solution LN Target Discovery, 
USA 
12. Fluorescein ACROS Organic™ Fisher Scientific, UK 
13. Fluorescent molecular weight marker (20-200 kDa) containing 
62 mM Tris-HCl, pH 8.0, 1 mM EDTA, 3% sucrose, 0.5% 
dithiothreitol, 2% SDS, and 0.005% bromophenol blue 
Sigma Aldrich, UK 
14. Glycerol Sigma Aldrich, UK 
15. Hydrochloric acid Sigma Aldrich, UK 
16. Isopropanol Sigma Aldrich, UK 
17. Lysozyme from chicken egg white Sigma Aldrich, UK 
18. N, N-dimethylacrylamide Sigma Aldrich, UK 
19. N, N, N’, N’-tetramethylenediamine (TEMED) Sigma Aldrich, UK 
20. PA 800 plus SDS-MW gel buffer, proprietary formulation, 
0.2% SDS, pH 8 (Beckman buffer)  
Beckman Coulter, 
UK 
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No. Chemical Supplier 
21. PA 800 plus sample buffer, 0.1 M TRIS-HCl, 1% SDS, pH 9 
(Beckman sample buffer) 
Beckman Coulter, 
UK 
22. Polyethylene oxide (PEO) 100 kDa, 200 kDa and 1 MDa Sigma Aldrich, UK 
23. Sodium dihydrogen phosphate  Sigma Aldrich, UK 
24. Sodium dodecyl sulfate (SDS) Sigma Aldrich, UK 
25. Sodium sulfide  Sigma Aldrich, UK 
26. Sodium tetraborate Sigma Aldrich, UK 
27. Sulfuric acid Sigma Aldrich, UK 
28. Thiourea Sigma Aldrich, UK 
29. TRIS-Borate-EDTA buffer (10x TBE) Sigma Aldrich, UK 
30. Tris(hydroxymethyl)aminomethane (Trizma® base or TRIS) Sigma Aldrich, UK 
31. Tris(hydroxymethyl)aminomethane hydrochloride  
(Trizma® hydrochloride or TRIS-HCl) 
Sigma Aldrich, UK 
 
Note: Benchmark fluorescent protein standard (Thermo Fisher Scientific, UK) consists of seven proteins 
with molecular weight of 12, 23, 33, 41, 65, 100 and 155 kDa16. Fluorescent molecular weight marker 
(Sigma Aldrich, UK) consists of six proteins i.e. trypsin inhibitor (20 kDa), carbonic anhydrase (29 kDa), 
alcohol dehydrogenase (39.8 kDa), bovine serum albumin (66 kDa), β-galactosidase (116 kDa) and myosin 
(200 kDa) 17. 
 
3.2.2 Preparation of samples 
 
Table 3.2: Sample buffers for protein separation using the commercial CE machine. 
No. Sample buffer 
1. Beckman sample buffer added 5% v/v BME 
2. 5 mM SDS, 5 mM sodium tetraborate buffer, pH 8.5 
3. 5 mM SDS, 5 mM sodium tetraborate buffer, pH 8.8 
4. 5 mM SDS, 5 mM sodium tetraborate buffer, pH 9.0 
5. 0.01 M TRIS-HCl, 0.1% SDS, pH 6.6 
6. 1x TBE, 0.1% SDS, pH 7.56 added 5% (v/v) BME 
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For capillary gel electrophoretic separations of proteins using the commercial CE system, 
a 6-mg/ml stock solution of each protein standard (lysozyme, CA and BSA) was prepared 
in deionized water (DI water, Direct-Q, Merck Millipore, UK). Each protein standard and 
a mixture of these three proteins were then prepared by diluting the stock solution using 
an appropriate buffer (Table 3.2). All protein samples were heated at 95°C for 5 minutes. 
The final concentration of protein standards and each protein in the mixture was 0.5 
mg/ml. For all experiments, 0.5 mg/ml of thiourea dissolved in DI water was used as an 
EOF marker. 
 
Fluorescein, BSA-FITC, benchmark fluorescent protein standard (11-155 kDa) and 
fluorescent molecular weight marker (20-200 kDa) were used to investigate protein 
separations using the cross-piece PDMS microdevice and the cross-piece PDMS 
microdevice coupled to a glass capillary. Fluorescein (4.5 mM) was prepared in 960 µl of 
DI water and added 40 µl of 1 M NaOH. BSA-FITC was dissolved in 0.2% SDS to 
achieve a concentration of 1 mg/ml and then heated at 95 °C for 5 minutes. The 
benchmark fluorescent protein standard (11-155 kDa) was used as received and without 
heating, while the fluorescent molecular weight marker (20-200 kDa) was heated at 65 °C 
for 5 minutes prior to being used. Fluorescein and protein samples were pipetted and 
mixed in a sample reservoir of a cross-piece PDMS microdevice prior to injection. 
 
3.2.3 Preparation of running buffers   
3.2.3.1 Diluted Beckman buffers 
 Beckman buffer was diluted in DI water to concentrations of 0.2x, 0.25x, 0.33x and 0.5x. 
The diluted Beckman buffers were then stirred at 25 °C overnight. For the diluted 
Beckman buffer mixed with EOTrol, 0.5 ml of EOTrol was added to 9.5 ml of 0.2x 
Beckman buffer and the mixture was stirred thoroughly. All buffers were degassed prior 
to use. 
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3.2.3.2 Dialysed Beckman buffers 
Beckman buffer was dialysed against DI water or 0.1x TBE buffer, pH 7 using a cellulose 
dialysis tube, benzoylated (Sigma Aldrich, UK), which separates compounds with a 
molecular weight of ≤ 1200 Da from compounds with molecular weights above 2000 Da. 
The dialysis tube was prepared by excessive washing with water to remove glycerin. 
Sulfur compounds were also removed from the tube by treating with a 0.3% (w/v) sodium 
sulfide solution at 70 °C for 1 minute. The tube was then washed with 60°C water for 2 
minutes, followed by 0.2% sulfuric acid and rinsed with hot water to remove the acid. 
Subsequently, Beckman buffer was poured into the dialysis tube, which was then 
immersed into DI water or 0.1x TBE buffer. Dialysis was performed for two days at 25 
°C, with the DI water or 0.1x TBE buffer being stirred throughout. After the dialysis 
process, 0.5% SDS was added to the dialysed Beckman buffer against 0.1x TBE buffer. 
All dialysed Beckman buffers were degassed before they were used. 
 
3.2.3.3 80/20 Beckman: 5 mM SDS, 5 mM sodium tetraborate buffer, pH 9 
8 ml of Beckman buffer was mixed with 2 ml of 5 mM SDS, 5 mM sodium tetraborate 
buffer, pH 9 to achieve a 8:2 volumetric ratio. The mixture was stirred thoroughly and 
degassed before use. 
 
3.2.3.4 PEO and dextran based buffers 
PEO having molecular weights of 100 kDa, 200 kDa and 1 MDa and dextran having 
molecular weight of 70 kDa and 2 MDa were investigated in this work. Both polymers 
were used to prepare buffers with different compositions (e.g. background electrolytes, 
polymer molecular weight and concentration, pH and additives) as shown in Table 3.4. 
For PEO, butylated hydroxytoluene (BHT) is added as a stabilizer to slow PEO 
degradation. However, the properties of BHT, most notably its poor solubility in water 
and significant absorption in the UV region of the electromagnetic spectrum, mean that it 
interferes with protein electrophoresis. By extensively rinsing PEO with acetone, BHT 
could be removed and washed out to a large extent. PEO was then left to dry in the air 
prior to use. 
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Samples with the chosen molecular weights of PEO and dextran were weighed to achieve 
the required concentration (%w/v). For PEO-based buffers, PEO was dissolved in 0.1 M 
(or 0.05 M) TRIS-CHES, 0.1% SDS buffer in which the pH of this buffer was adjusted 
with CHES to achieve a pH between 8.2 and 8.7. Most samples of dextran and dextran 
mixed with PEO were prepared in 0.05 M AMPD-CACO, 0.1% SDS buffer. Other 
dextran-based buffers were prepared in 0.1 M TRIS-HCl, 0.1% SDS buffer; 0.1 M TRIS-
borate, 0.1% SDS buffer or 0.1 M TRIS- NaH2PO4, 0.1% buffer. Other additives (i.e. 2% 
to 10% (v/v) glycerol and EOTrol) could be added to these buffers. All buffers were 
stirred at 25°C overnight, filtered through a 5 µm polyethersulfone (PES) membrane filter 
and degassed before use.  
 
3.2.3.5 PDMA based buffer 
PDMA was synthesized in water according to the protocol reported by Ren and co-
workers18. Briefly, 13.75 ml water and 0.475 ml isopropanol were added to the reaction 
flask containing 1.25 ml N, N-dimethylacrylamide. The mixture was degassed for 30 
minutes and heated in a water bath at 50°C for 20 minutes. After that, 0.08 ml of 
10%(v/v) N, N, N’, N’-tetramethylenediamine (TEMED) and 0.08 ml of 10% (w/v) 
ammonium peroxydisulfate (APS) were added. The polymerization was carried out at 
50°C for 1.5 hours. The reaction product was then dialysed against DI water for 2 days 
using a 1200 molecular weight cut-off dialysis sac and lyophilized. The yield of the final 
product was found to be 70.23%.  
 
The synthesized PDMA was dissolved in DI water at the concentration of 0.6 mg/ml and 
was characterized by gel permeation chromatography (PL-GPC 50, Agilent Technologies, 
UK). The average molecular weight of the synthesized PDMA obtained from the 
calibration curve of PEO standards (10-1000 kDa) was found to be ~388 kDa with the 
polydispersity index (PDI) of 3.21. 
  
3.2.4 Capillary gel electrophoresis using commercial CE instrument (Peregrine) 
The protocol for capillary gel electrophoresis of proteins is described in detail in Section 
2.4.1.2. Three protein standards (lysozyme, CA and BSA) and a mixture of these proteins 
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were injected from a cathode, while thiourea (the EOF marker) was injected from an 
anode. Each sample was repeated three times for each investigated buffer. The data were 
analysed as described in Section 2.4.1.3.1 and Section 2.4.1.3.2. Electropherograms and 
equiphase maps obtained from each buffer were compared.  
 
3.2.5 Capillary gel electrophoresis on microfluidic devices  
Two microdevices were used to perform protein separations for buffer assessment. One 
consists of a cross-piece injector and a separation channel made of PDMS (Figure 3.2a), 
while the other consists of a cross-piece PDMS injector and a glass capillary as a 
separation channel (Figure 3.2b).  
 
 
 
 
 
 
  
 
 
 
 
 
 
Figure 3.2: Microfluidic devices used to perform protein gel electrophoresis (a) A cross-piece PDMS 
microdevice; (b) A cross-piece PDMS microdevice with an enlarged channel for the insertion of a glass 
capillary; (c) Aluminium platform for holding either a cross-piece PDMS microdevice or a cross-piece 
PDMS microdevice coupled to a glass capillary. S = sample reservoir, SW = sample waste reservoir, B = 
buffer reservoir and BW = buffer waste reservoir. 
 
 
Both microdevices were filled with DI water after oxygen plasma bonding until they were 
used. For the wholly PDMS microdevice (Figure 3.2a), a tested polymer-based buffer 
was replaced DI water by filling the buffer via the buffer waste reservoir using a plastic 
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syringe. For the cross-piece PDMS microdevice coupled to a glass capillary (Figure 
3.2b), DI water was removed and a non-polymer buffer (i.e. 0.1x TBE buffer) was filled 
into the PDMS part. A 5-cm long detection window on a 7-cm long glass capillary was 
created by burning the polyimide coating off and cleaning with ethanol. The glass 
capillary was then treated with 1 M HCl for 5 minutes and filled with a polymer-based 
buffer using pressure for 20 minutes prior to being inserted into the enlarged end of the 
microdevice. The other end of the glass capillary was immersed in a buffer waste 
reservoir (a microcentrifuge tube), not shown in Figure 3.2b. The experimental setup for 
both microdevices is described in detail in Section 2.4.2.  
 
CE separations involved both an injection and separation phase. In the injection step, 
negative voltages were applied to the sample, the buffer and the buffer waste reservoir, 
while a positive voltage was applied to the sample waste reservoir for a given period of 
time. After injection, positive voltages were applied to the sample, the sample waste and 
the buffer waste reservoir, while negative voltage was applied to the buffer reservoir for a 
given period of time to allow separation. The magnitudes of the applied voltages were 
varied for each experiment. 
 
3.3 Results and discussion 
3.3.1 Separations of proteins in commercial Beckman buffer and its modified buffers 
using a commercial CE machine (Peregrine) 
3.3.1.1 Beckman running buffer and Beckman sample buffer 
One of the commercially available SDS-based buffers for capillary electrophoresis of 
proteins that were extensively used in many reports is SDS-MW gel buffer from 
Beckman Coulter19–40. This buffer referred to in this work as “Beckman buffer” was 
investigated to ascertain if it had the potential to be employed for droplet-based protein 
separation. Initially and as a control, Beckman buffer was employed as it typically is, as a 
sieving matrix in protein gel electrophoresis. Here a three-protein mixture was separated 
using a commercial capillary electrophoresis machine (Peregrine, deltaDOT Ltd., UK). 
All protein samples were prepared in the Beckman sample buffer. The capillary gel 
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electrophoresis was performed according to the protocol described in detail in Section 
2.4.1.2. 
 
 
 
Figure 3.3: The separation of a 3-protein mixture in Beckman buffer using the CE machine (a) GST 
processed electropherograms of lysozyme (1), CA (2), BSA (3) and a mixture of these proteins performed 
in Beckman buffer using a 34 cm long capillary having an effective length of 20 cm, at 25°C and using 
electric field strength of 441.18 V/cm (Note: Y-axes are offset due to overlaying). All samples were 
prepared in Beckman sample buffer with the addition of 2-mercaptoethanol (BME); (b) An equiphase map 
obtained from the separation of the mixture.  
 
 
Electropherograms of the three-protein mixture (red line) and the individual protein 
standards (lysozyme – blue line, carbonic anhydrase (CA) – pink line and bovine serum 
albumin (BSA) – green line) electrophoresed in Beckman buffer are overlaid as shown in 
Figure 3.3a. Of these three proteins, lysozyme (14.3 kDa) elutes first followed by CA (30 
kDa) and BSA (66 kDa), respectively. The elution order of proteins in gel electrophoresis 
is according to their size (or molecular weight); that is smaller proteins elute first 
followed by larger proteins41. To enable comparison to other buffer systems evaluated in 
this work, the overall analysis time and the resolution between the peaks was determined 
and logged. The overall analysis time (OAT) can be defined as the length of time between 
sample injection and when the last analyte elutes. The OAT is influenced not only by the 
separation matrix but also by the length of the capillary, the applied voltage, the largest 
protein analyte (in a size separation) and the presence of EOF.  Under the conditions 
described above, in Beckman buffer it is ~ 20 minutes. The resolution of separation 
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between lysozyme (1) and CA (2) and between CA (2) and BSA (3) according to 
Equation 1.14 are 5.42 and 7.71, respectively (Table 3.3).  
 
The investigation of EOF can be performed by injecting thiourea, a neutral marker, from 
the capillary outlet at the same time the sample is injected at the capillary inlet. Typically, 
SDS-protein complexes in gel electrophoresis will migrate under an electric field from a 
cathode (inlet) towards an anode (outlet). Meanwhile, thiourea injected from the outlet 
will migrate from the anode towards the cathode if the cathodic EOF (the flow of EOF 
towards a cathode) is present. The migrations of proteins and thiourea are therefore in the 
opposite direction and this can be observed in an equiphase map (see Section 2.4.1.3.2 
for the generation of equiphase map). In this case, the equiphase map (Figure 3.3b) 
shows only the lines with positive slope, which represent the migration of proteins 
injected from the inlet, whereas the lines with negative slope representing the migration 
of thiourea from the outlet are not observed. This indicates the absence or small 
magnitude of EOF when using Beckman buffer. Most protein size separation buffers 
contain reagents to suppress or eliminate EOF, as its presence leads to run-to-run 
variability in separation, leading to inaccuracy in size assessment of unknown proteins. 
Therefore testing for the presence of EOF in buffers created here is essential.  
 
3.3.1.2 Beckman running buffer and modified sample buffers 
Other reported modified Beckman buffer42 or modified sample buffers21,22, 29,23 for protein 
separation were also tested. Figure 3.4 shows electropherograms and equiphase maps of 
proteins in different sample buffers separated in Beckman buffer. Protein standards 
(lysozyme, CA and BSA) and a protein mixture of these protein standards were prepared 
in 10 mM TRIS-HCl buffer with 0.1% SDS, pH 6.6 (Figure 3.4a), 5 mM SDS, 5 mM 
sodium tetraborate buffer, pH 8.5 (Figure 3.4b) and 5 mM SDS, 5 mM sodium 
tetraborate buffer, pH 8.8 (Figure 3.4c).  
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Figure 3.4: The separation of a 3-protein mixture in Beckman buffer in which samples were prepared in (a) 
10 mM TRIS-HCl, 0.1% SDS, pH 6.6; (b) 5 mM SDS, 5 mM sodium tetraborate buffer, pH 8.5; (c) 5 mM 
SDS, 5 mM sodium tetraborate buffer, pH 8.8. For (a), (b) and (c), (i) Showing GST processed 
electropherograms of lysozyme (1), CA (2), BSA (3) and a mixture of these proteins performed in Beckman 
buffer using the CE machine that employed a 34 cm long capillary having an effective length of 20 cm, at 
25°C (Note: Y-axes are offset due to overlaying), (ii) Showing the equiphase map from the separation of 
the mixture. The electric field strength used in (a) was 300 V/cm and used in (b) and (c) was 450 V/cm. 
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Obvious peaks of salts (in the background electrolyte) are observed in the front of the 
electropherogram in Figure 3.4a (TRIS-HCl sample buffer) and the total analysis time is 
found to be 26.3 minutes for the separation field strength of 300 V/cm. Since the 
modified buffers were obtained from various published articles, different electric fields 
were used according to the published protocols. The electric fields were then extrapolated 
for the comparison of analysis times using Equation 1.8. Therefore, the analysis time for 
TRIS-HCl sample buffer is estimated to be 17.5 minutes at 450 V/cm by extrapolation to 
compare with sodium tetraborate sample buffers at pH 8.5 and pH 8.8 at 450 V/cm in 
which their analysis times are found from the electropherograms (Figure 3.4b and 
Figure 3.4c) to be 19.8 and 16.7 minutes, respectively. The total analysis times obtained 
from using different sample buffers are not significantly different from that of 
commercial Beckman sample buffer (~19 minutes at 450 V/cm by extrapolation). Also, 
no EOF is observed in the equiphase maps of these three sample buffers. 
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Table 3.3: Analytical results of proteins prepared in Beckman sample buffer or modified sample buffers separated in original or modified Beckman buffer. 
 
 
* Note: Two numbers of resolutions are the resolutions of lysozyme and CA peaks and CA and BSA peaks, respectively. NS = No Separation and NT = Not Tested. 
Buffer solution Glass capillary (Peregrine) Cross-piece PDMS 
microdevice 
Cross-piece PDMS coupled 
to a glass capillary 
Ref. 
No. Running buffer Sample buffer Field 
strength 
(V/cm) 
Analysis 
time 
(min) 
R 
 
Field 
strength 
(V/cm) 
Analysis 
time 
(min) 
R 
 
Field 
strength 
(V/cm) 
Analysis 
time 
(min) 
R 
 
1. Beckman buffer  Beckman sample buffer added 5% BME/ 
Sample buffer containing in protein 
ladder (Sigma Aldrich) 
441.18 20 5.42 
7.71 
135 3.2 NS NT NT NT - 
2. 0.2x Beckman buffer  Beckman sample buffer added 5% BME 441.18 NS NS  NT NT  NT NT  NT  NT  - 
3. 0.25x Beckman buffer  Beckman sample buffer added 5% BME 441.18 NS NS  NT  NT  NT NT  NT  NT  - 
4. 0.33x Beckman buffer  Beckman sample buffer added 5% BME 441.18 NS  NS  NT  NT  NT NT  NT  NT  - 
5. 0.5x Beckman buffer  Beckman sample buffer added 5% BME 441.18 NS  NS  NT  NT  NT NT  NT  NT  - 
6. 0.2x Beckman buffer 
added EOTrol 
Sample buffer containing in protein 
ladder (Sigma Aldrich) 
NT NT NT 121.67 NS NS NT NT NT - 
7. Dialysed Beckman 
against DI water 
Sample buffer containing in protein 
ladder (Sigma Aldrich) 
NT  NT  NT  NT  NT  NT  88.75 NS NS - 
8. Dialysed Beckman 
against 0.1x TBE 
Sample buffer containing in protein 
ladder (Sigma Aldrich) 
NT  NT  NT  NT  NT  NT  88.75 NS NS - 
9. Dialysed Beckman 
against 0.1x TBE 
added 0.5% SDS 
Sample buffer containing in protein 
ladder (Sigma Aldrich) 
 
NT  NT  NT  NT  NT  NT  88.75 NS NS - 
10. 80:20 Beckman: 5 mM 
SDS, 5 mM sodium 
tetraborate buffer, pH 9 
5 mM SDS, 5 mM sodium tetraborate 
buffer, pH 9 
462.4 16.5 4.30 
3.69 
NT NT  NT  NT  NT  NT  
42 
11. Beckman buffer 0.01 M TRIS-HCl, 0.1% SDS, pH 6.6 300 26.3 5.67 
6.28 
NT  NT  NT  NT  NT  NT  
29 
12. Beckman buffer 5 mM SDS, 5 mM sodium tetraborate 
buffer, pH 8.5 
450 19.8 4.47 
4.31 
NT  NT  NT  NT  NT  NT  
21,22 
13. Beckman buffer 5 mM SDS, 5 mM sodium tetraborate 
buffer, pH 8.8 
450 16.7 4.57 
4.47 
NT  NT  NT  NT  NT  NT  
23 
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The effect of pH of samples on protein separation was also investigated from these 
experiments. It was found that proteins prepared in sodium tetraborate buffer at pH 8.8 
migrated faster (Figure 3.5a) and the resolutions (Figure 3.5b) were higher than those 
prepared in pH 8.5 (Rlyso-CA = 4.47 (pH 8.5) and 4.57 (pH 8.8); RCA-BSA = 4.31 (pH 8.5) 
and 4.47 (pH 8.8)). This might be because SDS-protein complexes in sample buffer pH 
8.8 expose in more negatively charged environment than that of pH 8.5 and then tend to 
migrate towards the anode faster providing for less band broadening. Consequently, the 
resolution of separation of SDS-protein complexes in higher pH environment is higher 
than that of the lower pH. 
	
 
Figure 3.5: Effect of pH of samples on protein separation. (a) A plot of mobility versus molecular weight 
of proteins; (b) A plot of resolution versus molecular weight. Two sets of a 3-protein mixture (lysozyme, 
CA and BSA) prepared in 5 mM borate buffer, 5 mM SDS at pH 8.5 and pH 8.8 were separated in 
Beckman buffer using	the	CE	machine	that	employed	a 34 cm long capillary having an effective length of 
20 cm, at 25°C and using separation field strength of 450 V/cm. 
 
3.3.1.3 Modified Beckman running buffer and modified sample buffer 
The modified Beckman buffer according to Fruetel’s work42 was also tested. Beckman 
buffer was mixed with 5 mM SDS, 5 mM tetraborate buffer, pH 9.0 at the ratio of 80:20 
and was used to separate a protein mixture at 462.4 V/cm within 16.5 minutes. The 
resolutions between lysozyme and CA peaks and between CA and BSA peaks are 4.30 
and 3.69, respectively.  By extrapolating the electric field strength to 450 V/cm, the total 
analysis time is found to be ~17 minutes, which is not significantly different comparing to 
the original Beckman buffer. However, thiourea peaks are observed both in the 
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electropherograms (Figure 3.6a) and in the equiphase map (Figure 3.6b) indicating the 
presence of EOF. 
 
 
 
Figure 3.6: The separation of a 3-protein mixture in an 80/20 mixture of Beckman buffer and 5 mM SDS in 
5 mM sodium tetraborate buffer, pH 9.0 using the CE machine (a) GST processed electropherograms of 
lysozyme (1), CA (2), BSA (3) and a mixture of these proteins performed using a 34 cm long capillary 
having an effective length of 20 cm, at 25°C and using electric field strength of 462.4 V/cm. Thiourea 
peaks (4) are also observed in these electropherograms (Note: Y-axes are offset due to overlaying); (b) The 
equiphase map from the separation of the mixture.  
 
3.3.2 Separations of proteins in commercial Beckman buffer using a cross-piece 
PDMS microdevice 
The original Beckman running buffer was also tested in a PDMS microdevice for two 
reasons. First, the original Beckman running buffer serving as a baseline for other buffers 
in this work due to its reputation as an industrial gold standard shows good performance 
for protein separations as demonstrated in Section 3.3.1. Second, if this buffer works for 
protein separations in a PDMS microdevice, the development of buffers for droplet-based 
separations will be easier and less time-consuming. 
 
The electrophoresis of fluorescently labeled protein ladder (20-200 kDa from Sigma 
Aldrich, UK) was performed using the original Beckman buffer in a cross-piece PDMS 
microdevice. The sample was injected at t = 120 s according to the time in the 
electropherogram (Figure 3.7) and was detected at 0.5 cm from the injection point with 
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the analysis time of ~ 4 minutes. It was found that seven proteins in the ladder were not 
separated properly at this separation length using the separation field strength of 135 
V/cm. If the separation length is increased, the total analysis time will also increase. Too 
long of an analysis time will make this buffer not suitable for droplet-based protein 
separation in which rapid separation for each droplet is required. The other way to 
achieve higher resolution is to increase separation field strength. However, when higher 
voltages were applied to this buffer system, the current increased, leading to the buffer 
boiling and the formation of bubbles that interfered with the separation.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7: Electropherogram of a fluorescently labeled protein ladder (20-200 kDa fluorescent molecular 
weight marker, Sigma Aldrich, UK) performed in Beckman buffer solution in a cross-piece PDMS 
microdevice using electric field strength of 135 V/cm. Detection was done at 0.5 cm from the intersection. 
Note: The injection time was at 120 seconds according to the electropherogram. 
 
 
Although the original Beckman running buffer was not suitable to be used in PDMS 
microdevices due to the poor heat dissipation of the PDMS43, it was still useful as a 
control for buffer development in the commercial CE machine. Since the buffer 
development was performed parallel to the development of interfacing droplet-based 
microdevices (Chapter 5), it was found that some parts of the interfacing microdevices 
needed to be hydrophilic and some needed to be hydrophobic to achieve successful 
droplet injection. As a result, the change of the microdevice material to allow better heat 
dissipation was not easy.  
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Another way to address the buffer boiling was to deal with the background electrolyte of 
the Beckman buffer. The concentration of the background electrolyte in Beckman buffer 
can be modified to reduce the salt level, so it might be used with increased electric field 
strength and without buffer boiling44. The decrease in concentration of background 
electrolyte was performed by dilution and dialysis of Beckman buffer as discussed in 
detail in Section 3.3.3. 
 
3.3.3 Separations of proteins in diluted and dialysed Beckman buffer  
3.3.3.1 Diluted Beckman buffer in DI water  
Beckman buffer was diluted in DI water to achieve concentrations of 0.2x, 0.25x, 0.33x 
and 0.5x Beckman buffer. The diluted Beckman buffers were tested on the Peregrine 
instrument to investigate the separation efficiency of buffers. A protein standard (BSA) 
was injected in tandem with thiourea prepared in various concentrations of diluted 
Beckman buffer at either end of the capillary as described earlier and was electrophoresed 
at 441.18 V/cm.  
 
 
Figure 3.8: Electrophoresis of BSA and thiourea in various concentrations of diluted Beckman buffer using 
the CE machine. (a) GST processed electropherograms of BSA and thiourea performed in Beckman diluted 
in DI water at concentrations of 0.2x (green line), 0.25x (pink line), 0.33x (blue line) and 0.5x (red line) 
using a 34 cm long capillary having an effective length of 20 cm, at 25°C and using electric field strength 
of 441.18 V/cm. The peaks shown in these electropherograms are thiourea injected from the opposite end of 
the capillary to BSA, which is not observed (Note: Y-axes are offset due to overlaying); (b) An equiphase 
map shows the opposite direction of migration of thiourea due to high EOF.   
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Only thiourea peaks were observed, confirmed by the negative slopes of the lines in the 
equiphase map (Figure 3.8b), in the electropherograms (Figure 3.8a). It was found that 
thiourea migrated faster in lower concentration of Beckman buffer indicating the presence 
of higher EOF.  
 
To compensate for the reduction in concentration of the EOF suppressant in the diluted 
buffers, the 0.2x Beckman buffer was mixed with EOTrol (Target Discovery Inc., CA, 
USA). This is a dynamic coating solution for controlling EOF45 and was tested in a cross-
piece PDMS microdevice. Although the EOF was decreased, which allowed the 
successful injection of fluorescently labeled protein ladder into the separation channel, 
protein ladder was not separated either at 0.5 cm or at 1.0 cm from the injection point 
(Figure 3.9). The loss of resolution might be due to the dilution of the sieving matrix in 
Beckman buffer. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.9: Electropherograms of protein ladder (20-200 kDa fluorescent molecular weight marker, Sigma 
Aldrich, UK) performed in 0.2x Beckman mixed with EOTrol buffer on a cross-piece PDMS microdevice 
using electric field strength of 121.67 V/cm. The separations were observed at two detection points: 0.5 cm 
(black line) and 1.0 cm (blue line) measured from the intersection. Note: The actual injection time was not 
recorded and y-axes are offset due to overlaying. 
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3.3.3.2 Dialysed Beckman buffer against DI water or 0.1x TBE  
In order to reduce the concentration of background electrolyte without the dilution of the 
sieving matrix, Beckman buffer was dialysed against either DI water or 0.1x TBE buffer 
and both of them were tested for protein separations using a cross-piece PDMS 
microdevice filled with 0.1x TBE buffer coupled to a glass capillary filled with the 
dialysed Beckman buffer (against DI water or against 0.1x TBE buffer). The testing was 
performed using the PDMS microdevice coupled to the glass capillary due to two 
reasons. First, the coupling between PDMS and glass devices was also employed in the 
development of interfacing droplet-based microdevices from “Design 3” to “Design 6”, 
which is further described in Chapter 5. Second, using the glass capillary as a separation 
channel might improve the heat dissipation and hence allowed the use of a higher electric 
field to achieve greater resolution. It was found that there was sample leakage into the 
separation channel after the injection as shown in the electropherogram (Figure 3.10) as 
two long bright bands although high pull-back voltages were applied.  
 
 
 
 
 
 
 
  
 
 
 
Figure 3.10: An electropherogram of protein ladder (20-200 kDa fluorescent molecular weight marker, 
Sigma Aldrich, UK) electrophoresed in dialysed Beckman against DI water on a cross-piece PDMS 
microdevice coupled to a glass capillary using electric field strength of 88.75 V/cm. The cross-piece PDMS 
microdevice contained 0.1x TBE solution, while the 7-cm glass capillary contained dialysed Beckman 
buffer. Note: The actual injection time was not recorded. 
 
 
EOTrol was then applied to 0.1x TBE buffer in the PDMS part to control EOF. However, 
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PDMS part was successfully controlled and there was no sample leakage after the 
injection (Figure 3.11a). It was also found that by employing the dialysed Beckman 
buffer, the speed of protein migration in the glass capillary during separation within a run 
extremely fluctuated (moving too fast or too slow) due to the unstable current and 
proteins sometimes migrated in the wrong direction i.e. moving towards the cathode. 
These might be a result of the depletion of some background electrolyte molecules (such 
as SDS, salts and small molecules used to suppress EOF) during dialysis. The depletion 
of SDS might result in a change in the charge distribution within the SDS-protein 
complexes, which in turn will affect the separation of proteins. SDS at concentration of 
0.5% w/v was added to the Beckman buffer following dialysis; however, proteins were 
still not separated as depicted in Figure 3.11b. The dialysed Beckman buffers were not 
further used since the dialysis conditions were not reproducible and resulted in extreme 
effects on the buffer compositions, which in turn affected protein separations.  
 
 
Figure 3.11: Electropherograms of protein ladder (20-200 kDa fluorescent molecular weight marker, 
Sigma Aldrich, UK) performed in (a) dialysed Beckman against 0.1x TBE and (b) dialysed Beckman 
against 0.1x TBE added 0.5% SDS on a cross-piece PDMS microdevice coupled to a glass capillary using 
electric field strength of 88.75 V/cm. The cross-piece PDMS microdevice contained 0.1x TBE mixed with 
EOTrol solution, while the 7-cm glass capillary contained dialysed Beckman buffer. Note: Time shown in 
the electropherograms was not the actual time from the injection. 
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3.3.4 Separations of proteins in laboratory-made buffer solutions  
Three types of polymer (i.e. PDMA, PEO and dextran) were chosen based on published 
reports3,46,47,48 to prepare laboratory-made running buffers for gel electrophoresis of 
proteins. Several parameters (i.e. polymer concentration, molecular weight of polymer, 
background electrolyte buffer and pH) were varied and tested using either the commercial 
CE machine or cross-piece microdevices. The aim was to achieve a buffer that provided 
for rapid and high-resolution separation of proteins with compatibility for both PDMS 
and glass separation channels. 
 
3.3.4.1 Separations of proteins in PDMA-based buffer using a cross-piece PDMS 
microdevice 
The first polymer to be investigated was polydimethylacrylamide (PDMA), which was 
used to separate proteins in a microdevice within 15 seconds46.  PDMA was synthesized 
as described in Section 3.2.3.5 and was characterized using gel permeation 
chromatography (PL-GPC 50, Agilent Technologies, UK). The average molecular weight 
and polydispersity were found to be ~ 388 kDa and 3.21, respectively. Since PDMA itself 
absorbs UV light, buffer testing was not carried out using the CE machine (Peregrine) as 
the detection system is based on UV absorption. Instead, protein separations were 
conducted in cross-piece PDMS microdevices and detection was performed using 
fluorescence detection.  
 
The electropherograms (Figure 3.12) show two peaks of fluorescein (1 and 2) separated 
from BSA-FITC (3) in both 1.5% and 3% PDMA buffers with the resolution of 0.82 and 
1.08, respectively. The presence of overlapping fluorescein peaks may be due to the fact 
that fluorescein can exhibit in various forms49 (Figure 3.13) and might exhibit as 
monoanion and dianion forms in strongly basic solution. The low resolution of separation 
between small fluorescein molecule (MW = 332.31 g/mol) and the large BSA conjugate 
(MW ~ 66 kDa) indicates that the pore sizes afforded by 1.5% and 3% PDMA buffers 
were insufficient to provide for resolution and consequently the separation of proteins 
having molecular weight less than 66 kDa in the protein ladder (20-200 kDa fluorescent 
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molecular weight marker, Sigma Aldrich). However, the proteins having molecular 
weight more than 66 kDa were not tested. 
 
 
 
 
 
 
 
Figure 3.12: Electropherograms of fluorescein (1 and 2) and BSA-FITC (3) separated in (a) 1.5% PDMA 
in 0.085 M, 0.1% SDS, pH 9.3 using separation field strength of 133 V/cm (detection at 0.5 cm) and (b) 3% 
PDMA in 0.085 M, 0.1% SDS, pH 9.3 using separation field strength of 200 V/cm (detection at 2 cm). The 
sample was prepared in 0.2% SDS. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.13: Possible existing structures of fluorescein. Image reproduced from reference 49. 
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3.3.4.2 Separations of proteins in PEO and/or dextran-based buffer using the CE 
machine 
The second and the third tested polymers were poly (ethylene oxide) or PEO and dextran, 
which are linear and branched polymer, respectively. Various molecular weights and 
concentrations of PEO and dextran were initially tested using the CE machine 
(Peregrine). The analytical results of the tested buffers are shown in Table 3.4. Since the 
protein separations in dextran-based buffers did not yield good results (i.e. some protein 
peaks were difficult to be distinguished and that no resolution results are available as 
shown in Table 3.4), only results obtained from PEO-based buffers are discussed in 
detail. 
 
The effect of polymer concentration on protein separations was studied. There is a 
threshold concentration of a polymer in a solution. Below this threshold concentration, 
the polymer chains in the solution will be isolated from one another and is called dilute 
polymer solution50. Above the threshold concentration, the polymer chains begin to 
overlap and interact via the van der Waals force and hydrogen bonding to form a polymer 
network, which is called an entangled polymer solution50,51. The average pore size for the 
network in entangled polymer solution is expressed as 
 
        !! = 1.43!! !!∗ !! !                   (3.1) 
 
where ξb is an average pore size, c is the polymer concentration, c* is the threshold 
concentration obtained from 
 
                       !∗ ≅  !.!!                                 (3.2) 
 
and Rg is the radius of gyration of the polymer, which is defined as 
 
                                         !!! ≅ ! !!/6.2!!                               (3.3)  
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where η is viscosity, Mw is molecular weight of polymer and NA is Avogadro number12. 
According to Equation 3.1, the average pore size is inversely proportional to the 
concentration of polymer. Therefore the greater the concentration of the polymer smaller 
the resulting pore size. 
 
 
 
Figure 3.14: Effect of polymer concentration and effect of adding glycerol in running buffer. (a) 
Electropherograms of a protein mixture separated in 3% PEO 100 kDa (green line) and 5% PEO 100 kDa 
(pink line) in 0.1 M TRIS-CHES, 0.1% SDS, pH 8.7 and 3% PEO 100 kDa (blue line) and 5% PEO 100 
kDa (red line) in 0.1 M TRIS-CHES, 0.1% SDS, 5% glycerol, pH 8.7 (Note: Y-axes are offset due to 
overlaying); (b) Plot of mobility vs. molecular weight; (c) Plot of resolution vs. molecular weight. The 
separations of a protein mixture (lysozyme (1), CA (2) and BSA (3)) were performed using a 34 cm long 
capillary having an effective length of 20 cm, at 25°C and using electric field strength of 441.18 V/cm. All 
samples were prepared in 1x TBE buffer, 0.1% SDS, pH 7.56. Note: CA peak (2) in 5% PEO 100 kDa 
buffer containing 5% glycerol (red line) is indistinguishable. Therefore, mobility for CA and resolution 
results for this buffer are not available. 
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It was found from the electropherograms (Figure 3.14a) and the plot between mobility 
and the molecular weight of proteins (Figure 3.14b) comparing between 3% and 5% 
PEO 100 kDa that proteins migrated slower in higher concentration of PEO. The lower 
mobility of proteins in higher polymer concentration indicates that proteins have to 
migrate through a smaller pore size that makes the migration more difficult. This matches 
the relationship between the concentration of polymer and the pore size described in 
Equation 3.1. The slower migration of proteins in 5% PEO buffer was found to improve 
the resolution of protein separations (Figure 3.14c). Another way to improve resolution 
of protein separation was to add glycerol into buffer solutions. The adding of glycerol 
made buffers more viscous and hence made protein migration slower than that in the 
buffer without glycerol adding (Figure 3.14a and Figure 3.14b). However, the 
resolution of protein separation in the buffer with glycerol was actually found to be lower 
than that without glycerol (compare between 3% PEO buffer with and without glycerol as 
shown in Figure 3.14c). This might be because the slow migration of proteins in viscous 
buffers resulted in band broadening and consequently affected the resolution. Here, 
further work to establish the appropriate concentration of glycerol to increase resolution 
was not further investigated.  
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Table 3.4:  Analytical results of protein separated in various buffer solutions using a commercial CE machine (Peregrine). 
 
   Buffer Solution  Glass capillary (Peregrine) Ref. 
No. Polymer 
(%w/v) 
Polymer Base buffer  Field strength 
(V/cm) 
Analysis time 
(min) 
Resolution 
1. 3% PEO 100 kDa 0.1 M TRIS-CHES, 0.1% SDS, pH 8.21  441.18 6.4 IDP - 
2. 3% PEO 100 kDa 0.1 M TRIS-CHES, 0.1% SDS, pH 8.7  441.18 5.7 2.94, 3.41 3 
3. 3% PEO 100 kDa 0.1 M TRIS-CHES, 0.1% SDS, 5% glycerol, pH 8.7  441.18 7.0 2.73, 3.09 - 
4. 5% PEO 100 kDa 0.1 M TRIS-CHES, 0.1% SDS, pH 8.7  441.18 9.3 3.32, 4.03 - 
5. 5% PEO 100 kDa 0.1 M TRIS-CHES, 0.1% SDS, 5% glycerol, pH 8.21  441.18 11.9 NS - 
6. 5% PEO 100 kDa 0.1 M TRIS-CHES, 0.1% SDS, 5% glycerol, pH 8.7  441.18 14.6 IDP - 
7. 5% PEO 100 kDa 0.1 M TRIS-CHES, 0.1% SDS, 2% glycerol, pH 8.53  441.18 10.9 1.96, 0.77 - 
8. 7% PEO 100 kDa 0.1 M TRIS-CHES, 0.1% SDS, 2% glycerol, pH 8.53  441.18 14.2 5.31, 5.72 - 
9. 3% PEO 200 kDa 0.1 M TRIS-CHES, 0.1% SDS, 2.5% glycerol, pH 8.4  441.18 8.2 IDP - 
10. 1% PEO 1 MDa 0.1 M TRIS-CHES, 0.1% SDS, 10% glycerol, pH 8.24  441.18 5.6 0.94, 2.00 - 
11. 3% PEO 1 MDa 0.1 M TRIS-CHES, 0.1% SDS, pH 8.22  441.18 NS NS - 
12. 3% PEO 1 MDa 0.1 M TRIS-CHES, 0.1% SDS, 2.5% glycerol, pH 8.4  441.18 NS NS - 
13. 3% 
2% 
PEO 100 kDa 
PEO 200 kDa 
0.1 M TRIS-CHES, 0.1% SDS, 2% glycerol, pH 8.3  441.18 10.4 2.46, 5.13 - 
14. 3% 
2% 
PEO 100 kDa 
PEO 200 kDa 
0.1 M TRIS-CHES, 0.1% SDS, 2% glycerol, pH 8.53  441.18 11.3 IDP, 0.3 - 
15. 4% 
0.5% 
PEO 100 kDa 
PEO 200 kDa 
0.1 M TRIS-CHES, 0.1% SDS, 2% glycerol, pH 8.51  441.18 11.1 1.34, 1.66 - 
16. 4% 
1% 
PEO 100 kDa 
PEO 200 kDa 
0.1 M TRIS-CHES, 0.1% SDS, 2% glycerol, pH 8.51  441.18 NS NS - 
17. 5% 
1.5% 
PEO 100 kDa 
PEO 200 kDa 
0.1 M TRIS-CHES, 0.1% SDS, 2% glycerol, pH 8.53  441.18 12.7 1.57, 1.87 - 
18. 6% 
0.5% 
PEO 100 kDa 
PEO 200 kDa 
0.1 M TRIS-CHES, 0.1% SDS, 2% glycerol, pH 8.53  441.18 13.4 2.70, 2.59 - 
19. 2.5% Dextran 2 MDa 0.05 M AMPD-CACO, 0.1% SDS, pH 7.72  441.18 5.2 IDP - 
20. 5% Dextran 2 MDa 0.05 M AMPD-CACO, 0.1% SDS, pH 7.72  441.18 NS NS - 
21. 6% Dextran 2 MDa 0.1 M TRIS-HCl, 0.1% SDS, pH 8  441.18 NS NS 47 
22. 10% Dextran 2 MDa 0.05 M AMPD-CACO, 0.1% SDS, pH 8.82  441.18 NS NS 3 
23. 10% Dextran 2 MDa 0.1 M TRIS-Borate, 0.1%SDS, 10% glycerol, pH 8.3  441.18 23.5 IDP - 
24. 10% Dextran 2 MDa 0.1 M TRIS-NaH2PO4, 0.1%SDS, 10% glycerol, pH 8.3  320 13.2 2.78, 2.47 48 
25. 15% Dextran 70 kDa     0.1 M TRIS-CHES, 0.1%SDS, pH 8.7  441.18 NS NS - 
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* Note: Two numbers of resolutions are the resolutions of lysozyme and CA peaks and CA and BSA peaks, respectively. NS = No Separation and IDP = 
Indistinguishable Peaks. 
 
 
 
 
 
 
 
Buffer Solution  Glass capillary (Peregrine) Ref. 
No. Polymer 
(%w/v) 
Polymer Base buffer  Field strength 
(V/cm) 
Analysis time 
(min) 
Resolution 
26. 2.5% 
1% 
Dextran 2 MDa 
PEO 100 kDa 
0.05 M AMPD-CACO, 0.1% SDS, pH 7.72  441.18 8 IDP - 
27. 5% 
0.5% 
Dextran 2 MDa 
PEO 100 kDa 
0.05 M AMPD-CACO, 0.1% SDS, 2% glycerol, pH 7.72  441.18 12.6 IDP - 
28. 7% 
0.5% 
Dextran 2 MDa 
PEO 100 kDa 
0.05 M AMPD-CACO, 0.1% SDS, 2% glycerol, pH 7.72  441.18 8.3 1.94, 3.72 - 
29. 2.5% 
0.5% 
Dextran 2 MDa 
PEO 1 MDa 
0.05 M AMPD-CACO, 0.1% SDS, pH 7.72  441.18 6.2 IDP - 
30. 5% 
0.25% 
Dextran 2 MDa 
PEO 1 MDa 
0.05 M AMPD-CACO, 0.1% SDS, pH 7.72  441.18 7.3 IDP, 2.52 - 
31. 5% 
0.5% 
Dextran 2 MDa 
PEO 1 MDa 
0.05 M AMPD-CACO, 0.1% SDS, pH 7.72  441.18 9.2 2.66, 3.69 - 
32. 5%. 
0.5% 
Dextran 2 MDa 
PEO 1 MDa 
0.05 M AMPD-CACO, 0.1% SDS, 2% glycerol, pH 7.72  441.18 9.5 IDP - 
33. 5% 
0.5% 
Dextran 2 MDa 
PEO 1 MDa 
0.05 M AMPD-CACO, 0.1% SDS, EOTrol, pH 7.72  441.18 9.4 IDP - 
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Table 3.5: Analytical results of protein separated in various buffer solutions using a cross-piece PDMS microdevice or a PDMS microdevice coupled to a glass capillary. 
 
 
* Note: The superscript numbers on the resolution value designate the number of the peak (e.g. 1.01-2 is the resolution value between peak 1 and peak 2). NS = No 
Separation and NT = Not Tested. 
Buffer solution Cross-piece PDMS microdevice Cross-piece coupled to a glass capillary 
No. Polymer 
(%w/v) 
Polymer Base buffer Field 
strength 
(V/cm) 
Analysis 
time (min) 
Resolution 
 
Field 
strength 
(V/cm) 
Analysis 
time (min) 
Resolution 
 
1. 1.5% PDMA 0.085 M sodium tetraborate buffer, pH 9.3 75 NS NS NT NT NT 
2. 3.0% PDMA 0.085 M sodium tetraborate buffer, pH 9.3 100 NS NS NT NT NT 
3. 5% PEO 100 kDa 0.05 M TRIS-CHES, 0.1% SDS, pH 8.5 208.33 1.58 
(at 1.3 cm) 
1.01-2, 1.32-3, 
1.23-4, 1.34-5, 
1.55-6, 1.66-7 
NT NT NT 
4. 6% PEO 100 kDa 0.05 M TRIS-CHES, 0.1% SDS, pH 8.5 167.5 1.46 
(at 1.0 cm) 
1.01-2, 1.52-3, 
1.13-4, 1.24-5, 
1.95-6, 1.66-7 
188 3.15 
(at 2.0 cm) 
0.81-2, 1.02-3, 
0.83-4, 1.14-5, 
1.15-6, 1.36-7 
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Figure 3.15: Effect of polymer concentration of mixed polymer molecular weight. (a) Electropherograms 
of a protein mixture separated in 3% PEO 100 kDa mixed with 2% PEO 200 kDa (green line), 5% PEO 100 
kDa mixed with 1.5% PEO 200 kDa (pink line), and 6% PEO 100 kDa mixed with 0.5% PEO 200 kDa (red 
line) in 0.1 M TRIS-CHES, 0.1% SDS, 2% glycerol, pH 8.5 (Note: Y-axes are offset due to overlaying); (b) 
Plot of mobility vs. molecular weight; (c) Plot of resolution vs. molecular weight. The separations of a 
protein mixture (lysozyme (1), CA (2) and BSA (3)) were performed using a 34 cm long capillary having 
an effective length of 20 cm, at 25°C and using electric field strength of 441.18 V/cm. All samples were 
prepared in 1x TBE buffer, 0.1% SDS, pH 7.56. Note: Lysozyme peak (1) is not shown in 3% PEO 100 
kDa mixed with 2% PEO 200 kDa buffer. Therefore, mobility for lysozyme and resolution between 
lysozyme and CA are not available.  
 
 
Mixtures of polymers with different molecular weights were also investigated. Protein 
migration in the mixed polymers from the highest to the lowest mobility was in the order 
of (Figure 3.15a and Figure 3.15b). 
• 3% PEO 100 kDa mixed with 2% PEO 200 kDa,  
• 5% PEO 100 kDa mixed with 1.5% PEO 200 kDa and  
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Since higher concentrations of PEO 100 kDa than that of PEO 200 kDa were used in this 
case and the fact that the polymer with shorter chain length forms denser polymer 
networks than the polymers with longer chain length52, the pore size seemed to depend 
more on the concentration of PEO 100 kDa than that of PEO 200 kDa. The highest 
resolution was obtained from 6% PEO 100 kDa mixed with 0.5% PEO 200 kDa having 
the slowest mobility, as expected. 
 
 
 
 
Figure 3.16: Effect of buffer pH. (a) Electropherograms of a protein mixture separated in 3% PEO 100 kDa 
mixed with 2% PEO 200 kDa in 0.1 M TRIS-CHES, 0.1% SDS, 2% glycerol, pH 8.3 (red line) and pH 8.5 
(green line) (Note: Y-axes are offset due to overlaying); (b) Plot of mobility vs. molecular weight; (c) Plot 
of resolution vs. molecular weight. The separations of a protein mixture (lysozyme (1), CA (2) and BSA 
(3)) were performed using a 34 cm long capillary having an effective length of 20 cm, at 25°C and using 
electric field strength of 441.18 V/cm. All samples were prepared in 1x TBE buffer, 0.1% SDS, pH 7.56. 
Note: Lysozyme peak (1) is not shown in buffer pH 8.5. Therefore, mobility for lysozyme and resolution 
between lysozyme and CA are not available.  
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The other effect that was investigated was the pH of the buffer (Figure 3.16a). In this 
experiment, a mixture of proteins prepared in 1x TBE buffer at pH 7.56 containing 0.1% 
SDS was injected from the inlet of the capillary and separated in two similar buffers 
having the same components (3% PEO 100 kDa mixed with 2% PEO 200 kDa in 0.1 M 
TRIS-CHES, 0.1% SDS, 2% glycerol) but different pH (pH 8.3 and pH 8.5). It was found 
that proteins migrated faster in pH 8.3 than that of pH 8.5 as shown in Figure 3.16b. The 
resolution was improved when proteins migrated faster (Figure 3.16c) resulting in less 
band broadening53, 54.  
 
According to the literature, at high pH, cathodic EOF (EOF direction towards a cathode) 
is normally present as a result of the deprotonation of the silanol groups on the capillary 
wall55. The cathodic EOF causes the migration of proteins in gel electrophoresis to slow 
down. Herein, the peak of thiourea injected from the outlet of the capillary as EOF 
marker (moving in the opposite direction to the samples) was observed in the 
electropherograms of both buffers at 17.12 s and 34.79 s and corresponded to the 
electrophoretic mobilities (µeo) of 3.09 × 10-9 cm2/Vs and 1.52 × 10-9 cm2/Vs for buffer 
pH 8.5 and buffer pH 8.3, respectively. Accordingly, EOF occurred in buffer pH 8.5 was 
higher than that of pH 8.3 and this might cause the slow migration of protein in pH 8.5.  
 
Another possible reason, during the stability check prior to the separation (Figure 3.17a), 
the current was recorded at every 1 V, while the voltage was varied from 0 V to 16 V. 
The current was also recorded at the separation voltage (15 kV) over the period of 
separation (Figure 3.17b and Figure 3.17c). It was found that the recorded current 
obtained from buffer pH 8.3 was always higher than that of buffer pH 8.5 either before or 
during separation. The higher current observed in buffer pH 8.3 might be as a result of the 
increase in ionization of the organic base (TRIS) leading to faster migration of proteins.  
 
Consequently, the results of the mobility calculations for proteins and EOF, along with 
the differences in current observed during the experiments indicate that the reduced 
migration of proteins in higher pH of buffer may be a result of either the presence of 
cathodic EOF or the low separation current or both of them. 
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Figure 3.17: Comparison of the current during electrophoresis in 3% PEO 100 kDa mixed with 2% PEO 
200 kDa in 0.1 M TRIS-CHES, 0.1% SDS, 2% glycerol, pH 8.3 and pH 8.5. (a) Plots between current and 
voltage of buffer pH 8.3 (red line) and buffer pH 8.5 (black line). Plots of current and time during 
separation in (b) buffer pH 8.3 and (c) buffer pH 8.5. 
 
 
According to the results, protein separations in some tested buffers provided such low 
resolution that some protein peaks could not be distinguished from the others (no 
resolution, as shown in Table 3.4). It was found that the buffer that provided for the 
highest resolution was 7% PEO 100 kDa in 0.1 M TRIS-CHES, 0.1% SDS, 2% glycerol, 
pH 8.53. The resolution of separation between lysozyme and CA peaks and between CA 
and BSA peaks are 5.31 and 5.72, respectively. However, the analysis time was quite 
long (~14 minutes) compared to most of the tested buffers in Table 3.4, which might not 
be suitable for protein separations using a droplet-based format in which rapid separation 
is necessary.  
 
The next buffer providing highest resolution was 5% PEO 100 kDa in 0.1 M TRIS-
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using this buffer is only 9.3 minutes. Due to the high resolution and shorter analysis time 
this buffer provided, it was chosen to be tested further in the cross-piece PDMS 
microdevice. 
 
3.3.4.3 Separations of proteins in PEO-based buffer using microdevices 
The mixture of fluorescein and a fluorescently labeled protein ladder (11-155 kDa 
Benchmark fluorescent protein standard) was separated in 5% PEO 100 kDa in 0.05 M 
TRIS-CHES, 0.1% SDS, pH 8.5 in a cross-piece PDMS microdevice (Figure 3.18).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.18: Electrophoretic separation of a fluorescently labeled protein ladder (11-155 kDa Benchmark 
fluorescent protein standard) performed in a cross-piece PDMS microdevice. (a) An electropherogram 
showing the fluorescein peak in the front followed by 7 protein bands of protein ladder separated in 5% 
PEO (100 kDa) in 0.05 M TRIS-CHES 0.1% SDS, pH 8.5 using electric field strength of 208.33 V/cm. 
Detection was done at 1.3 cm from the intersection; (b) A plot of mobility versus molecular weight of 11-
155 kDa protein ladder; (c) A plot of resolution versus molecular weight. Note: The injection time was at 
80 seconds according to the electropherogram. 
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Fluorescein was added as a marker for ease of observation due to its high fluorescence 
intensity. Although the concentration of the buffer used in the CE instrument was 0.1 M, 
the buffer concentration used in the PDMS microdevice was 0.05 M to address the buffer 
boiling. The pH of the buffer was also decreased from 8.7 to 8.5 to reduce EOF. 
According to the electropherogram (Figure 3.18a), seven peaks of proteins were 
successfully separated in 5% PEO 100 kDa buffer (using the field strength of ~208 V/cm 
and detected at 1.3 cm).  
 
 
Figure 3.19: Electrophoretic separation of a fluorescently labeled protein ladder (11-155 kDa Benchmark 
fluorescent protein standard) performed in a cross-piece PDMS microdevice. (a) An electropherogram 
showing the fluorescein peak in the front followed by 7 protein bands of protein ladder separated in 6% 
PEO (100 kDa) in 0.05 M TRIS-CHES 0.1% SDS, pH 8.5 using electric field strength of 167.5 V/cm. 
Detection was done at 1.0 cm from the intersection; (b) Showing three repetitions of protein separations; (c) 
A plot of mobility versus molecular weight; (d) A plot of resolution versus molecular weight. Note: The 
injection time was at 120 seconds according to the electropherogram. 
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The higher resolution could be improved by increasing the concentration of PEO 100 
kDa. The separation of the protein ladder was therefore performed in 6% PEO 100 
kDa in 0.05 M TRIS-CHES, 0.1% SDS, pH 8.5 (using the field strength of ~168 
V/cm and detected at 1.0 cm) and the results were shown in Figure 3.19. By 
comparing the resolutions of protein ladder separated in 5% PEO and 6% PEO buffers 
(Table 3.3), it was found that they were not significantly different for most of the 
peaks. 6% PEO 100 kDa buffer was therefore chosen and tested in another format of 
the separation device, which was a PDMS microdevice coupled to a glass capillary 
(Figure 3.2b), because similar resolutions were achieved when using this buffer with 
shorter length of detection and lower separation field strength.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.20: Electropherograms comparing between BSA peak in fluorescently labeled protein ladder 
(11-155 kDa Benchmark fluorescent protein standard) and the injected BSA-FITC. The separations 
were performed in a cross-piece PDMS microdevice using 6% PEO (100 kDa) in 0.05 M TRIS-CHES, 
0.1% SDS, pH 8.5 at separation field strength of 167.5 V/cm and were detected at 1.0 cm from the 
injection point (Note: Y-axes are offset due to overlaying). 
 
 
The mixture of BSA-FITC and fluorescein was also separated in 6% PEO 100 kDa in 
0.05 M TRIS-CHES, 0.1% SDS, pH 8.5 in the cross-piece PDMS microdevice using 
the same conditions as that of protein ladder separation. The electropherogram of 
fluorescein mixed with BSA-FITC (red line in Figure 3.20) shows three peaks in 
which the first peak labeled as 1 is fluorescein and the other two peaks are BSA-
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FITC. The two peaks of BSA-FITC belong to monomer (66 kDa) and dimer (132 
kDa) since BSA can typically form covalent dimer and oligomers53. The formation of 
BSA aggregation is due to the thiol-disulfide interchange reaction. BSA contains 35 
cysteine residues of which 34 residues are covalently bonded via intramolecular 
disulfide bonds. This leaves one cysteine residue with a free thiol group (R-S-) that 
then reacts with a disulfide group on another BSA and forms an intermolecular 
disulfide bond and generates a new free thiol group, which may further react with 
another BSA54. 
 
The electropherograms of BSA-FITC and the protein ladder are overlaid and 
fluorescein peaks are aligned as depicted in Figure 3.20 to confirm the order of 
protein elution in the protein ladder. The electrophoretic mobilities of the BSA peak 
in the protein ladder and in BSA-FITC (with respect to fluorescein peak) are found to 
be 1.04×10-8 m2/Vs and 1.08×10-8 m2/Vs, respectively. The similar electrophoretic 
mobilities confirm that the sixth peak in the electropherogram of the protein ladder 
was BSA (66 kDa) and that the first four peaks of the protein ladder (excluding 
fluorescein peak) are proteins having lower molecular weights than BSA and the last 
two peaks are proteins having higher molecular weights than BSA.  
 
The separation of the protein ladder was then performed in 6% PEO 100 kDa buffer 
using a cross-piece PDMS microdevice coupled to a glass capillary. Although 
different buffers were employed in the PDMS part (0.1x TBE buffer) and the 
capillary part (6% PEO buffer), seven separated protein bands were successfully 
obtained within ~3 minutes at the detection point of 2.0 cm. It was found that the 
mobilities of proteins separated in this format (Figure 3.21b) were lower than that of 
the entire PDMS format (Figure 3.19c) despite the separation field using in the cross-
piece PDMS coupled to the glass capillary was higher. EOF in the glass capillary 
might be higher than that of the PDMS microdevice; therefore, this retarded the 
migration of the proteins in the capillary. In addition, the slow migration of proteins 
in the glass capillary caused the broadening of the peaks, which in turn resulted in a 
decreasing in the resolution (Table 3.5). According to this result, it indicated that 6% 
PEO 100 kDa buffer could be used for droplet-based protein separation. The analysis 
time could be decreased by increasing the separation field and decreasing the distance 
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of detection. The glass capillary could also be treated with 1 M HCl for a longer 
period of time prior to filling up with the running buffer to suppress EOF.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.21: Electrophoretic separation of a fluorescently labeled protein ladder (11-155 kDa 
Benchmark fluorescent protein standard) performed in a cross-piece PDMS microdevice coupled to a 
glass capillary. (a) An electropherogram showing the fluorescein peak in the front followed by 7 
protein bands of protein ladder separated in 6% PEO (100 kDa) in 0.05 M TRIS-CHES 0.1% SDS, pH 
8.5 using electric field strength of 188 V/cm. Detection was done at 2.0 cm from the intersection; (b) A 
plot of mobility versus molecular weight; (d) A plot of resolution versus molecular weight. Note: The 
injection time was at 120 seconds according to the electropherogram. 
 
3.4 Conclusion 
Protein gel electrophoresis using droplet-based microfluidic devices require high-
speed and high-resolution separation; therefore, a buffer solution that can provide for 
these aspects was developed in this work. The developed buffer also needs to be 
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compatible with the materials from which the microchannels are fabricated (i.e. 
PDMS and a glass capillary). Both commercial and laboratory-made buffers were 
investigated in terms of analysis time, resolution and compatibility with PDMS and 
glass channels. 
 
One of the commercial buffers for SDS-protein complex separation (Beckman buffer) 
was studied. The original and the modified Beckman buffers were tested using both a 
commercial CE machine and PDMS microdevices. It was found that when the 
original Beckman running buffer together with either original or modified Beckman 
sample buffers was employed for protein separation using the CE machine, high-
resolution separation of proteins was achieved but with a long analysis time (~ 20 
minutes). However, Beckman running buffer could not be used to separate proteins in 
PDMS microdevices since high Joule heating occurred due to the inefficient heat 
dissipation the PDMS provided when a high separation field was applied. 
Consequently, the dilution and dialysis of Beckman running buffer was performed to 
reduce the concentration of the background electrolyte, which should in turn reduce 
Joule heating and permit a higher field to be applied. It was found that the loss of 
resolution and high EOF were problems when diluted Beckman buffer was employed. 
The dialysed Beckman buffer; on the other hand, resulted in changes in buffer 
composition, which affected the migration dynamics of proteins.  Overall, the 
Beckman buffer, though an excellent matrix for size separation on capillary systems, 
proved challenging to adapt to a chip format. The buffer recipe is maintained as 
company know-how and could not be ascertained prior to this work, making its 
modification tedious and irreproducible. Consequently, buffers developed within the 
scope of this work allowed greater control over their recipe and preparation, and 
proved more successful.  
 
Different compositions of laboratory-made buffers based on PEO and dextran were 
prepared and initially tested using the CE machine. Although, many buffer recipes 
provided for shorter analysis time than that of Beckman buffer, the resolution 
afforded at times was so low that a significant number of the protein peaks could not 
be distinguished.  However, from the range of polymers and polymer lengths, one 
recipe provided for high-resolution and short analysis time. This was 5% PEO 100 
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kDa in 0.1 M TRIS-CHES, 0.1% SDS, pH 8.7 and it was chosen to test the 
separations on-chip. 
 
5% PEO 100 kDa in 0.05 M TRIS-CHES, 0.1% SDS, pH 8.5 was then tested for 
protein separation in a cross-piece PDMS microdevice. The lower concentration of 
the background electrolyte and the lower pH were employed to minimize Joule 
heating and EOF. This buffer was further optimized by increasing the concentration 
of PEO from 5% (w/v) to 6% (w/v). The results show that proteins separated in 6% 
PEO buffer with shorter separation length and lower field strength and had similar 
resolution to that of 5% PEO buffer. Moreover, proteins were also successfully 
separated in 6% PEO buffer using a cross-piece PDMS microdevice coupled to a 
glass capillary. Consequently, 6% PEO 100 kDa in 0.05 M TRIS-CHES, 0.1% SDS, 
pH 8.5 was chosen as the buffer for droplet-based protein separation, which will be 
described in detail in Chapter 6. 
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4.1 Introduction 
Many detection methods are employed for capillary electrophoresis such as 
absorbance detection, fluorescence detection, electrochemical detection and refractive 
index detection1,2. Of these detection methods, the UV-Vis detector and fluorescence 
detector are primarily utilized in commercial CE instruments. However, fluorescence 
detection is 1000-fold more sensitive than absorbance detection3. Consequently, the 
high sensitivity of fluorescence detection is more suited to the detection of low 
volume samples as typically handled in the microdroplets employed in this work. 
 
In order to use fluorescence detection, samples need to have a fluorophore or be 
labeled with fluorophore that matches the excitation and emission wavelength of the 
detection system. Due to the high cost of commercial fluorescently labeled proteins, 
laboratory-labeled proteins were used in this work. The in-house development and use 
of these protocols had the additional benefit of enabling a variety of proteins 
including proteins released from cultured cells to be labeled. Some of the fluorescent 
dyes cited in the literature for labeling proteins and used to perform capillary 
electrophoresis in microdevices are listed in Table 4.1.  
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Table 4.1: Fluorescent dyes used to label proteins for electrophoresis in microdevices. 
 
Fluorescent dye λex 
(nm) 
λem 
(nm) 
Samples Ref. 
Agilent dye 650 680 - BioRad protein ladder 4 
Alexa Fluor 488 490 525 - myoglobin 
- OV, trypsin inhibitor and lipoprotein 
5 
6 
Alexa Fluor 633 633 652 - actin, BSA, CO, HPA, PNA, OV, protein A, streptavidin, transferrin and WG 
- fetal calf serum proteins 
7 
8 
FC 390 465 - SEA, SEB, ricin, OV, IgG and α-lactalbumin  
- proteins from E.coli lysate 
- viral proteins  
- CCK, α-lactalbumin, CA, BSA, OVA and IgG 
9 
10 
11 
12 
Fluorescein-MAL 494 518 - Calmodulin 13 
 FITC 495 525 - β-lactoglobulin A, thyroglobin and myoglobin, HSA 
- CA, OV, BSA and conalbumin 
- fluorescent high molecular weight standard (Sigma) 
- OV 
- Digestion of BSA and proteins extracted from E.coli 
- BSA tryptic digest 
- proteins extracted from E.coli 
14,15 
16 
17 
18 
19 
20 
21 
Cy3 550 570 - CA II, β-lactoglobulin A and streptavidin 22 
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Fluorescent dye λex 
(nm) 
λem 
(nm) 
Samples Ref. 
Cy5 650 670 - lysozyme, CA, trypsin inhibitor 23 
NanoOrange 470 570 - α-lactalbumin, β-lactoglobulin A and β-lactoglobulin B 24, 25 
NHS-Fluorescein 491 518 - α-lactalbumin, pepsinogen, egg albumin, BSA, β-galactosidase and lysozyme 13 
OPA 340 455 - amino acids 26 
Sypro Orange 450 590 - bovine insulin, lysozyme, myoglobin, trypsin inhibitor, trypsin, CA, OV, serum albumin, BSA, 
phosphorylase B, β-galactosidase , myosin, proteins extracted from human Jurkat cells 
- BSA 
27 
 
4 
Sypro Red 547 631 - α-lactalbumin, β-lactoglobulin A and β-lactoglobulin B 
- actin, parvalbumin, BSA and trypsin inhibitor 
24 
28 
5/6-TAMRA, SE 546 579 - tryptic digest of BSA 
- tryptic digest from cytochrome c 
29 
30 
TRITC 557 576 - tryptic peptides of β-casein 31 
TNS 325 450 - IgG, transferrin, l-antitrypsin and albumin 32 
 
 
Note: bovine serum albumin (BSA), carbonic anhydrase (CA), Cholecystikinin flanking peptide (CCK), concanavalin A (CO), helix pomatia lectin (HPA), human serum 
albumin (HSA), immunoglobulin G (IgG), lectin peanut agglutinin (PNA), ovalbumin (OV), staphylococcal enterotoxin A (SEA), staphylococcal enterotoxin B (SEB), wheat 
germ agglutinin (WG), Fluorescamine (FC), Fluorescein-5-maleimide (Fluorescein-MAL), Fluorescein isothiocyanate (FITC), Indocarbocyanine (Cy3), Indodicarbocyanine 
(Cy5), 5/6-carboxyfluorescein succinimidyl ester (NHS-Fluorescein), ortho-Phthalaldehyde (OPA), 5/6-carboxytet- ramethylrhodamine, succinimidyl ester (5/6-TAMRA, 
SE), Tetramethylrhodamine isothiocyanate (TRITC), 2-Toluidinonaphthalene-6-sulfonate (TNS) 
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Among the dyes having the excitation and emission wavelengths to match our detection 
system (i.e. λex = 470-490 nm and λem = 510 nm cut-on), fluorescein isothiocyanate 
(FITC), 5/6-carboxyfluorescein succinimidyl ester (NHS-fluorescein) and NanoOrange 
were employed for labeling proteins in this work. FITC was employed since it has been 
studied for a long time and widely used as a fluorescent label for proteins33,34,35,36. FITC 
combines with a protein through a reaction between the isothiocyanate group of FITC and 
free amino groups (amino terminal and primary amines) of the protein to form a stable 
thiourea bond as shown in Figure 4.1. 
 
 
 
 
 
 
Figure 4.1:  The reaction of protein conjugated with FITC. 
 
NHS-Fluorescein is the second fluorescent dye chosen for labeling proteins due to its 
high reactivity toward primary amines leading to the formation of a stable linkage. NHS-
Fluorescein reacts with primary amines on proteins to form amide bonds and release NHS 
as a by-product as illustrated in Figure4.2. 
 
 
 
 
 
 
 
Figure 4.2:  The reaction of protein conjugated with NHS-Fluorescein. 
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The third fluorescent dye chosen to label proteins in this work was NanoOrange, due to 
the many benefits it provides. For example, the labeling process is simple, fast and 
sensitive37. Moreover, NanoOrange is non-fluorescent when it is not bound to proteins. 
This allows the direct use of the protein-dye conjugate after labeling without a 
complicated excess dye removal process. Although, the information on the structure of 
NanoOrange has not been made public, it has been reported to interact with proteins via 
non-covalent bonds (i.e. electrostatic and/or hydrophobic interactions), which was 
performed with detergent-coated proteins38,39. 
 
4.2 Experimental 
4.2.1 Chemicals 
Samples and chemicals used in this chapter, which have not been mentioned in Chapter 
3, are shown in Table 4.2. 
 
Table 4.2: Samples and chemicals used in Chapter 4. 
 
No. Chemical Supplier 
1. 5-(and 6-)carboxyfluorescein, succinimidyl ester (NHS-
Fluorescein) 
Thermo Fisher Scientific, UK 
2.  Ammonium chloride Sigma Aldrich, UK 
3. Dimethyl sulfoxide (DMSO) Sigma Aldrich, UK 
4. Fluorescein-5, 6-isothiocyanate (FITC) Sigma Aldrich, UK 
5.  NanoOrange® Protein Quantitation Kit Thermo Fisher Scientific, UK 
6. Sodium azide Sigma Aldrich, UK 
7. Sodium carbonate Sigma Aldrich, UK 
8. Sodium bicarbonate Sigma Aldrich, UK 
9. Trypsin inhibitor from chicken egg white Sigma Aldrich, UK 
10. Xylene cyanol FF Sigma Aldrich, UK 
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4.2.2 Labeling protocol  
4.2.2.1 FITC labeling 
Lysozyme and BSA were labeled with fluorescein isothiocyanate (FITC) according to the 
Sigma Aldrich protocol40. 2 mg/ml of each protein was dissolved in 0.1 M sodium 
carbonate buffer pH 9.0, while FITC was dissolved in anhydrous dimethyl sulfoxide 
(DMSO) at 1 mg/ml. 50 µl of FITC solution was added to a 1 ml of protein in 5 µl 
aliquots, while continuously stirring the protein solution. The protein-FITC solution was 
then incubated in the dark at 4°C for 8 hours. After that ammonium chloride (NH4Cl) was 
added to the solution to a final concentration of 50 mM and the solution was further 
incubated for 2 hours at 4°C. Then xylene cyanol and glycerol were added at 0.1% (v/v) 
and 0.5% (v/v), respectively. The unbound FITC was separated from the conjugate using 
5 kDa MWCO polyethersulfone (PES) membrane (Vivaspin 500 MWCO 5000, GE 
Healthcare Life Sciences, UK). Finally, sodium azide at a concentration of 15 mM was 
added as a preservative before the conjugate solution was stored in the dark at 4°C. 
Following the conjugation, the conjugate (diluted in DI water) was then measured for 
absorption at 495 and 280 nm using a LAMBDA 25 UV/Vis spectrophotometer (Perkin 
Elmer, UK). Then, the molar F/P ratio was calculated according to Equation 4.1 to 
determine the efficiency of the FITC-protein conjugation.  
            !"!"# × !!"#/!"#!!"#![ !.!"×!!"# ]/!!"#!.!% = !!"#×!!!"#! !.!"×!!"#    (4.1)  
 
MW is the molecular weight of the protein, 389 is the molecular weight of FITC, 195 is 
the absorption !!"#!.!% of bound FITC at 490 nm at pH 13.0, (0.35×A495) is the correction 
factor due to the absorbance of FITC at 280 nm, !!"#!.!% is the absorption at 280 nm of a 
protein at 1.0 mg/ml and C is a constant value given for a protein defined as 
       
       C = MW×E2800.1%389×195        (4.2)  
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4.2.2.2 NHS-Fluorescein labeling 
The first step in this process41 involved the dissolution of 1.3 mg (2.75 µmol) NHS-
Fluorescein in 50 µl DMSO. A 15-fold molar excess of NHS-Fluorescein (an optimal 
ratio) was used to label protein with this dye. Accordingly, 1.05 µmol (19.1 µl) and 0.23 
µmol (4.15 µl) of NHS-Fluorescein were added to 2 mg/ml lysozyme and 2 mg/ml BSA, 
respectively. The mixtures were incubated at room temperature for 1 hour. After that the 
excess dye was removed using a Pierce dye removal column (Thermo Fisher Scientific, 
UK). The removal process was performed twice for more complete dye removal. 0.1% 
(w/v) sodium azide was then added to the labeled protein solutions. After the conjugation, 
the conjugate (diluted in DI water) was measured absorption at 494 and 280 nm. The 
molar F/P ratio was calculated as Equation 4.3 to determine the efficiency of the NHS-
Fluorescein-protein conjugation. 
 Moles fluor/mole protein = Amax of the labeled proteinεfluor× protein concentration (M)× dilution factor  (4.3) 
 
Where ε!"#$%  = NHS-Fluorescein molar extinction coefficient = 70,000 M-1cm-1 
                Protein concentration M = A280−(Amax×CF)εprotein ×dilution factor      (4.4) 
 
Where ε!"#$%&' is protein molar extinction coefficient, Amax is A494 and CF is correction 
factor (A280/ Amax = 0.3). 
 
4.2.2.3 NanoOrange labeling 
NanoOrange reagent (500x in DMSO) and NanoOrange diluent (10x contains 2 mM 
sodium azide) were obtained as part of the NanoOrange protein quantitation kit (Thermo 
Fisher Scientific, UK). 1x NanoOrange diluent was prepared by diluting the NanoOrange 
protein quantitation diluent 10-fold in DI water. NanoOrange protein reagent was then 
diluted 500-fold into the 1x protein quantitation diluent. The protein with the desired 
concentration was diluted 1:200 into the 1x NanoOrange reagent. The sample was 
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incubated in the dark at 95°C for 10 min and cooled to room temperature in the dark for 
20 min prior to being used. 
 
4.2.3 Electrophoresis of fluorescently labeled proteins 
Free FITC, lysozyme conjugated FITC, NHS-Fluorescein and lysozyme conjugated NHS-
Fluorescein, were used to investigate protein separations using cross-piece PDMS 
microdevices. Lysozyme conjugated FITC and lysozyme conjugated NHS-Fluorescein 
were prepared in 0.1% SDS buffer and heated at 95 °C for 5 min. The stock solution of 
FITC (3.85 mM) was prepared in 960 µl of DI water and added 40 µl of 1 M NaOH to 
completely dissolve FITC. 38.5 µM FITC was then prepared from the stock solution in DI 
water. The stock solution of NHS-Fluorescein (59.1 mM) was prepared in DMSO and 
was diluted to 0.59 mM in 0.1x TBE buffer. The electrophoresis of FITC, NHS-
Fluorescein, lysozyme conjugated with FITC and lysozyme conjugated NHS-Fluorescein 
were performed in 6% PEO 100 kDa in 0.05 M TRIS-CHES, 0.1% SDS, pH 8.5 using 
cross-piece PDMS microdevices as described in detail in Section 3.2.5.  
 
For BSA conjugated NanoOrange, it was generated as droplets using the robotic droplet 
generator as described in Section 2.3. The electrophoresis was performed in 6% PEO 
buffer using the interfacing droplet-based microdevice “Design 6” as described in detail 
in Section 5.3.6.          
 
4.2.4 Study the influence of SDS on the fluorescence intensity of the protein 
conjugated NanoOrange 
This study was performed to investigate the effect of 0.1% SDS contained in the 
separation buffer, which was higher than the recommended value (0.01% SDS), on the 
fluorescence intensity of protein conjugated NanoOrange. The fluorescence intensities of 
the buffers only i.e. 0.05 M TRIS-CHES with 0%, 0.01% and 0.1% SDS were measured 
as the control using the fluorescence detection described in Section 2.4.2.1. Then 10 µl of 
0.01 mg/ml lysozyme conjugated 1x NanoOrange was added to each buffer and the 
fluorescence intensity was measured again. 
 Chapter IV  
 
 162 
4.3 Results and Discussion 
4.3.1 FITC labeling proteins 
Lysozyme and BSA were labeled with FITC according to the protocol described in 
Section 4.2.2.1. The absorption of the conjugates was measured at the wavelengths of 
280 nm (maximum absorbance of protein) and 495 nm (maximum absorbance of FITC) 
to permit calculation of the efficiency of labeling. Figure 4.3a and Figure 4.3b show the 
absorption spectra of lysozyme-FITC and BSA-FITC, respectively. The degree of 
labeling is expressed as a ratio between fluorophore and protein molar concentrations 
(F/P ratio) of the conjugate, which represents the number of dye molecules conjugated to 
the protein molecule42.  
 
 
 
 
Figure 4.3:  Absorption spectra of (a) lysozyme conjugated FITC and (b) BSA conjugated FITC. Both 
protein conjugates were prepared in DI water. 
 
The molar F/P ratio calculated according to the Equation 4.1 (Section 4.2.2.1) for 
lysozyme-FITC is 0.045 and for BSA-FITC is 0.218; however, the acceptable value for 
molar F/P ratio should be between 0.3-1.0. The low molar F/P ratio might be due to the 
exposure of the conjugates to the light during the unbound FITC removal process. This 
can cause the degradation of the conjugate products since FITC is light-sensitive43,44.  
Another possibility is the use of mixed-isomer FITC to label proteins since it is less 
reactive than the use of N-Hydroxysuccinimide (NHS)-fluorescein41.  
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Figure 4.4: Electrophoresis performed in 6% PEO 100 kDa in 0.05 M TRIS-CHES, 0.1% SDS, pH 8.5 
using a cross-piece PDMS microdevice. The electric field was applied at ~168 V/cm and the detection was 
made at 1 cm. The electropherograms of (a) lysozyme-FITC prepared in 0.1% SDS buffer and heated at 95 
°C for 5 min and (b) 38.5 µM FITC dissolved in DI water. 
 
The lysozyme conjugated FITC was also electrophoresed in 6% PEO 100 kDa in 0.05 M 
TRIS-CHES, 0.1% SDS, pH 8.5 buffer using a cross-piece PDMS microdevice. 
Lysozyme conjugated FITC is expected to provide a single peak; however, several sharp 
peaks and several broader peaks are observed in the electropherogram (Figure 4.4a). The 
sharp peaks are air bubbles migrating into the glass capillary, whereas several broader 
peaks (in red circle of Figure 4.4a) are from the single injection of lysozyme conjugated 
FITC. These broad peaks might belong to lysozyme-FITC and unbound FITC that was 
not completely removed from the sample. Free FITC was also electrophoresed in 6% 
PEO buffer and it was found that seven obvious peaks were observed in the 
electropherogram (Figure 4.4b). The peaks obtained from free FITC might be from 
various forms of FITC in aqueous solution (Figure 4.5) and the product of the unbound 
FITC that reacted with primary amine of TRIS in 6% PEO buffer (Figure 4.6). Among 
the possible forms of free FITC (Figure 4.5) of those analysed in 6% PEO buffer (pH 
8.5), the anionic and dianionic forms should be most abundant in the basic solution, while 
the cationic form should not exist45. 
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Figure 4.5: Possible forms of FITC in an aqueous solution (a) neutral species (p-quinoid); (b) neutral 
species (lactone); (c) neutral species (zwitterion); (d) cation; (e) anion (carboxylate); (f) anion (phenolate) 
and (g) dianion 
 
 
 
 
 
 
 
Figure 4.6: The reaction of free FITC with TRIS containing in 6% PEO buffer. 
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According to the results, protein labeling with FITC provided for a lower degree of 
labeling (F/P ratio) than the recommended value from literature. The fluorescence 
intensity might therefore be too low to be detected, especially when the protein–FITC 
complex is employed in the droplet format. In addition, the unbound FITC remaining in 
the conjugate samples due to the incomplete removal provided for several peaks in the 
electropherogram. This made it very difficult to distinguish the protein conjugates from 
the other irrelevant peaks. The protocol for protein labeling with FITC was also 
complicated and time-consuming.  Consequently, a more reactive fluorescent dye with 
simpler labeling and dye removing protocols that could provide for higher F/P ratios was 
employed and discussed in Section 4.3.2. 
  
4.3.2 NHS-Fluorescein labeling proteins 
According to the results, the labeling protocol of NHS-Fluorescein was simpler than that 
of FITC. Proteins (lysozyme and BSA) were labeled with NHS-Fluorescein according to 
the protocol described in Section 4.2.2.2 and the conjugates were measured for the 
absorbance at 280 nm (maximum absorbance of protein) and 494 nm (maximum 
absorbance of NHS-Fluorescein) (Figure 4.7) for the calculation of the F/P ratio.  
 
 
 
 
 
Figure 4.7:  Absorption spectra of (a) lysozyme conjugated NHS-Fluorescein and (b) BSA conjugated 
NHS-Fluorescein. Both protein conjugates were prepared in DI water. 
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The F/P ratio for lysozyme conjugated NHS-Fluorescein is 0.23, which is higher than that 
of FITC and for BSA conjugated NHS-Fluorescein is 0.13, which is lower than that of 
FITC. However, the degrees of labeling of both proteins are still lower than the 
recommended values (F/P ratio ~ 0.3-1.0). 
 
 
 
 
  
 
 
 
  
  
 
 
Figure 4.8:  The electropherogram of NHS-Fluorescein performed in 6% PEO 100 kDa in 0.05 M TRIS-
CHES, 0.1% SDS, pH 8.5 using a cross-piece PDMS microdevice. The electric field was applied at ~168 
V/cm and the detection was made at 1 cm. 0.5 mM NHS-Fluorescein was prepared in 0.1x TBE buffer. 
 
 
Free NHS-Fluorescein was electrophoresed in 6% PEO buffer as a control. At least three 
peaks are obviously observed in the electropherogram (Figure 4.8). These peaks might be 
NHS-Fluorescein, hydrolysed NHS-Fluorescein and the product from the reaction 
between NHS-Fluorescein and TRIS in 6% PEO buffer (Figure 4.9). The electrophoretic 
mobilities for peak 1, 2 and 3 are 1.60×10-8, 1.53×10-8 and 7.65×10-9 m2/Vs, 
respectively. 
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Figure 4.9:  The reaction of NHS-Fluorescein in 6% PEO buffer (a) The hydrolysis of NHS-Fluorescein 
and (b) The reaction between NHS-Fluorescein and TRIS. 
 
 
When lysozyme conjugated NHS-Fluorescein was electrophoresed in 6% PEO buffer, 
three peaks are observed in the electropherogram (Figure 4.10a) with the mobilities of 
1.31×10-8 (peak 1), 1.27×10-8 (peak 2) and 1.02×10-8 m2/Vs (peak 3). Since it was 
difficult to distinguish the lysozyme conjugate peak from the products of free NHS-
Fluorescein peaks, the free NHS-Fluorescein was then added to the lysozyme conjugate 
sample, which was depleted from the sample reservoir after several runs, to help 
distinguish the lysozyme conjugate peak. Figure 4.10a shows the first electrophoresis of 
lysozyme conjugated NHS-Fluorescein, which was initially added at the volume of 16 µl 
in the sample reservoir. The second electrophoresis was performed right after the first run 
as shown in Figure 4.10b. It was found that the intensity of all three peaks of the second 
run slightly decreased from the first run (Table 4.2). The free NHS-Fluorescein (0.1 mM) 
was added at 4-µl increments to the sample reservoir containing the rest of the lysozyme 
conjugate sample. The intensities of peak 1 and peak 2 significantly increased in the third 
run (Table 4.3) in which the NHS-Fluorescein was first added to the sample reservoir 
(Figure 4.10c). However, after NHS-Fluorescein was further added to the sample 
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reservoir in the fourth run, the intensities of all three peaks were higher (Table 4.3). It 
was also found that the fourth peak having the lowest mobility appeared in this run 
(Figure 4.10d). Since the first three peaks observed in the electropherograms of the 
lysozyme conjugate shows a significant change in the intensities after NHS-Fluorescein 
was added, it could be inferred that all the observed peaks belong to NHS-Fluorescein 
rather than the lysozyme conjugate. The fourth peak appeared in the electropherogram 
(Figure 4.10d) might be another form of NHS-Fluorescein; however, it might be only 
readily observed when the concentration of NHS-Fluorescein is high enough. 
 
 
 
Figure 4.10:  The electropherograms of lysozyme-NHS-Fluorescein electrophoresed in 6% PEO 100 kDa 
in 0.05 M TRIS-CHES, 0.1% SDS, pH 8.5 using a cross-piece PDMS microdevice (a) First injection of 
lysozyme-NHS-Fluorescein; (b) Second injection of lysozyme-NHS-Fluorescein; (c) First addition of 4 µl 
0.1 mM NHS-Fluorescein to the depleted lysozyme-NHS-Fluorescein and (d) Second addition of 4 µl 0.1 
mM NHS-Fluorescein to the depleted lysozyme-NHS-Fluorescein. The electric field was applied at ~168 
V/cm and the detection was made at 1 cm. Lysozyme-NHS-Fluorescein was prepared in 0.1% SDS buffer 
and heated at 95 °C for 5 min, while 0.1 mM NHS-Fluorescein was prepared in 0.1x TBE buffer.  
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Table 4.3: Showing the mobility and intensity of the peaks obtained from the electrophoresis of lysozyme 
conjugated NHS-Fluorescein with the addition of NHS-Fluorescein. 
 
Experiment Mobility (×10-8 m2/Vs) Intensity (a.u.) 
Peak 1 Peak 2 Peak 3 Peak 4 Peak 1 Peak 2 Peak 3 Peak 4 
1st run: injection of 
lysozyme conjugate 
1.32 1.27 0.99 - 37 35 13 - 
2nd run: injection of 
lysozyme conjugate 
1.32 1.28 1.02 - 34 30 10 - 
3rd run: 1st addition of 4 
µl NHS-Fluorescein 
1.32 1.27 1.02 - 46 43 5 - 
4th run: 2nd addition of 
4 µl NHS-Fluorescein 
1.32 1.27 1.02 0.95 126 150 34 54 
 
 
According to the results, proteins conjugated with NHS-Fluorescein had low F/P ratios 
indicating the low fluorescence intensity of the conjugates. This was confirmed by the 
electrophoresis of the lysozyme conjugate since the lysozyme conjugate peak was not 
observed. The low degree of protein labeling with NHS-Fluorescein might be due to the 
less reactive NHS-Fluorescein, which was possibly caused by the hydrolysis of NHS-
Fluorescein when it encountered the moisture after the thawing process. Another possible 
reason might be the incomplete removal of the unbound dye, which in turn interfered with 
the absorption measurement and therefore the calculation of F/P ratio. The intensities of 
the free NHS-Fluorescein and its products in the protein conjugate samples might 
overcome the intensity of the protein conjugate. As a result, a fluorescent dye that could 
be used to label proteins without the dye removal process after the labeling was required. 
 
4.3.3 NanoOrange labeling proteins 
In addition to the advantages of using NanoOrange described in Section 4.1, NanoOrange 
does not react with primary amines or undergo hydrolysis in the presence of water. 
Consequently, it does not react with TRIS in the aqueous buffer as FITC and NHS-
Fluorescein do, resulting in fewer free-dye related peaks in the electropherogram. 
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Figure 4.11: Effect of SDS concentration on the fluorescence intensity of protein conjugated NanoOrange. 
(a) The background intensity of 0.05 M TRIS-CHES, pH 8.5 buffer containing various concentrations of 
SDS (i) 0% SDS, (ii) 0.01% SDS and (iii) 0.1% SDS; (b) 10 µl of 0.01 mg/ml lysozyme conjugated 1x 
NanoOrange was added to 0.05 M TRIS-CHES, pH 8.5 buffer containing (i) 0% SDS, (ii) 0.01% SDS and 
(iii) 0.1% SDS; (c) A graph translating the fluorescence intensity from the images in Figure 4.11a and 
Figure 4.11b into the values in which the blue columns show the intensity of the background buffer 
containing 0-0.1% SDS and the red columns show the intensity of the buffer added 10 µl of 0.01 mg/ml 
lysozyme conjugated NanoOrange. 
 
 
Prior to performing the electrophoresis, lysozyme conjugated NanoOrange was employed 
to demonstrate the effect of the concentration of SDS on the fluorescence intensity of the 
protein conjugated NanoOrange since a higher concentration of SDS (i.e. > 0.1% SDS) 
than the recommended concentration in the protocol (i.e. 0.01% SDS) was used in the 
separation system (i.e. both sample buffer and separation buffer contained SDS). The 
fluorescence intensity of the background buffers with various concentrations of SDS (i.e. 
0 - 0.1% SDS) was recorded as a control (Figure 4.11a and Figure 4.11c). 10 µl of 0.01 
mg/ml lysozyme conjugated NanoOrange was then added to each buffer prior to 
measuring the fluorescence intensity again. It was found that the fluorescence intensity 
increased with rising SDS concentration in the buffer (Figure 4.11b and Figure 4.11c). 
According to the literature, NanoOrange diluent already contains detergents including 
SDS; as a result, the addition of SDS in the buffer could lead to the formation of micelles 
(if the total concentration of SDS reaches the CMC) that can bind to the dye leading to 
the high background fluorescence39. The CMC of SDS in the similar buffer system (0.1 
M TRIS-CHES buffer, pH 8.6 containing 1% PEO) to the one in the experiment was 
(a) i. ii. iii. 
Buffer with 
0% SDS 
Buffer with 
0.01% SDS 
Buffer with 
0.1% SDS 
(b) i. ii. iii. 
Add lysozyme 
conjugate in buffer 
with 0% SDS 
Add lysozyme 
conjugate in buffer 
with 0.01% SDS 
Add lysozyme 
conjugate in buffer 
with 0.1% SDS 
0	
50	
100	
150	
200	
250	
300	
0	 0.01	 0.1	
in
te
ns
ity
	(a
.u
.)	
%	SDS	(w/v)	
Buﬀer	
Buﬀer	with	0.01	mg/ml	
lysozyme-NanoOrange	
(c) 
 Chapter IV  
 
 171 
reported to be ~ 3 mM46; therefore, it was possible that SDS micelles might be present in 
our buffer system leading to the increase in the fluorescence intensity due to the binding 
of the dye to SDS micelles. 
 
It was also found that when NanoOrange was added to lysozyme solution, precipitation 
occurred (Figure 4.11b and Figure 4.12a) even at the concentration recommended in the 
protocol (0.01 mg/ml). The precipitation was also observed with the other proteins (i.e. 
BSA (Figure 4.12b) and trypsin inhibitor (data not shown)) that conjugated with 
NanoOrange. These precipitates interfered with the separation of proteins in that they 
flowed into the separation channel and generated erroneous peaks in the 
electropherograms. This could lead to misinterpretation and difficulty in distinguishing 
protein peaks, especially when several proteins were separated. The precipitation might 
also be one cause of the low fluorescence intensity of protein conjugates as observed in 
Figure 4.12. Owing to the low fluorescence intensity of proteins conjugated NanoOrange 
and the high fluorescence intensity of the background electrolyte containing SDS, the 
signal to noise ratio could be low and made the protein conjugates difficult to detect. 
 
 
 
 
 
 
 
 
 
 
Figure 4.12: Fluorescence intensity of protein conjugated NanoOrange. (a) Lysozyme conjugated 
NanoOrange droplet and (b) BSA conjugated NanoOrange droplet. The concentration of the proteins 
conjugated dye used to generate droplets were 0.5 mg/ml. 
 
 
The electrophoresis of BSA conjugated NanoOrange released from droplets was 
performed to investigate the fluorescence intensity and determine whether it was strong 
enough to be observed using our detection system. The electrophoresis of five BSA-
NanoOrange droplets in 6% PEO buffer using the interfacing microdevice “Design 6” 
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(discussed in Chapter 5) was successfully detected as illustrated in the electropherogram 
(Figure 4.13). In this experiment, each droplet performed double injections resulting in 
two peaks.  
 
 
 
 
  
  
 
 
 
 
 
 
Figure 4.13: An electropherogram of BSA conjugated NanoOrange obtained from the injections of five 
droplets into 6% PEO 100 kDa in 0.05 M TRIS-CHES, 0.1% SDS, pH 8.5 using the interfacing droplet-
based microdevice “Design 6”. The electrophoresis was performed at the electric field strength of ~ 333 
V/cm and detected at 1.0 cm. 
 
 
Although the fluorescence intensity of BSA-NanoOrange droplets was acceptable, other 
proteins conjugated with NanoOrange (i.e. lysozyme and trypsin inhibitor) did not 
provide sufficiently high enough intensity. Their peaks could not be distinguished from 
the baseline due to the high background fluorescence intensity (data not shown). 
Additionally, the presence of precipitates in protein conjugates was also a problem when 
using NanoOrange dye as discussed in detail earlier. Consequently, NanoOrange was not 
further used for protein labeling for droplet-based separations in this work.  
 
4.4 Conclusion 
Three fluorescent dyes were investigated in this work for protein labeling. The initial 
criterion for the chosen fluorescent dyes was the compatibility of the excitation and 
emission wavelengths with the detection system used in this work (λex = 470-490 nm and 
λem = a long pass 510 nm cut-on filter). FITC was the first dye used to label proteins as it 
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has already been extensively studied and widely applied. It was found that the labeling 
protocol of FITC was a multi-step, complicated and time-consuming procedure. The 
degree of labeling (F/P ratio) was also low therefore resulting in the low fluorescence 
intensity of the conjugate. In addition, it was difficult to entirely remove the unbound 
FITC from the conjugate. The unbound FITC remaining in the conjugate sample could 
react with water and TRIS in the running buffer yielding additional fluorescent products, 
which interfered with protein separations.  
 
NHS-Fluorescein was the second dye that was studied since it was more reactive than 
FITC and the labeling protocol was simpler than that of FITC. However, similar problems 
were encountered with NHS-Fluorescein to those observed with FITC. These included 
low F/P ratios and interference of the fluorescent products from the reaction of the 
unbound dye with water and primary amines. Therefore, the fluorescent labeling of 
proteins, which does not involve the unbound dye removal, was employed instead.  
 
NanoOrange was the third dye to be tested since it provided for more convenient and 
more rapid labeling than that of two aforementioned dyes. Moreover, dye removal was 
not required because the unbound NanoOrange does not fluoresce and does not react with 
water or TRIS in the running buffer. It was nonetheless found that proteins conjugated to 
NanoOrange easily precipitated and provided for low fluorescence intensity. Although the 
total fluorescence intensity increased in the presence of SDS in the running buffer, the 
increase in the intensity might be due to the binding between NanoOrange and SDS 
micelles instead of the protein conjugate.  
 
Owing to the problems caused by these fluorescent dyes, commercial fluorescently 
labeled proteins were finally employed in this work despite the fact that they were 
expensive. The criteria for choosing the commercially fluorescent protein conjugates 
were that they had to be compatible with our detection system, provided for high 
fluorescence intensity and did not react with the components of the separation buffer. It 
was found that some purchased protein conjugates failed to fluoresce and could not be 
used. Therefore, only three commercially available fluorescently labeled proteins were 
used in this work. These were BSA-FITC (Sigma Aldrich), fluorescent molecular weight 
marker (20-200 kDa, Sigma Aldrich) and benchmark fluorescent protein standard (11-155 
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kDa, Thermo Fisher Scientific). Of these three purchased protein conjugates, the protein 
ladder from Sigma Aldrich was no longer available during this work despite the fact that 
it provided for higher intensity than the protein ladder from Thermo Fisher Scientific. 
Consequently, only BSA-FITC from Sigma Aldrich and the protein ladder from Thermo 
Fisher Scientific were used as benchmarks for the majority of microchip separations 
performed in this work. 
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5.1 Introduction 
The importance of multidimensional protein separations in modern day biology has been 
discussed in detail in Section 1.8, but at a basic level multidimensional separations 
provide for high peak capacity and high resolution separations of complex mixtures of 
proteins and other biomolecules1. Critical to the success of any multidimensional 
separation methodology, is the efficient interfacing (or joining) of two or more distinct 
separation techniques so that separated analytes from one dimension can be transferred to 
the next.  
The coupling between capillary electrophoresis and/or column chromatography (e.g. CE-
CE, LC-LC and LC-CE) can be achieved by employing several types of interfaces (such 
as dialysis interfaces2, porous junction interfaces3,4, tee-union interfaces5, flow gating 
interfaces6, microreactor interfaces7, nicked-sleeve interfaces8, hydrodynamic interfaces9 
and six-port valves10) to connect the separation dimensions. Another format that has been 
increasingly used for 2D separations involves the use of planar chip-based microfluidic 
devices for performing multidimensional electrophoretic separations. In previous reports, 
dimensions were most usually connected through the use of intersecting channels11–19, 
PDMS membranes20, staggered configurations of two-dimensional separation channels21, 
microvalves22,23, gel-based pseudo-valves24,25,26,27, narrow channels28 and small open 
channels29 connecting between two-dimensional separation channels as an interface 
(described in detail in Section 1.8). Although these formats provide for improved 
automated and rapid separations, significant dispersion of analytes at such interfaces has 
proved to be highly problematic. In addition, when CE is performed in either a capillary 
or chip-based format injection, bias is commonly encountered. This describes the 
situation when analytes are injected electrokinetically, with higher mobility analytes 
moving faster and being injected in higher amounts than lower mobility analytes within 
the same sample. This phenomenon significantly hampers the ability to perform reliable 
and quantitative analyses30. On the other hand, hydrodynamic injection provides for bias-
free introduction of analyte molecules, but is less well-suited to the delivery of precise 
and sub-nL sample volumes to the separation column. Accordingly, we proposed a novel 
approach for transferring separated analytes from a first to a second dimension by 
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compartmentalizing the separated analyte bands into droplets contained within a 
continuous carrier phase31–33. Droplet contents can subsequently be released and injected 
into a separation channel for further analysis. By adopting this method, band dispersion at 
the interface is minimized and the injected amount of analyte is better controlled. 
 
 
 
Figure 5.1:  Compartmentalization of analyte bands into droplets (a) A schematic showing separated 
analyte bands from a first dimension being compartmentalized into droplets that are transferred downstream 
for further analysis; (b) A mixture of fluorescent dyes was injected at the cross-channel part of a 
microdevice shown in the inset (color images). The mixture was separated using CGE and the separated 
bands moved along the straight channel to a T-junction where droplets could be generated. Schematics are 
reproduced from reference 34 and 35. 
 
Previously, Edgar and co-workers34 reported the compartmentalization of separated 
amino acids containing D/L glutamate into droplets for further separation in a second 
dimension. In his work, the amino acid mixture was first separated by CZE, with the 
separated bands being encapsulated into droplets at a modified flow-focusing geometry 
where droplet generation was induced by EOF (Figure 5.1a). The generated droplets 
were collected at an exit reservoir placed downstream and the droplet contents were then 
injected into a glass capillary for separation by MEKC. Recently, the 
compartmentalization of separated analytes into droplet format was reported by Draper 
and co-workers35, who separated a mixture of two fluorescent dyes (5-Carboxyfluorescein 
and Fluorescein) by CGE. Such an approach is potentially advantageous, since the gel 
buffer minimizes EOF and longitudinal diffusion of analytes. The authors demonstrated 
(a) (b) 
0.5 cm 
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that separated analyte bands could be maneuvered towards a T-junction where droplets of 
eluted bands were formed (Figure 5.1b). Both studies show successful 
compartmentalization of separated analyte bands from a first separation dimension into 
droplets, and that the generated droplets can be transferred to another separation 
dimension or another analytical component. 
Many research groups have investigated the transfer of droplets to a second separation 
dimension. Typically, droplets containing eluted analyte bands from a first separation 
dimension are aqueous and dispersed within an immiscible oil phase. In order to transfer 
droplet contents to a buffer solution in a second dimension, the oil surrounding each 
droplet must be depleted and removed so that it will not interfere with the separation. To 
this end, Edgar and co-workers36 presented the fusion of aqueous droplets containing a 
mixture of amino acids with an immiscible boundary to release droplet contents into a 
separation channel. A PDMS microdevice consisting of a droplet generation part and a 
separation part was fabricated for this purpose (Figure 5.2a). The surface of the 
separation channel was then selectively patterned to achieve a hydrophilic surface, while 
the surface of the droplet generation region remained hydrophobic. Droplets of labeled 
amino acids could be generated at a T-junction geometry, with droplets then moving 
towards the separation channel where they fused with the immiscible boundary to release 
droplet contents into the hydrophilic CZE separation channel. Significantly, the 
hydrophilic surface of the separation channel prevented oil from entering and wetting the 
surface and enhanced EOF, which allowed the efficient separation of amino acids. 
However, the selective patterning of the microdevice surface is complex, inconvenient 
and time-consuming. 
Kennedy and co-workers37 reported on the use of a K-shaped channel for sampling 
analyte plugs segmented within an immiscible oil stream into an electrophoresis channel. 
In this study, a T-junction (where sample plugs were generated) and a serpentine channel 
were rendered hydrophobic, whereas, a K-shaped interface and an electrophoresis 
channel were hydrophilic. At the junction between the K-shaped interface and the 
segmented flow channel (Figure 5.2b) where an aqueous buffer met an oil stream, a 
virtual wall (water/oil interface) is created. Briefly, a generated sample plug (a mixture of 
amino acids) flows along the serpentine channel until it reaches the K-shaped interface. 
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The sample plug then makes contact with the virtual wall and the aqueous sample in the 
plug merges with the aqueous buffer solution in the interface. A small amount of sample 
is then electrokinetically injected into the electrophoresis channel for further separation. 
In this case, the virtual wall prevents the oil stream in the segmented flow channel from 
entering the electrophoresis channel. In addition, it also prevents the aqueous buffer from 
flowing into the segmented flow channel. 
 
 
Figure 5.2: Droplet-based interfacing microdevices employing surface modification. (a) A droplet 
generated at a hydrophobic T-junction channel moves towards a hydrophilic separation channel where it 
fuses with an immiscible boundary allowing the droplet contents to be injected into the separation channel; 
(b) A schematic showing a sample plug moving along a segmented flow channel prior to merging with a 
virtual wall at a K-shaped interface. Here, only small amount of the sample is injected into the separation 
channel; (c) A parallel electrophoretic analysis on a microdevice employing K-shaped interfaces for the 
transfer of sample plugs; (d) A schematic and images showing the transfer of sample plugs obtained from a 
microdialysis probe (not shown) into a separation channel using a hydrophilic extraction bridge. Schematics 
and images reproduced from reference 36, 37, 38 and 39, respectively. 
 
(a) (b) 
(c) 
 
(d) 
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Another study by Kennedy and co-workers38 employs K-shaped interfaces for parallel 
electrophoretic separations. A glass microdevice consisting of three sets of a K-shaped 
interface and an electrophoretic separation system is depicted in Figure 5.2c. Each set 
was composed of a segmented flow channel that was selectively made hydrophobic, a K-
shaped interface and an electrophoresis channel containing an aqueous buffer solution. 
The operation of the system was similar to that described in the previous study37, with the 
added advantage that it provided for high-throughput analysis of segmented samples in a 
parallel manner. 
A final study by Kennedy and co-workers39 involved the use of a hydrophilic extraction 
bridge as an interface to extract microdialysis samples from segmented plugs into a 
separation channel. A dual-chip system consisting of a PDMS microdevice integrated 
with a microdialysis probe for the generation of sample plugs and a glass microdevice 
with selectively modified surfaces to perform electrophoresis was used in this work. 
Sample plugs containing dialysate and other reagents were generated in the PDMS 
microdevice and were transferred to the glass microdevice via a high purity 
perfluoroalkoxy plus (HPFA+) tube. When the sample plug contacted the hydrophilic 
extraction bridge, the aqueous sample was transferred into the extraction channel with 
some delivered into the electrophoresis channel for further separation as depicted in 
Figure 5.2d. 
Although all interfacing microdevices developed by Kennedy and co-workers were 
successful in their aims, they suffered from two disadvantages. First, they all required 
selective modification of channel walls, and second they wasted a large proportion of the 
analytical sample since only small amount is sampled into the electrophoresis channel, 
whilst the rest flows to waste. 
Kelly and co-workers40 proposed a droplet-based interfacing microdevice coupled to ESI-
MS for the separation and analysis of peptides (Figure 5.3a). Briefly, analyte droplets 
were generated and moved downstream to an interface where an array of 3 µm wide 
apertures formed by cylindrical posts were located. Several apertures at the interface 
provided for an imbalance of pressure that prevented appreciable mixing of oil and 
aqueous streams. Therefore, aqueous droplet contents could merge with the aqueous 
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stream and pass through an ESI emitter placed downstream. The major difficulty 
associated with this technique was the requirement for precise pressure control to release 
droplet contents into the aqueous stream. 
 
 
 
 
Figure 5.3: Droplet-based interfacing microdevices coupled to mass spectrometry analysis (a) A 
micrograph showing an analyte plug being transferred into an aqueous stream employing an array of 
apertures as an interface for pressure control; (b) An integrated platform for protein analysis consisting of a 
droplet generation part, which compartmentalizes eluted bands from HPLC, and an electrospray ionization 
emitter for mass spectrometry analysis of proteins in droplets. Schematics and image reproduced from 
reference 40 and 41, respectively. 
 
Ji and co-workers41 demonstrated another droplet-based microdevice coupled to ESI-MS. 
In this work, separated proteins from HPLC were encapsulated in droplets along with 
trypsin to allow for on-line digestion prior to delivery to the ESI emitter (Figure 5.3b). 
When ESI occurs (ionization voltage = 2.0 kV), the oil phase forming droplets at the 
emitter tip moved along the outer surface of the emitter away from the tip, possibly by the 
effects of gravity and interfacial tension41,42. However, the drawback of this technique is 
that oil interferes with MS analysis when ionization voltages above 2.0 kV are used. 
Niu and co-workers31 presented an extremely interesting approach for interfacing 
microdevices. In this work, separated bands of a peptide mixture from an LC separation 
were collected in the form of droplets prior to transferal to a second CE separation. The 
droplet contents were injected into a separation channel by employing a pillar-structured 
microdevice with a pressure source to eliminate the oil surrounding droplets, as shown in 
Figure 5.4a. This technique provided for several advantages over the immiscible 
(a) 
 
(b) 
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boundary technique36, the use of K-shaped interfaces37, 38 and the use of an extraction 
bridge39 in that there is no need to selectively modify channel walls. However, oil 
depletion occurs in an active manner (since a pressure source is used) making it difficult 
to reduce the size of the entire system.  
 
 
 
 
 
 
 
 
 
Figure 5.4: Droplet-based interfacing microdevices developed by Niu and co-workers (a) A schematic 
showing the compartmentalization of eluted bands from the first separation dimension into droplets (left) 
and droplet injection into the second dimension employing a pillar-structured microdevice to eliminate oil 
surrounding droplets (right); (b) Schematics of the Nano LC-MALDI-MS droplet-based interfacing 
microdevice (i) Separated analyte bands from Nano-LC are compartmentalized into droplets, (ii) Droplet 
contents are collected at the tip of the probe prior to the deposition onto the MALDI stage, whilst oil is 
absorbed into an oleophilic film; (c) Schematics illustrating the interfacing microdevices utilizing an 
oleophilic membrane as an oil depletion unit (i) An entire microdevice made of PDMS (left) and a PDMS 
microdevice coupled to a glass capillary (right), (ii) A schematic depicting the injection of a droplet through 
an open channel, while oil is depleted via the oleophilic membrane. Schematics reproduced from reference 
31, 32 and 33, respectively. 
(c) 
 
i. ii.  
(a)  
(b) 
 
i. ii.  
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The same group later introduced the use of an oleophilic foam to eliminate the oil phase 
during droplet injection32,33. Figure 5.4bi shows the encapsulation of Nano LC-separated 
proteins into droplets that were then delivered for further analysis by matrix-assisted laser 
desorption/ionization (MALDI) mass spectrometry. The oil phase was eliminated by 
absorption into an oleophilic foam, while droplet contents were collected at the tip of the 
tube prior to deposition onto a MALDI plate as depicted in Figure 5.4bii32. The 
oleophilic foam was also employed for droplet-based separation of proteins33. Herein, two 
designs of the interfacing microdevices were proposed for the separation of proteins using 
CZE and CGE. Figure 5.4ci shows an entire PDMS microdevice (left) used for CZE 
separations and a PDMS microdevice coupled to a glass capillary (right) used for CGE 
separations. Droplet injection in both designs occurs at the open channel of the PDMS 
part where oil is absorbed into an oleophilic foam, while droplet contents are injected into 
a separation channel as shown in Figure 5.4cii. Although this technique provided for 
passive oil depletion, the difficulty in the setup of the experiment was still a problem that 
needed to be addressed. 
Although much effort has focused on the development of interfacing microdevices for 
droplet-based separation of amino acids, peptides and proteins; microdevices reported in 
the literature still suffer from many disadvantages such as the need for selective surface 
modification, unacceptable sample wastage, the need for precise pressure control, active 
oil depletion and difficulty in experimental setup. The development of an interfacing 
microdevice for droplet-based analysis that provides for ease of fabrication, automation 
of oil depletion in a passive manner and high-throughput separation of proteins is 
therefore required. The evaluation of six novel interfacing microdevices are discussed and 
contrasted in detail in this chapter, with a view to their application in droplet-based 
separation of proteins. 
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5.2 Droplet generation 
5.2.1 Techniques for droplet generation 
5.2.1.1 Droplet generation using a T-junction microdevice 
A T-junction PDMS microdevice (100 µm wide and 100 µm deep) was fabricated as 
described in Section 2.1.1. FC-40 oil filled up a 3-ml plastic syringe connected to a 
polyethylene tube (I.D. 1.09 mm and O.D. 2.98 mm purchased from Smiths Medical, 
Kent, UK), while an aqueous sample filled up a 1-ml plastic syringe connected to the 
other polyethylene tube. Both tubes were placed into reservoirs on the microdevice and 
the infused flow rates were set at 12 and 1.8 µl/min for the oil and the sample, 
respectively. The generated droplets were collected in a 100 µm I.D. PTFE tube that was 
inserted into an open enlarged channel of the microdevice until they were used. 
 
5.2.1.2 Droplet generation using a robotic droplet generator 
The experimental setup and the operation of droplet generation using a robotic droplet 
generator were described in detail in Section 2.3.  
 
5.2.2 Results and Discussion 
T-junction microdevices were employed to generate droplets used to evaluate developed 
interfacing microdevices, Design 1 and Design 2, while the robotic droplet generator was 
employed to generate droplets used in Design 3-Design 6. It was found from these 
experiments that appropriate droplet sizes were required to achieve successful single 
droplet injection and frequency of droplet generation (which in turn defines the distance 
between each droplet) needed to be optimized to ensure successful separation without 
cross contamination between adjacent droplets.  
 
In the case of T-junction microdevices, it was difficult to achieve the required droplet size 
and the required frequency of droplet generation simultaneously by synchronous 
adjustment of both oil and aqueous liquid flow rates. The other problem with T-junction 
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microdevices was the difficulty in handling or manipulating the entire system when low 
sample volume (tens microliters) was used.  
 
By utilizing the robotic droplet generator to generate droplets, those two problems found 
in T-junction microdevices were solved. By adjusting a refilled flow rate, the frequency 
of droplet generation and the residence times of the tube in the oil and in the sample 
phase, droplet size and distance between each droplet were varied to achieve the 
requirement. Normally, the droplet size increases with the increase of the refilled flow 
rate and/or the residence time of the tube in each phase. Meanwhile, the distance between 
each droplet increases with the increasing of the refilled flow rate and/or with the 
decreasing of the droplet generation frequency and the residence time of the tube in each 
phase. In addition, the sample volume used with the robotic droplet generator could be 
very low (i.e. down to ~20 µl)43. Due to the limitation of sample volume (protein ladder) 
used in this work and the need to control the size and the distance between each droplet, 
the robotic droplet generator was therefore used in most of our experiments. 
 
5.3 Evaluation of interfacing droplet-based microfluidic designs 
5.3.1 Design 1 
5.3.1.1 Schematics of designs and fabrication 
The initial interface design is illustrated in Figure 5.5a, with the top and the bottom 
layers being shown in Figure 5.6ai and Figure 5.6aii, respectively. This embodiment of 
the interfacing microdevice was designed for use with single-channel or parallel-channel 
separations, containing two identical separation systems (located on the upper half and 
the lower half of the blue dashed box in Figure 5.5b and also shown in Figure 5.6b). 
Each droplet-based separation system consists of a separation channel (100 µm wide and 
100 µm deep) connected to a buffer reservoir at one end and a buffer waste reservoir at 
the other end, an orthogonal side channel (droplet delivery channel) with an enlarged end 
for the insertion of a droplet delivery tube and two oil depletion units containing a pillar 
in each unit. It should be noted that open spaces are structured in the bottom layer 
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(Figure 5.6aii) below at the oil depletion units to allow oil to absorb into a PTFE 
membrane underneath the microdevice.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.5: Schematics and an image illustrating the structure of the initial interface design used to perform 
single or multiple separations (a) A schematic of the entire microdevice consisting of a top layer (black 
solid lines) and a bottom layer (black and red dashed lines) of PDMS. The top PDMS layer contains two 
parallel separation channels with reservoirs at each end (the left reservoir is the “buffer reservoir” and the 
right reservoir is the “buffer waste reservoir”), two channels with enlarged ends to allow insertion of the 
droplet delivery tubes and four oil depletion units (with a pillar in each unit). The bottom PDMS layer 
consists of four open circles at the same positions as the oil depletion units in the top layer; (b) An 
enlargement of the oil depletion units. 
 
 
 
(b)  For insertion of droplet delivery tube 
Droplet delivery channel 
Separation channels 
extended to a buffer 
waster reservoir 
Oil depletion units 
Extended to  
a buffer reservoir 
A pillar 
(a)  
Buffer waste reservoir Buffer reservoir 
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Figure 5.6:  (a) A schematic showing the separated top and bottom PDMS layers: (i) Top layer, (ii) Bottom 
layer; (b) An image showing a separation channel connected to two sides of pillar-structured oil depletion 
units and a channel for delivering droplets. 
 
 
The entire microdevice was made of PDMS and fabricated as described in detail in 
Section 2.1.1. The top and the bottom PDMS layers were 3 mm and 300-500 mm deep, 
respectively. The reduced thickness of the bottom layer ensured that the oil depletion 
units were as close to the PTFE membrane as possible, thus allowing efficient oil 
removal. Prior to assembly of the PDMS layers, biopsy punches (1 and 4 mm in diameter) 
were used to create four open spaces in the bottom layer and to create two reservoirs in 
the top layer. The two PDMS layers were then bonded under a microscope after oxygen 
plasma treatment to ensure that all open spaces were precisely aligned underneath the oil 
depletion units.  
 
5.3.1.2 Droplet injection 
The microdevice was filled with 3% PDMA in 8.5 mM borate buffer through the buffer 
reservoir. Any buffer remaining in the oil depletion units was removed using a non-
fibrous tissue. For single-channel separations, a small part of one side channel was cut 
open for the insertion of a droplet delivery tube (100 µm I.D. PTFE tube, Cole Parmer) as 
(a)  i. 
ii. 
Open spaces 
(b)  
Droplet delivery channel 
The other  
separation channel 
 Separation channel 
A pillar A pillar 
100µm 
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shown in Figure 5.7. The microdevice along with the inserted tube was then placed onto 
the PTFE membrane. While an electric field was applied across the separation channel 
(with the cathode being placed in the buffer reservoir and the anode in the buffer waste 
reservoir), droplets were delivered from the droplet delivery tube to the microdevice 
using a precision syringe pump (PHD 2000, Harvard Apparatus). Droplets were then 
injected and separations performed inside the separation channel. 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.7: A top view schematic of the microdevice during droplet injection experiment. One end of the 
droplet delivery tube is inserted into a side channel of the microdevice, while the other end is connected to 
the syringe pump to drive droplets towards a separation channel. An electric field is applied across the 
separation channel by placing a cathode in the buffer reservoir and an anode in the buffer waste reservoir. 
 
5.3.1.3 Results and Discussion 
The first microfluidic interface was inspired by the previous work of Niu et al31 as 
discussed in Section 5.1. Briefly, a pillar-structured channel together with an oil 
aspiration system was employed to eliminate oil that surrounds droplets prior to their 
injection into a separation channel. This structure should provide for a number of key 
advantages. For example, oil depletion could be achieved without surface modification of 
the channel walls and oil contamination in the separation channel could be drastically 
reduced. However, the need for two pumps to deliver droplets and to aspirate the oil 
makes the size of the entire system unacceptably large for many applications. Ideally, 
complete oil depletion should be achieved in an entirely passive manner (i.e. without the 
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need for a pump to aspirate the continuous oil phase). Accordingly, the droplet interface 
described by Niu31 was redesigned as depicted in Figure 5.5a and is described in detail in 
Section 5.3.1.1.  
 
There are three key features of this new design. First, although the pillar-structures are 
similar to those in Niu’s original design31, instead of using a one-sided oil removal 
channel, two oil-removal channels containing pillars are used to accelerate the oil 
removal process. Second, passive oil depletion is achieved by placing a thin PTFE 
hydrophobic/oleophilic membrane underneath the microdevice, so that oil is absorbed 
into the foam. Third, the new design allows either single-channel or parallel-channel 
separations to be performed. 
 
The basic principle behind droplet injection using this new design makes use of a pre-
formed droplet being delivered by a pressure source towards a separation channel. Prior 
to entering the separation channel, the droplet is trapped between the pillars on two sides 
and the oil surrounding the droplet is filtered out through small channels between the 
pillars and absorbed into the PTFE membrane. In principle, this construct should allow 
droplet contents to be injected into the separation channel without appreciable oil 
contamination.  
 
Unfortunately, it was found that this interfacing droplet-based design was plagued by a 
number of operational issues. First, the bottom PDMS layer needed to be cut to the same 
size and located at the same position as the oil depletion units on the top PDMS layer. 
Owing to the fact that the size of each oil depletion unit was small (790 × 650 µm) and 
the bottom layer thin (~ 500 µm), it was difficult to ensure precise alignment. A biopsy 
puncher (with an inner diameter of 1 mm) was used to create the open spaces instead of 
using a blade. Although the size of the open spaces was larger than that of the oil 
depletion units, the use of the biopsy puncher provided for better localization of the open 
spaces. The design also required precise alignment between the two PDMS slabs so that 
the open spaces on the bottom layer were placed exactly underneath the oil depletion 
units. Although this process was performed under a microscope, it was still difficult to 
align all the oil depletion units at the same time. 
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Figure 5.8: Illustration of the droplet injection process. (a) The injection of a mixture of a fluorescent dye 
and a food dye. (i) The microdevice prior to injection at t = 0 s, (ii) The first sample plug is injected into the 
separation channel (t = 50 s) and moves towards the anode, (iii) The first sample plug stops being injected 
at t = 53 s, (iv) The next sample plug is injected at t = 54 s (v) A sample plug is injected at t = 63 s, whilst 
the previous one is still being injected. Buffer solution leakage can be observed at the right oil depletion 
unit in each image; (b) A dead volume exists at the connection between the droplet delivery tube and the 
droplet delivery channel. Oil surrounding the droplets is thus accumulated and causes droplets merge prior 
to injection; (c) Diffusion of the sample into the oil depletion units. Experiments were performed at an 
infusing flow rate of 0.12 µl/min and an electric field strength of 85.7 V/cm. 
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Prior to droplet injection, the microdevice was filled with 3% PDMA buffer solution, 
which was one of the tested laboratory-made buffers described in Section 3.3.4.1, 
through the buffer reservoir. Two problems can potentially occur at this stage. First, the 
microdevice is easily broken since the thin bottom layer cannot withstand the high 
pressures that often occur when filling the microdevice with highly viscous fluids. 
Conversely, low viscosity buffer may leak out through the open spaces of the oil 
depletion units as exemplified in Figure 5.8a. This occurs since the surface at the edge of 
the open spaces is hydrophilic due to the plasma treatment prior to device bonding. After 
filling up the microdevice with buffer solution, the system was set up for droplet injection 
as described in Section 5.3.1.2. 
 
An electric field strength of 85.7 V/cm was applied across the separation channel. 
Importantly, the associated current was found to be stable over the timescale of the 
experiment. Droplets were delivered to the separation channel at the flow rate of 0.12 
µl/min, with the first injection in Figure 5.8aii commencing at t = 50 s. Although 
injections are successful with the contained analytes migrating along the separation 
channel toward an anode, each injection was not entirely associated with a single droplet. 
Indeed, it was found that the dead volume at the connection between the droplet delivery 
tube and the droplet delivery channel (shown in Figure 5.8b) caused droplets moving 
from the tube into the channel to merge either before or immediately after passing this 
dead volume, thus forming an extended sample plug. 
 
It was also observed (Figure 5.8aii, 5.8aiv and 5.8av) that the injection frequency and the 
injection volume of the sample plug were not perfectly reproducible. The volume of the 
injected plug depends on the period of the injection time, which in turn is controlled by 
the flow of the oil in the tube (data not shown). It was observed that each time the oil 
flow pushed a droplet to merge with the long sample plug, the sample plug was injected 
into the separation channel and the injection temporarily terminated (Figure 5.8aiii) 
when droplets stopped merging. Accordingly, the frequency and the volume of the 
merging droplet had a direct influence on the injection behaviour. Moreover, it was 
observed that analytes gradually diffused into the small channels between pillars and 
eventually filled the oil depletion unit (Figure 5.8c). This suggested that the oil 
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surrounding droplets was depleted (to some extent) into the dead volume instead of being 
depleted by the pillars and the oil depletion units. Once this dead volume was full of the 
oil and the oil depletion units were full of analytes, droplets stopped merging and 
injection was completely terminated. 
 
Although the use of pillars along with the PTFE membrane for passive oil depletion was 
not investigated due to the dead volume issue, the initial interface design was discarded 
due to the problems associated with difficulties in fabrication, the fragility of the device, 
compatibility with buffer solutions and the unacceptably large dead volume between the 
connection. Accordingly, a new design of interfacing droplet-based microdevices was 
investigated and is described in Section 5.3.2. 
 
5.3.2 Design 2 
5.3.2.1 Schematics of designs and fabrication 
The entire “Design 2” microdevice is depicted in Figure 5.9a and consists of a top layer 
(Figure 5.9bi) and bottom layer (Figure 5.9biii). This microdevice was designed to 
perform both single-channel and parallel-channel separations. The upper PDMS layer 
contains two separation channels (100 µm wide and 100 µm deep) sharing a common 
buffer reservoir and a common buffer waste reservoir (4 mm I.D.) at each end (Figure 
5.9bi). The bottom PDMS layer is 150-300 µm thick (Figure 5.9bii) and is used to seal 
the device. Both top and bottom layers were treated with oxygen plasma to activate the 
surface. The bottom layer was then cut into two pieces, placed 2-3 mm apart (Figure 
5.9biii) and bonded to the top layer. The separation in the bottom layer allows droplets to 
be transferred into the separation channels via open channels. 
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Figure 5.9: Schematics illustrating the structure of “Design 2” for single or multiple separations (a) A 
schematic of the entire microdevice consisting of a top layer (solid lines) and a bottom layer (dashed lines) 
in PDMS. The top PDMS layer consists of two parallel separation channels with reservoirs at each end (the 
left reservoir is the “buffer reservoir” and the right reservoir is the “buffer waste reservoir”). The bottom 
PDMS layer is cut into two pieces and placed 2-3 mm apart beneath the top layer; (b) Schematics showing 
the separated top and bottom PDMS layers: (i) Top layer, (ii) Bottom layer before being cut and (iii) 
Bottom layer cut after oxygen plasma treatment. 
 
 
5.3.2.2 Droplet injection 
Two droplet delivery tubes (containing droplets of fluorescein mixed with food dye) were 
cut at a 30° angle at one end and placed onto a PTFE membrane as shown in Figure 5.10.  
The microdevice was filled with 0.1x TBE buffer through the buffer reservoir. It was then 
aligned with the delivery tubes such that the open channels were placed onto the 30° cut 
of the tubes. Both the microdevice and the tubes were secured in place by an acrylic plate. 
Droplets in the delivery tubes were pumped towards the microdevice, while an electric 
field was applied across the separation channels. At the junction (as with the previous 
devices) the oil surrounding the droplets was absorbed into the PTFE membrane, whilst 
the droplet contents were released and injected into the separation channels, where they 
moved towards the detector. 
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Figure 5.10: Schematics showing the experimental setup used for droplet injection using the interfacing 
microdevice “Design 2”. (a) The interfacing microdevice placed on droplet delivery tubes. Both tubes are 
on a PTFE membrane. The open channels are aligned to the mouths of the two droplet delivery tubes cut at 
30° to the edge. The other ends of the tubes are connected to precision syringe pumps; (b) A platform to 
hold the microdevice during the experiments consists of two acrylic plates: a top plate and a bottom plate. 
The microdevice along with the tubes and the PTFE membrane is placed on the bottom plate of the 
platform, whilst the top plate is put on the microdevice to secure everything in place. There is a square 
cavity on the top plate at the position of the buffer reservoir so that a Pt electrode can be immersed into the 
buffer reservoir through the cavity. 
 
 
5.3.2.3 Results and Discussion 
“Design 2” was developed based on previous work by Niu and co-workers33, as described 
in Section 5.1. The interfacing microdevice in this study allowed the oil surrounding 
droplets to be absorbed passively into a hydrophobic and oleophilic PTFE membrane via 
an open channel prior to droplet injections. The design of this microdevice (Figure 5.4ci) 
was simpler than that of his previous work (Figure 5.4a)31. Accordingly, it was used as a 
model to create “Design 2” as illustrated in Figure 5.9a.  
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The outstanding feature of “Design 2” is that the design is not complicated and thus 
should be easy to fabricate and multiplex. Furthermore, the carrier phase is passively 
depleted using a thin PTFE membrane. Finally, droplets can be transferred to the 
separation channel directly, which should alleviate the problems in “Design 1” associated 
with dead volumes. 
The process of droplet injection using “Design 2” involves a pre-generated droplet in the 
droplet delivery tube being delivered towards a separation channel using a syringe pump. 
When the droplet reaches the mouth of the tube, the oil surrounding the droplet is 
passively absorbed into the PTFE membrane, while the contents of the aqueous droplet 
merge with a buffer solution in a separation channel above.  
The fabrication of microdevices based on “Design 2” was easier than those based on 
“Design 1” since the alignment of the top and the bottom layers could be achieved 
without a microscope. After plasma treatment, the bottom layer was cut and separated 
with 2-3 mm gap (Figure 5.9biii) and bonded to the top layer. The separation channels 
therefore contain two parts; a closed-channel part formed by three hydrophilic walls and 
an open-channel part (2-3 mm long) confined by two hydrophobic edges of the bottom 
layer. The width of the open-channel part needs to be 2-3 mm so that two droplet delivery 
tubes could be placed in between the open channels. Current fluctuations within the 
closed-channel were found to be similar to those observed in open-channels with a 2-3 
mm gap and typically between 1 and 3 A. However, when the gap of the open channel 
was over 6 mm, significantly larger current fluctuations were observed. 
The entire PDMS microdevice was filled with 0.1x TBE buffer solution through the 
buffer reservoir. The buffer solution flowed by capillary action from the buffer reservoir 
along the separation channel to the buffer waste reservoir, but did not leak at the edges of 
the intersection since the edges of the bottom layer are hydrophobic. A droplet delivery 
tubes placed between the open channel and the PTFE membrane created a junction where 
droplets could be transferred into the separation channel. 
Figure 5.11 shows the successful injection of the mixture of fluorescein and food dye in 
parallel separation channels: upper channel (Figure 5.11a) and lower channel (Figure 
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5.11b). Droplets were injected continuously using this design without the accumulation of 
buffer solution at the junction (which causes dilution of droplet contents) as a result of 
Laplace’s law (Equation 5.1) 
 
    Δ! ! !!          (5.1) 
 
According to Equation 5.1, the differential pressure across the liquid surface (ΔP) is 
directly proportional to the surface tension (γ) and inversely proportional to the axial 
radius of the curvature along the channel direction (r)33.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.11: Droplet injections in parallel channels. (a) The injection of an analyte mixture droplet into the 
upper separation channel. (i) The droplet prior to injection at t = 0 s, (ii) The droplet is injected at t = 1 s, 
(iii) The whole droplet is successfully injected and moves along the separation channel towards the anode at 
t = 2 s; (b) The injection of the analyte mixture droplet into the lower separation channel. (i) The droplet 
prior to injection at t = 107 s, (ii) The droplet is injected at t = 110 s, (iii) The whole droplet is successfully 
injected into the separation channel at t = 111 s. Some of the analyte mixture moves towards the anode 
(right arrow) but some moves in the opposite direction towards the cathode (left arrow). The arrows 
indicate the direction of the analyte mixture movement; (c) Droplet injection in the lower channel (right), 
while a droplet in the other tubing (left) moves towards the upper channel. 
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At the junction, droplet curvature could be either convex or concave with respect to the 
channel walls. Specifically, it will be convex if the liquid surface is above the channel 
walls and concave if the liquid surface is below the channel walls. According to Laplace’s 
law, the radius of the mouth of the droplet delivery tube (r1 > 50 µm) is larger than that of 
the channel (r2 = 50 µm); hence, the pressure in the channel (P2) is greater than that of the 
tube (P1). The liquid in the channel where it meets the mouth of the tube should therefore 
be pushed due to the higher pressure in the channel such that the curvature of the liquid is 
over the channel walls. Moreover, the oil will be absorbed into the PTFE membrane when 
it reaches the mouth of the tube. Consequently, the pressure due to the oil flow at the 
mouth of the tube decreases. Accordingly, the curvature of the buffer solution at the 
junction could be convex when there is no injection. However, when the buffer solution 
at the junction evaporates, the liquid curvature could be concave and the liquid from the 
buffer reservoir will be pulled to fill up the junction.  
 
During droplet injections, the aqueous droplet contents (released from a droplet after oil 
depletion) accumulate at the junction and the oil flow pushes it into the channel. Since the 
radius of the buffer or buffer waste reservoir (r3 = 2 mm) is much larger than that of the 
separation channel (r2 = 50 µm), the differential pressure at the reservoir is almost 
negligible. Accordingly, the same volume of buffer (as the volume of the injected droplet) 
flows towards the buffer reservoir. This prevents buffer solution from accumulating at the 
junction and dilution of the released droplet contents therefore does not occur. 
 
Two factors affecting droplet injections are the injected droplet volume and the distance 
between the separation channel and the mouth of the tube. It was found that each droplet 
was injected into both separation channels as multiple injections instead of single 
injection (Figure 5.11a and Figure 5.11b). The average volume of the droplets generated 
by the T-junction geometry and stored in tubing (100 µm I.D.) was 3.4 nL corresponding 
to the average droplet length of 435 µm. This droplet volume provided for double 
injections for each droplet in which the volume of each injection was between 1.4 and 1.9 
nL (corresponding to injection lengths between 185 and 232 µm). Unsurprisingly, 
multiple injections made it difficult to distinguish separated bands originating from each 
droplet. However, if the volume of the droplet is less than 1.4 nL, the droplet might not be 
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immediately injected into the separation channel but might remain at the mouth of the 
tube until it merges with the next droplet(s) to reach the threshold volume required for 
injection. In order to achieve a single injection, the minimum volume required is that 
which enables a droplet to contact the buffer solution in the separation channel, thus 
allowing droplet contents to merge (with the facilitation of pressure from oil flow in the 
tube) with the buffer solution. Based on our experiments (for this design) the minimum 
and maximum volume for droplets to be injected as a single injection was approximately 
1.4 nL and 1.9 nL, respectively. The volume of injected droplets actually depends on the 
distance between the separation channel and the mouth of the tube in which the distance 
is determined by the thickness of the bottom layer and the pressure obtained from the top 
piece of the platform used to secure the microdevice in place (Figure 5.10b).  
 
Figure 5.11bi shows a long droplet forming via the merging of several small droplets 
since the distance between each droplet is small and no surfactant has been added to the 
oil. Increasing the oil flow rate could increase the distance between each droplet, but this 
would change the size of droplets produced. To achieve both the required droplet size 
and the required distance between each droplet, both oil and sample flow rates needed to 
be adjusted in the concerted manner. Although possible, this was difficult to achieve 
using a T-junction geometry. 
 
Another problem encountered using the current design was the increase in EOF while 
performing droplet injection (as shown in Figure 5.11biii). Once the droplet was injected 
into the separation channel, some of the fluorescein mixture moved towards the anode 
(right handed-side arrow) as expected, but some analyte moved towards the cathode (left 
handed-side arrow). This indicated the presence of EOF. It should also be noted that 
another possible reason for movement towards the cathode is evaporation of the buffer 
solution.  
 
Although this design was successful in allowing injection of droplets into parallel 
separation channels, it could not be used in conjunction with high viscosity buffer 
solutions commonly developed for protein separations. The high viscosity buffer 
solutions caused not only the damage to the microdevice, but also leakage of the buffer in 
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the open channel. Moreover, the surface chemistry of the entire PDMS microdevice was 
difficult to control since the hydrophilic properties of oxidized PDMS surfaces degrade 
over time reverting to their native hydrophobic state44,45,46. The resulting change of EOF 
due to the change in surface chemistry over the experimental timescale was difficult to 
eliminate. Additionally, the experimental setup was not convenient since it needed precise 
alignment between the mouth of droplet delivery tube and the open channel. Accordingly, 
a third generation interfacing microdevice was designed. 
 
5.3.3 Design 3 
5.3.3.1 Design schematics and fabrication procedures 
The third generation interfacing microdevices illustrated in Figure 5.12 consist of 
identical top layers (Figure 5.12ai) with two different designs for the bottom layers 
(Figure 5.12aii and Figure 5.12aiii). The top layer (Figure 5.12ai) is composed of a T-
junction droplet delivery channel (100 µm wide and 100 µm deep) in which the left and 
the right ends are enlarged to allow insertion of a droplet delivery tube and a glass 
capillary (that serves as a separation channel). The side channel is connected to a 4 mm 
I.D. buffer reservoir, while a buffer waste reservoir (a microcentrifuge tube) is placed at 
the end of the glass capillary. Two different structures for the bottom layer were designed 
and are depicted in Figure 5.12aii and Figure 5.12aiii. Both bottom layers were cut into 
different shapes after plasma treatment. The first design (“Design 3.1”) is identical to 
“Design 2” shown in Figure 5.9biii. This was cut and placed 2-3 mm separately prior to 
being bonded with the top layer, in which an open channel (for oil depletion) was 
confined between the droplet delivery tube and the buffer reservoir (Figure 5.12bi). A 
rectangular PDMS piece was removed from the second design of the bottom layer after 
plasma treatment. This bottom layer was bonded to the top layer by placing the open 
rectangular space of the bottom layer at the T-junction geometry of the top layer and was 
designated as “Design 3.2” (Figure 5.12bii). 
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Figure 5.12: Schematics illustrating the third generation interfacing microdevice with two open-channel 
structures. (a) Separated top layer and bottom PDMS layers (i) Top layer consisting of a T-junction droplet 
delivery channel with an expansion at the left and right sides to allow insertion of droplet delivery tube and 
a glass capillary, respectively. A buffer reservoir is placed at one end of the channel, whilst a buffer waste 
reservoir (not shown) is placed at the end of the capillary, (ii) Initial design of the bottom layer. A flat 
PDMS layer is cut and placed 2-3 mm separately after oxygen plasma treatment, (iii) Second design of the 
bottom layer. A rectangular, thin PDMS layer is removed after oxygen plasma treatment; (b) Entire 
microdevices after bonding the top and bottom layers (i) The top layer of microdevice bonded with the first 
design of the bottom layer “Design 3.1”, (ii) The top layer of microdevice bonded with the second design of 
the bottom layer “Design 3.2”. 
 
 
5.3.3.2 Droplet injection 
Both microdevices depicted in Figure 5.13 were configured and operated in the same 
manner for droplet injection experiments. Each setup comprised a PDMS microdevice, a 
droplet delivery tube, a glass capillary, a syringe pump, two electrodes, a high-voltage 
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power supply and a fluorescence detector. The PDMS part of the microdevice was filled 
with 0.1% (w/v) SDS. A 5-cm long detection window on a 7-cm long glass capillary was 
created by burning the polyimide coating off and cleaning with ethanol. The glass 
capillary was then treated with 1 M HCl for 5 minutes and filled with 6% PEO in 0.05 M 
TRIS-CHES, 0.1% SDS, pH 8.5 prior to being inserted into the right end of the 
microdevice. One end of the droplet delivery tube containing only FC-40 oil (for oil 
leakage testing) or fluorescein droplets was inserted into the left end of the microdevice, 
while the other end of the tube was connected to a syringe pump. The entire microdevice 
was then placed onto a PTFE membrane, ensuring that the open channel was precisely 
above the membrane. Oil surrounding droplets was absorbed into the PTFE membrane 
via the open channel, while the droplet contents migrated further under an electric field 
into the glass capillary to be separated.   
 
 
 
 
 
 
 
 
 
  
 
 
  
 
 
Figure 5.13: Schematics illustrating the experimental set up used for droplet injection using the third 
generation interfacing microdevices. (a) “Design 3.1” with the separated bottom layer; (b) “Design 3.2” 
with the open, rectangular bottom layer. Both microdevices are configured in the same manner, i.e. droplet 
delivery tube and a glass capillary are inserted into the left and the right enlarged channels, respectively, 
and the open channel is placed on a PTFE membrane for oil depletion. A cathode is placed at a buffer 
reservoir, while an anode is placed at a buffer waste reservoir for application of an electric field.  
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5.3.3.3 Results and Discussion 
The basic idea behind “Design 3” was to simplify the experimental setup and operation 
when compared to “Design 2” (Section 5.3.2.2) and to ensure that viscous buffer 
solutions could be used without any problems. Briefly, “Design 2” needed precise 
alignment between the open channel and the mouth of the delivery tube so that droplet 
contents could be successfully injected into the separation channel, while the oil 
surrounding the droplets could be absorbed into the PTFE membrane. Moreover, the 
entire microdevice (for “Design 2”) was made of PDMS, making it difficult to fill the 
microdevice with viscous buffer solution without structural deformation and/or leakage of 
the buffer solution in the open channel. Accordingly, the third generation interfacing 
microdevices were designed to solve these problems. Three key features of “Design 3” 
are desired. First, the design should be simple and the devices are easy to fabricate. 
Second, the device should be buffer-friendly, allowing operation with both non-viscous 
and viscous buffer solutions without leakage. Finally, the microdevice should be easy to 
handle and configure during experiment. 
 
To solve the problems described above, two T-junction interfacing microdevices 
(“Design 3.1” and “Design 3.2”) were fabricated as illustrated in Figure 5.12b. The 
fabrication of both deisgns was facile and the insertion of either droplet delivery tube or a 
glass capillary into enlarged ends of both microdevices was easy and rapid.  
 
The difference between the two microdevices lies in the bottom layers. Figure 5.12bi 
shows the microdevice with two separated sections of the bottom layer (“Design 3.1”) to 
provide for an open channel. It should be noted that the position of the open channel in 
“Design 3.1” differed from that of “Design 2”, in that the open channel of “Design 3.1” 
was on the left-hand side of the buffer reservoir, while the open channel in “Design 2” 
was on the right-hand side of the buffer reservoir. Figure 5.12bii shows the microdevice 
with a rectangular open space on the bottom layer (“Design 3.2”) creating a T-geometry 
open channel in which the buffer reservoir is close to the open channel. The purpose of 
assessing both “Design 3.1” and “Design 3.2” was to investigate whether the different 
position of the buffer reservoir with respect to the open channel would affect droplet 
injection.  
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First, the effect of the presence of oil in the PDMS part of the microdevice containing 
0.1% SDS was studied by pressurizing only the FC-40 oil through the tube into the 
PDMS channel and observing any variation in current. It was found from the experiments 
that current varied between 10 and 13 µA and 5 and 8 µA for “Design 3.1” and for 
“Design 3.2”, respectively, as the oil flow rate increased from 0.1 to 1.5 µl/min. At a flow 
rate of 0.15 µl/min (which was the same used to deliver droplets), the current was stable 
over the period that the electric field was applied (cathode = -500 V, anode = 800 V for 
30 minutes) for both designs. This indicated that the presence of the FC-40 oil in the 
PDMS channel containing the aqueous buffer did not affect current variation since the oil 
must already have absorbed into the PTFE membrane at the open channels in both 
microdevices. 
 
 
 
Figure 5.14: Images showing the injection of droplets and the migration of droplet content towards the 
separation channel performed in microdevice “Design 3.1”. (a) A droplet leaves the mouth of the droplet 
delivery tube and moves into the droplet delivery channel; (b) The droplet content is accumulated at the 
mouth of the tube and its movement ceases; (c) After a period of time, the droplet contents start moving 
again. 
 
 
Figure 5.14a is obtained using Design 3.1 and shows a fluorescein droplet reaching the 
mouth of the tube and entering the PDMS channel, where the oil surrounding the droplet 
is depleted and the droplet contents are released from the droplet. Instead of moving 
along the PDMS channel into the glass capillary under an applied electric field, the 
droplet contents move slowly and finally stopped (Figure 5.14b). After a given period of 
time (50 s) droplet movement begins again, as shown in Figure 5.14c. Unfortunately, the 
subsequent movement of the droplet content is parabolic in nature and likely to be caused 
(a) (b) (c) 
100 µm 100 µm 100 µm 
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by hydrodynamic pressure from the oil flow rather than the electric field. This suggests 
that the electric field distribution along the entire microdevice is non-uniform due to the 
poor positioning of the buffer reservoir. The electric field in the left branch of the T-
junction was far weaker than that in the right branch; hence, droplet contents could move 
under the pressure until reaching a location (at the T-junction) with a stronger electric 
field, thus allowing further movement under an electric field into the glass capillary. 
Since the position of the buffer reservoir in “Design 3.1” and “Design 3.2” were at the 
same place, it could be assumed that the electric field distribution was approximately 
constant. Accordingly, both designs were deemed unsuitable for droplet injection. 
 
5.3.4 Design 4 
5.3.4.1 Schematics of designs and fabrication 
The fourth generation of interfacing microdevices depicted in Figure 5.15 consists of two 
different designs of the top PDMS layers (Figure 5.15ai and Figure 5.15aii) and a 
common bottom PDMS layer containing a rectangular open space for oil depletion 
(Figure 5.15aiii). The top layer designs are similar in that each design consists of a U-
shaped droplet delivery channel (100 µm wide and 100 µm deep) with an enlarged 
channel for the insertion of a droplet delivery tube at the middle of the U-shaped channel, 
a buffer reservoir (4 mm I.D.) and the other enlarged channel for insertion of a glass 
capillary, which are placed at each end of the U-shaped channel. The key difference 
between these two designs relates to the geometry of the U-shaped channel. The U-
shaped channel designated as “Design 4.1” is round, whereas the U-shaped channel 
designated as “Design 4.2” is square in shape. However, the bottom layer for both designs 
is identical. A small rectangular open space in the middle of the bottom layer was cut 
after plasma treatment. A small amount of methanol was then deposited on the plasma-
treated surface of the bottom layer to protect the oxidized surface during the bonding 
process47,48. Subsequently, the plasma-treated top and bottom layers were aligned and 
bonded under a microscope to ensure that the edge of the open space on the bottom layer 
was in alignment with the edge between the enlarged channel (for droplet delivery tubing) 
and the curve (“Design 4.1”) or the straight line (“Design 4.2”) of the U-shaped channel. 
 Chapter V 
 
 
 
 
209 
Finally, the bonded microdevice was placed on a hot plate at 65°C for 3 minutes to 
remove the methanol prior to being filled with water to maintain device hydrophilicity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.15: Schematics illustrating the fourth interfacing microdevices containing two similar open-
channel designs. (a) Separated top and bottom PDMS layers: (i) Top layer of “Design 4.1” consisting of a 
round U-shaped droplet delivery channel, (ii) Top layer of “Design 4.2” consisting of a square U-shaped 
droplet delivery channel. Both designs consist of an enlarged channel in the middle of the U-shaped channel 
for insertion of droplet delivery tube, a buffer reservoir and the other enlarged channel for the insertion of a 
glass capillary at each end of the U-shaped channel, (iii) Bottom layer of both “Design 4.1” and “Design 
4.2” consisting of a rectangular open space on a PDMS sheet, which is cut after oxygen plasma treatment; 
(b) The entire microdevices after bonding: (i) “Design 4.1”, (ii) “Design 4.2”. 
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5.3.4.2 Droplet injection 
Both (completed) microdevices are depicted in Figure 5.16 and operated in the same 
manner for droplet injection experiments. The PDMS part of the microdevice was filled 
with 0.1% (w/v) SDS. A 5-cm long detection window of a 7-cm long glass capillary was 
prepared as described in Section 5.3.3.2. The glass capillary was then treated with 1 M 
HCl for 5 minutes, filled with 6% PEO in 0.05 M TRIS-CHES, 0.1% SDS (pH 8.5) and 
inserted into the right enlarged channel of the microdevice. The droplet delivery tube 
connected to a syringe pump at one end was inserted into the left enlarged channel of the 
microdevice. The entire microdevice was then placed on a PTFE membrane. During 
droplet injection, the oil surrounding droplets was absorbed into the PTFE membrane at 
the open channel, while droplet contents migrated further under an applied electric field 
into the glass capillary for separation.   
 
 
 
  
 
 
 
 
 
 
 
 
 
Figure 5.16: Schematics illustrating the process of droplet injection using the fourth generation of 
interfacing microdevices. (a) “Design 4.1” with a round U-shaped PDMS channel; (b) “Design 4.2” with a 
square U-shaped PDMS channel. Both microdevices are operated in the same manner. A droplet delivery 
tube is inserted into the enlarged channel at the middle of the U-shaped channel, while a glass capillary is 
inserted into the other enlarged channel. The entire microdevice is placed on a PTFE membrane, which 
serves as an oil depletion unit. A cathode is placed at a buffer reservoir, while an anode is placed at a buffer 
waste reservoir. 
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5.3.4.3 Results and Discussion 
The fourth generation interfacing microdevices were developed to address the issue of 
unequal electric field distribution that occurred in the third design structures. The fourth 
generation devices possess three key features. First, the electric field can be equally 
distributed all over the entire microdevice due to the appropriate positioning of buffer 
reservoirs. Second, both designs can be used with either viscous or non-viscous buffer 
solutions since the running buffer (either viscous or non-viscous) is only filled up in the 
capillary part, which prevents the leakage of the buffer at the open channel in the PDMS 
part. Finally, the experimental setup and device operation are simple and convenient. 
 
Fabrication of microdevices based on “Design 4.1” and “Design 4.2” was more 
complicated than that of the third generation microdevices described previously. 
Extremely precise alignment of the top and the bottom layer was required for both 
“Design 4.1” and “Design 4.2” to ensure successful droplet injection. The key factors 
affecting droplet injection in both designs were the volume of incoming droplets and the 
position of the mouth of the delivery tube. Droplets used in these experiments were 
generated by a robotic droplet generator as described in Section 5.2.1.2; therefore, the 
volume of the generated droplets could be controlled by adjusting the parameters of the 
robotic droplet generator during droplet generation. In addition, the position of the mouth 
of the droplet delivery tube was ideally placed exactly at the edge between the closed and 
the open part of the microdevice (shown in Figure 5.15bi), allowing a droplet with an 
optimized volume to be injected as a whole droplet (a single injection). However, lower 
droplet volumes were required to achieve droplet injection when the mouth of the tubing 
extended into the U-shaped PDMS channel. This could result in multiple injections of 
droplet contents. Conversely, higher droplet volumes were required when the mouth of 
the tubing was placed behind the edge. Several droplets therefore merged together to 
achieve the required volume prior to injection, causing sample contamination if each 
droplet possesses a different chemical payload.  
 
Initially, “Design 4.1” was fabricated and tested. The results indicated that a single 
injection of each droplet could be achieved when the mouth of the tube was placed in the 
correct position as shown in Figure 5.17. The droplet content (fluorescein) formed a 
 Chapter V 
 
 
 
 
212 
spherical plug in the U-shaped PDMS channel, while the oil was completely absorbed 
into a PTFE membrane placed underneath the open part of the microdevice (Figure 
5.17b). Subsequently, fluorescein migrated under an applied electric field along the 
PDMS channel (red dashed lines) towards the anode and finally entered a glass capillary 
for detection.  
 
 
 
Figure 5.17: Images showing the injection of a droplet in “Design 4.1”. The red dashed lines indicate the 
open PDMS channel of the microdevice. (a) A droplet moves towards the mouth of the droplet delivery 
tube; (b) The droplet contents form a spherical plug when the droplet reaches the open PDMS channel, 
while the oil is absorbed into the PTFE membrane underneath; (c) The droplet content migrates towards a 
glass capillary placed downstream (the movement direction indicated by a yellow arrow). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.18: An electropherogram of fluorescein obtained from droplet injections performed in the 
microdevice “Design 4.1”. Three fluorescein droplets were injected and detected inside a glass capillary. 
Each droplet was injected as single injection. The electric field used in this experiment was ~ 253 V/cm. 
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Unfortunately, a number of experimental issues were encountered using the fourth 
generation microdevices. First, misalignment between the top and the bottom layer, 
especially at the edge between the closed and the open part of the microdevice, caused 
leakage of droplet content outside the U-shaped PDMS channel during droplet injection. 
Second, insertion of the droplet delivery tube was difficult to perfectly reproduce, 
resulting in a change in the required volume for a successful single injection. Third, the 
sealing of the top and the bottom layer at the edge illustrated in Figure 5.15bi was easily 
compromised during the insertion of the tube, which could cause leakage of droplet 
content during droplet injection. The final issues related to the fact that the distance that 
droplet content travelled in the U-shaped PDMS channel after injection was too long and 
resulted in significant dilution as shown in the electropherogram of fluorescein in Figure 
5.18. Each broad peak in the electropherogram was obtained from a single injection of a 
fluorescein droplet, reflecting the dilution of fluorescein after injection. 
 
 
 
 
 
 
 
Figure 5.19: Images showing the injection of a droplet performed using “Design 4.2”. The red dashed lines 
indicate the open PDMS channel of the microdevice. (a) A droplet enters the PDMS channel of the 
microdevice; (b) The droplet contents form a spherical plug; (c) The droplet content migrates along the 
PDMS channel and then into a glass capillary (with movement direction indicated by a yellow arrow). 
 
 
To this end, “Design 4.2” was then developed by replacing the round U-shaped channel 
with a square U-shaped channel as depicted in Figure 5.15bii. The alignment of the 
square U-shaped channel on the top layer with the open space on the bottom layer was far 
simpler than that of the round U-shaped channel in “Design 4.1”. Precise alignment 
facilitated insertion of a droplet delivery tube at the right position and therefore allowed 
successful single injection of fluorescein droplets as shown in Figure 5.19. However, if 
(c) (b) (a) 
100 µm 100 µm 100 µm 
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the microdevice was misaligned, leakage of droplet contents as in “Design 4.1” occurred 
as shown in Figure 5.20c.  
 
 
 
 
 
 
 
Figure 5.20: Images showing multiple injection of a droplet performed using Design 4.2. The red dashed 
lines indicate the open PDMS channel of the microdevice. (a) A part of a droplet is injected into the PDMS 
channel; (b) The injected droplet content migrates along the PDMS channel, with material being left at the 
mouth of the tube; (c) Most of the droplet content migrates towards a glass capillary (the movement 
direction indicated by a yellow arrow), while a small portion of the droplet diffuses at the top and the 
bottom edges of the tube (blue arrows). 
 
 
According to the observation in the experiment, each fluorescein droplet was not injected 
as a whole droplet due to the imperfect position of the inserted droplet delivery tube. The 
required volume to be injected was less than the volume of the generated droplet; 
therefore, the major part of the droplet was injected into the square U-shaped channel 
with the minor portion being left at the mouth of the tube until it merges with the next 
droplet, thus achieving the required volume. It could be inferred from the size of the 
fluorescein peaks in the electropherogram (Figure 5.21) that the volume of each injection 
was essentially identical. The reproducible injected volume could be useful for 
quantitative analysis. However, if each droplet contains different analytes, merging of 
droplets prior to injection will cause unacceptable cross contamination. Another 
observation was the existence of “narrower” fluorescein peaks due to the decrease in the 
length of the U-shaped channel. 
 
 
 
(b) (c) (a) 
100 µm 100 µm 100 µm 
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Figure 5.21: An electropherogram of fluorescein obtained from droplet injections performed in a “Design 
4.2” microdevice. Five fluorescein droplets were injected and detected inside a glass capillary. Each droplet 
was injected as multiple injections. 
 
 
Although “Design 4.2” provided for a more convenient way of alignment between the top 
and the bottom layer of the microdevice (leading to better performance of droplet 
injection), the easy breakage of the sealing at the edge (Figure 5.15bii) was still 
problematic. The fourth generation of the interfacing microdevices was therefore 
improved and is discussed in Section 5.3.5. 
 
5.3.5 Design 5 
5.3.5.1 Schematics of designs and fabrication 
The design of the fifth generation interfacing microdevice is illustrated in Figure 5.22 
and is similar to that of “Design 4.2”. The 3D-printed microdevice consists of a top and a 
bottom layer made of acrylonitrile butadiene styrene (ABS). The top layer consists of a 
square U-shaped channel (200 µm × 200 µm cross-section) with an enlarged channel for 
the insertion of a droplet delivery tube at the middle of the U-shaped channel, a buffer 
reservoir (4 mm I.D.), the other enlarged channel for the insertion of a glass capillary 
placed at each end of the U-shaped channel and four small round holes at four edges of 
the top layer as depicted in Figure 5.22ai and Figure 5.22aiii.  
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Figure 5.22: Schematics and images depicting the structure of the fifth generation interfacing microdevices 
made of acrylonitrile butadiene styrene or ABS (a) Separated top and bottom layer: (i) Modified top layer 
from “Design 4.2” with four holes, (ii) Bottom layer with four post, (iii) A photograph showing the back of 
the top layer of the 3D-printed microdevice, (iv) A photograph of the front of the top layer showing a 4 mm 
I.D. buffer reservoir, (v) A photograph of the bottom layer; (b) The entire microdevice after assembling: (i) 
A schematic showing inside the microdevice, (ii) A photograph of the assembled microdevice showing the 
buffer reservoir and the side channel for the insertion of a droplet delivery tube, (iii) A photograph of the 
assembled microdevice showing the buffer reservoir and the side channel for the insertion of glass 
capillary. 
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The bottom layer consists of a rectangular hole in which a PTFE membrane will be 
placed (Figure 5.22av) and four posts at four edges of the bottom layer. The fabrication 
of the microdevice by 3D printing is described in detail in Section 2.1.2. By employing 
posts and holes, the top and the bottom layers were easily assembled or disassembled. 
Figure 5.22bi shows the inside structure of the microdevice after assembling the top and 
the bottom pieces. The edge of the rectangular hole in the bottom layer is placed 
underneath the top layer between the U-shaped channel and the enlarged channel for the 
insertion of the droplet delivery tube. After the 3D-printed microdevice had been 
fabricated, the wax filling (used as a support material during 3D printing49) was removed 
by sonication of the microdevice in 10% SDS at 70°C for 2 hours. The microdevice was 
then rinsed with water and placed in an oven at 70°C for 30 minutes. If the wax was not 
completely removed, it seeped out after the heating. 
 
5.3.5.2 Droplet injection 
The experimental setup for droplet injection employing “Design 5” (Figure 5.23) was 
similar to that of “Design 4.2” as described in Section 5.3.4.2. The only difference being 
that the PTFE membrane was placed in between the top and the bottom layer of the 
microdevice. 
 
 
 
  
 
 
 
 
Figure 5.23: A schematic showing the experimental set up of droplet injection using the fifth generation 
interfacing microdevice developed from “Design 4.2”. A PTFE membrane is cut into a small piece, folded 
and placed into the square hole of the bottom layer prior to being assembled with the top layer. A droplet 
delivery tube is inserted into the enlarged channel at the middle of the U-shaped channel, while a glass 
capillary is inserted into the other enlarged channel. A cathode is placed at a buffer reservoir, while an 
anode is placed at a buffer waste reservoir, which is a microcentrifuge tube (not shown) for the application 
of an electric field. 
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5.3.5.3 Results and Discussion 
The fifth generation of interfacing microdevice (“Design 5”) was developed from 
“Design 4.2”. The major improvements of the fifth design are the robustness of the 
microdevice and more convenient alignment of the top and bottom layers. Other 
advantages of “Design 5” are the same as those described for “Design 4.2” and are 
mentioned in Section 5.3.4.3. In principle, droplet injection using “Design 5” works in 
the same manner as that of “Design 4.2” and is described in detail in Section 5.3.4.2. 
 
 
 
 
 
 
 
 
 
Figure 5.24: Images showing hydrophilic testing on the surface of 3D-printed pieces of microdevices (a) 
Red food dye was dropped onto the surface of each 3D-printed piece. Before (right) and after (left) surface 
treatment with 10% SDS at 70°C for 2 hours; (b) Red food dye filled up the entire channel of the 
microdevice. 
 
 
Due to the shortage of alternative materials for 3D-printing, ABS was the only option at 
the time experiments were conducted. The contact angle, which is the angle measuring 
between the liquid and solid surface, indicates the degree of wetting. High wettability has 
large contact angle (more than 90°), while low wettability has low contact angle (less than 
90°)50. It was found from experiment that before the ABS 3D-printed microdevice was 
treated with 10% SDS at 70°C for 2 hours, the contact angle of the droplet in Figure 
5.24a (right) was large. The surface of the microdevice (Figure 5.24a (right)) was 
therefore considered to be hydrophobic. However, the surface of the 3D-printed 
microdevice became more hydrophilic (indicated by a smaller water contact angle) after 
the surface treatment as shown in Figure 5.24a (left). The entire channel of the treated 
3D-printed microdevice was easily filled with red food dye from the buffer reservoir as 
shown in Figure 5.24b. The microdevice was flushed with water and dried prior to being 
(a) (b) 
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refilled with red dye again. This process was repeated every 15 minutes for 1.5 hours. It 
was found that the hydrophilicity of the microdevice gradually decreased, making it 
difficult for the liquid to penetrate along the entire channel. The other problem with the 
3D-printed microdevice was the opacity of the ABS material, which made it impossible 
for droplet injection to be observed. Due to the hydrophobicity and the opacity of the 
ABS 3D-printed microdevice, it was not further used for droplet injection experiments. 
 
5.3.6 Design 6 
5.3.6.1 Schematics of designs and fabrication 
The entire microdevice of the sixth design is illustrated in Figure 5.25a. The top layer of 
the microdevice consists of a single channel (100 µm wide and 100 µm deep) with a 
buffer reservoir (I.D. = 4 mm) and an enlarged channel at each end (Figure 5.25bi). The 
bottom layer is a flat PDMS sheet with the thickness of 0.15 – 0.3 mm (Figure 5.25bii).  
 
 
 
 
 
 
 
 
 
 
Figure 5.25: Schematics depicting the structure of the sixth design of interfacing microdevices. (a) A 
schematic of the entire microdevice consisting of a top (solid lines) and a bottom (dashed lines) layer of 
PDMS; (b) Schematics showing the separated top and bottom PDMS layers: (i) The top layer consisting of 
a straight channel connected to a buffer reservoir at one end and an enlarged channel for the insertion of a 
glass capillary at the other end, (ii) The 2-3 mm separated PDMS bottom layer after plasma treatment. 
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The fabrication of “Design 6” was as described for “Design 2”. Briefly, the plasma-
treated bottom layer was cut, separated by 2-3 mm (Figure 5.25bii) and bonded to the 
plasma-treated top layer. The cut bottom layer created the open part of the channel in 
which droplet contents would be injected into a glass capillary. 
 
5.3.6.2 Droplet injection 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.26: Schematics showing the experimental setup of droplet injection experiment using the sixth 
design of the interfacing microdevices. (a) A droplet delivery tube cut a 30° angle at one end was placed 
onto a PTFE membrane, while the other end of the tube was connected to a syringe pump. The microdevice 
with an inserted glass capillary was then placed on the tube by aligning the PDMS channel onto the mouth 
of the tube; (b) An acrylic platform used to hold the microdevice consisting of two plates. The microdevice 
along with the tube, the glass capillary and the PTFE membrane is placed on the bottom plate of the 
platform. The top plate is then put on the microdevice to secure everything in place. One Pt electrode is 
immersed into a buffer reservoir through a square cavity on the top acrylic plate, while the other Pt 
electrode is immersed into a buffer waste reservoir (a microcentrifuge tube which is not shown) placed at 
the end of the capillary. 
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A 5-cm long glass capillary was prepared by removing 4-cm of the polyimide coating to 
create a detection window as described in Section 5.3.3.2. The glass capillary was rinsed 
with 1 M HCl for 5 minutes and was then filled with 6% PEO (100 kDa) in 0.05 M TRIS-
CHES, 0.1% SDS, pH 8.5. The capillary was inserted into an enlarged end of the 
microdevice that was already filled with 0.1% SDS. Meanwhile, a droplet delivery tube 
containing fluorescein droplets was cut a 30° angle at one end and placed onto a PTFE 
membrane, which was situated on a platform (Figure 5.26b). The open channel of the 
microdevice was then aligned onto the 30° cut mouth of the tube. Subsequently, the 
microdevice and tube were covered by the top acrylic plate. Droplets were delivered from 
the tube towards the open channel of the microdevice, while an electric field was applied 
using two Pt electrodes. At the junction, oil surrounding droplets were absorbed into the 
PTFE membrane, whilst droplet contents were injected into the PDMS channel in which 
they migrated under the electric field prior to detection. 
 
5.3.6.3 Results and Discussion 
The sixth generation of interfacing microdevices was fabricated based on the microdevice 
described by Niu and co-workers33 in Section 5.1 (Figure 5.4ci). The principle of droplet 
injection when using microdevice “Design 6” is the same as that of “Design 2”. However, 
the design of the sixth generation is different from that of the second generation. The 
microdevice “Design 2” is made of PDMS; therefore, droplet contents are injected and 
separated in the entire PDMS channel. The microdevice “Design 6”, however, consists of 
a PDMS part and a glass capillary part in which droplet contents are injected into the 
PDMS part and separated inside the glass capillary. 
The key features of “Design 6” are that the design is simple, easy to fabricate and trivial 
to parallelize for high-throughput analysis. Oil depletion occurs passively by employing a 
PTFE membrane as an oil depletion unit. Moreover, either viscous or non-viscous buffer 
solutions can be used with this design without the leakage of buffer at an open channel. 
Moreover, this design prevents the microdevice from breaking due to the insertion of a 
droplet delivery tube as described for both “Design 4.1” and “Design 4.2”. 
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Droplet injection performed using “Design 6” occurs in the same manner as that for 
“Design 2” and is described in detail in Section 5.3.2.2. The only difference being that 
after injection, separation and detection were performed in a PDMS channel for “Design 
2” and in a glass capillary for “Design 6”. The use of a glass capillary afforded several 
advantages. First, the buffer solution used in the PDMS part and in the capillary part did 
not have to be the same. This allowed a non-viscous buffer to be used in the PDMS part 
and more viscous buffer (i.e. gel based buffer) to be used in the glass capillary. By doing 
this, the non-viscous buffer solution in the PDMS part did not leak out at the open 
channel and the viscous buffer solution could be filled into the capillary without causing 
breakage of the microdevice. Second, EOF in the glass capillary was more controllable 
than that in the PDMS channel due to the well-characterized glass capillary surface. 
Finally, the glass capillary was easy to prepare and replace in case it was blocked or 
damaged.  
 
 
 
 
 
Figure 5.27: Images showing the injection of a fluorescein droplet. (a) A fluorescein droplet moves 
towards the mouth of the tube at the flow rate of 0.3 µl/min; (b) The oil surrounding the droplet is absorbed 
into a PTFE membrane, whilst fluorescein released from the droplet forms a spherical shape at the mouth of 
the tube; (c) Fluorescein is successfully injected into the PDMS channel (red dashed lines) and migrates 
under an electric field (333.33 V/cm) towards an anode. 
 
 
Figure 5.27 shows the injection of a fluorescein droplet employing the “Design 6” 
microdevice. The fluorescein droplet forms a spherical shape at the mouth of the tube cut 
at 30° (to facilitate the droplet injection) whilst the oil surrounding the droplet was 
absorbed into the PTFE membrane (Figure 5.27b). The droplet contents were then 
injected into the open PDMS channel and moved further into the glass capillary to be 
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separated and/or detected (Figure 5.27c). The current during the experiment was found to 
be stable and the electric field was equally distributed all over the microdevice. Although 
successful droplet injection was achieved using “Design 6”, the same problem as that 
occurred in “Design 2” still remained. Put simply, the inconvenience of the experimental 
setup (i.e. the alignment of the mouth of the tube and the PDMS channel) meant that 
experiments were time-consuming. 
 
5.4 Conclusion 
Six generations of interfacing microdevices were designed, fabricated and evaluated for 
use in the droplet-based separation of proteins (Table 5.1). All microdevices incorporated 
passive oil depletion using a PTFE membrane as the oil depletion unit. The fabrication 
process for most of the designs was simple, except for “Design 1”, “Design 4.1” and 
“Design 4.2” in which the connection between the top and the bottom layer of the 
microdevices required extremely precise alignment to ensure reproducible droplet 
injection.  
 
All designs consisted of two parts for droplet injection and droplet content separation. 
Both parts needed to be transparent to visible light, to ensure that droplet injection could 
be observed and that the separated analytes could be detected on-line. All but one of the 
microdevices (excluding “Design 5”) employed PDMS as the substrate material in the 
droplet injection part because of its transparency, durability, flexibility, ease of 
fabrication and ability to be rapidly prototyped. For “Design 5”, droplet injection could 
not be observed since ABS was employed as the substrate material. For the separation 
part, PDMS was used in “Design 1” and “Design 2”, with the remaining designs utilizing 
a glass capillary. Since PDMS was used in both parts of “Design 1” and “Design 2”, the 
entire microdevice was entirely made of PDMS as depicted in Figure 5.5a and Figure 
5.9a, respectively. Wholly PDMS microdevices encountered problems when using 
viscous buffer solutions. Filling up the PDMS microdevices with a viscous buffer 
solution caused not only the leakage of the buffer solution at the open channel but also 
the breakage of the microdevices due to the need for high pressures. Accordingly, 
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“Design 1” and “Design 2” were not used as interfacing microdevices. For the other 
designs using PDMS in the droplet injection part and a glass capillary as a separation 
channel, a non-viscous buffer solution could fill up in the PDMS part, while a viscous 
buffer solution could be filled up in the glass capillary without any operational issues. 
 
It was found that the measured current was stable during the experiments for all 
microdevices except “Design 5”, which was not tested. The electric field was also equally 
distributed across the entire microdevice for most of the designs except for “Design 3.1” 
and “Design 3.2” as previously discussed (Section 5.3.3.3). As a result, “Design 3.1” and 
“Design 3.2” were discarded at viable options for the interfacing microdevice. 
 
According to the results obtained from the evaluation of six designs of interfacing 
microdevices (Table 5.1), “Design 6” was deemed the most promising design for an 
interfacing microdevice for droplet-based separations of proteins. Although “Design 6” 
provided for many advantages over the other designs, the experimental setup was still 
problematic. Consequently, the microdevice “Design 6” needed further investigation and 
refinement. This process is discussed in detail in Chapter 6.  
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Table 5.1: Showing the summary of properties used as criteria to choose one out of six interfacing microdevices to be further used. 
 
Design 
 
Properties 
1 2 3.1 and 3.2 4.1 and 4.2 5 6 
1. Ease of fabrication (alignment/ bonding) No Yes Yes No Yes Yes 
2. Materials used in the system PDMS PDMS PDMS/ Glass 
capillary 
PDMS/ Glass 
capillary 
ABS/ Glass 
capillary 
PDMS/ Glass 
capillary 
3. Robustness No No with 
viscous buffer 
No. Tubing can 
break the sealing. 
No. Tubing can 
break the sealing. 
Yes Yes 
4. Stable separation current  Yes Yes Yes Yes N/A Yes 
5. Uniform electric field distribution Yes Yes No Yes N/A Yes 
6. Compatibility with buffer solution 
(viscous or non-viscous buffer) 
Non- viscous Non-viscous Non-viscous or 
viscous 
Non-viscous or 
viscous 
Non-viscous 
or viscous 
Non-viscous or 
viscous 
7. Ease of manipulation Yes No Yes Yes No No 
8. Oil depletion mechanism Passive Passive Passive Passive Passive Passive 
9. Successful droplet injection Yes Yes Yes Yes N/A Yes 
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6.1 Introduction 
Three components central to achieving successful droplet-based separation of proteins 
were investigated in previous chapters. These included a buffer for rapid and high-
resolution protein separation (Chapter 3), a fluorescently labeled protein mixture 
(Chapter 4) and an interfacing microdevice (Chapter 5). The fluorescently labeled 
protein mixture used as a representative of proteins separated from the first separation 
dimension was the commercial benchmark fluorescent protein standard 11-155 kDa 
(Thermo Fisher Scientific, UK) as other laboratory-labeled protein mixtures studied in 
Chapter 4 presented several challenges as detailed in Section 4.3. The promising buffer 
for capillary gel electrophoresis of proteins chosen from the investigation in Chapter 3 
was 6% PEO 100 kDa in 0.05 M TRIS-CHES, 0.1% SDS, pH 8.5 buffer since it reached 
the requirements mentioned in Section 3.4 and significantly it could separate the 
benchmark fluorescent protein standard (11-155 kDa) reproducibly. For the interfacing 
microdevice, “Design 6” was chosen due to the advantages it provided over other designs 
discussed in Chapter 5. In this chapter, all three crucial and functional elements will be 
integrated, tested and assessed. The performance of the entire system as one unit will be 
examined to determine if it can be applied to successful and robust droplet-based protein 
separation.  
 
6.2 Experimental 
6.2.1 Droplet-based separation experiment 
6.2.1.1 Droplet generation 
Droplets of the following samples were generated according to Section 2.3. A stock 
solution of fluorescein (4.5 mM) prepared according to Section 3.2.2 was diluted 300x 
and 1000x in 0.1x TBE buffer to achieve 4.5 µM and 15 µM fluorescein solution. BSA-
FITC was dissolved in 0.2% SDS to achieve a concentration of 0.5 mg/ml and then 
heated at 95 °C for 5 minutes. Benchmark fluorescent protein standard (11-155 kDa, 
Thermo Fisher Scientific, UK) was diluted by adding 1.2 µl of 4.5 µM fluorescein and 
18.8 µl DI water to achieve 0.33x fluorescent protein standard. 
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6.2.1.2 Experimental setup for droplet injection and separation 
6.2.1.2.1 One-piece and Two-piece droplet delivery tubes 
The generated droplets were directly collected in the tube (100 µm I.D. and 30 cm long) 
used to withdraw the sample during droplet generation. One end of the droplet collecting 
tube was detached from the robotic droplet generator, while the other end remained 
connecting to the glass syringe. This tube could be used as a single-piece or dual-piece 
droplet delivery tube that transferred droplets to the interfacing microdevice. In the case 
of the single-piece droplet delivery tube, the tube was cut at a 30° angle at the free end 
using a blade and could be directly placed underneath the open channel of the interfacing 
microdevice (Figure 6.1a). 
 
The dual-piece droplet delivery tube, the droplet collecting tube was cut straight at the 
free end. The other tube (100 µm I.D. and 2 cm long) was cut a 30° angle at one end and 
cut straight at the other end. The two straight-cut ends of these two tubes were joined 
using a 0.38 mm I.D. tube (polyethylene tube, Smiths Medical, UK) as a sleeve. Each end 
of the sleeve was melted using a wax pen (Max Wax, USA) and squeezed to fix both 
tubes (Figure 6.1b).  
 
 
 
 
 
 
 
 
Figure 6.1: Illustrations of (a) one-piece and (b) two-piece droplet delivery tube. 
 
6.2.1.2.2 Assembly of the interfacing droplet-based separation unit 
Two platforms were employed for the assembly of the interfacing droplet-based 
separation unit. Herein, the utilization of the old platform is described, while the use of 
the new platform is described in detail in Section 6.3.4. 
(a) (b) 
sleeve 
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The droplet delivery tube (either one-piece or two-piece tube) cut a 30° angle at one end 
was placed onto a PTFE membrane, which was situated on the old platform (Figure 6.2 
and Figure 5.25b) and secured by adhesive tape. The interfacing PDMS microdevice 
“Design 6” was filled with 0.1% SDS or 0.005 M TRIS-CHES, 0.1% SDS, pH 8.5 and 
cut open at the enlarged end for the insertion of a glass capillary (5 cm or 7 cm long) 
prepared according to Section 5.2.6.2 and filled with 6% PEO 100 kDa in 0.05 M TRIS-
CHES, 0.1% SDS, pH 8.5. The open channel (100 µm wide and 200-300 µm long) of the 
PDMS microdevice was then aligned above the 30° cut mouth of the tube. Subsequently, 
the microdevice and the tube were covered by the top acrylic plate. The entire platform 
was then fixed onto the microscope stage. 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.2: A photograph showing the assembly of the interfacing droplet-based microdevice on the old 
platform. 
 
6.2.1.3 Droplet injection and separation 
Droplets were delivered from the tube towards the open channel of the microdevice, 
while an electric field was applied using two platinum electrodes. At the junction, oil 
surrounding the droplets was absorbed into the PTFE membrane, whilst droplet contents 
were injected into the PDMS channel. Once the aqueous phase containing the sample 
fused with the aqueous phase within the separation channel, the samples migrated under 
the electric field down the length of the separation channel prior to detection. 
Top acrylic plate 
Bottom acrylic plate 
(platform) 
Droplet delivery tube 
PTFE membrane 
Interfacing microdevice 
Pt electrode 
Glass capillary 
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6.2.2 Buffer testing using a cross-piece PDMS microdevice coupled to a glass 
capillary 
The testing of the buffer to be used in the interfacing PDMS microdevice was performed 
in a cross-piece PDMS microdevice coupled to a glass capillary (Figure 3.1b) for the 
convenient experimental setup. The glass capillary was filled with 6% PEO 100 kDa in 
0.05 M TRIS-CHES, 0.1% SDS, pH 8.5 buffer, while the cross-piece PDMS microdevice 
was filled with various buffers, which were 0.1% SDS; 0.1x TBE buffer; 0.05 or 0.005 M 
TRIS-CHES, 0.1% SDS, pH 8.5 and 6% PEO buffer. 0.5 mg/ml BSA-FITC in 0.2% SDS 
was used as a sample to investigate the injection in the cross-piece microdevice. 
 
6.3 Results and Discussion 
Droplet-based separations of the commercially fluorescent protein ladder in the 
developed buffer employing the interfacing microdevice “Design 6” were performed. The 
experiment can be divided into three main steps, which were droplet generation using the 
robotic droplet generator, the assembly of the interfacing droplet-based microdevice and 
droplet injection and separation. Figure 6.3 shows what caused the problems at each step 
of the experiment. The problems and the solutions are discussed in detail in the following 
sections. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.3: Diagram showing the problems occurred in each part of the experiment. 
Droplet generation 
Protein sample 
Pressure 
Assembly of the 
interfacing microdevice 
Connection 
between two tubes 
Alignment between the 
open channel and the 
droplet delivery tube 
Droplet injection & 
protein separation 
Multiple injection 
No protein 
separation 
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6.3.1 Droplet generation  
All droplets used in this chapter were generated using the robotic droplet generator as 
described in detail in Section 2.3. This is because droplet size and interdroplet spacing 
were more conveniently controlled than using T-junction microdevices as mentioned 
earlier in Section 5.2.2. Among the samples used to generate droplets in this work, 
protein samples were the most challenging and lead to several problems. It was found that 
during droplet generation using the robot, vibration caused by the motion of the carousel 
would on occasion result in the formation of small bubbles within the suspended SDS-
protein samples. The presence of proteins and surfactant lowered the surface tension 
between the liquid air interface resulting in conditions where bubble under minor 
vibration was significantly higher. These bubbles were often drawn in together with the 
protein sample resulting in droplets containing both analytes and air bubbles. Other 
problems with protein samples, especially the commercially available fluorescently 
labeled protein ladder, were the high viscosity and high cost. The high viscosity of the 
commercial protein ladder that contained glycerol restricted the use of the “low refilled 
flow rate” setting to withdraw protein samples into the tube, which in turn affected the 
control of droplet size. Due to the high cost of the commercial fluorescently labeled 
protein ladder, the sample volume for droplet generation was used as low as possible for 
each experiment. However, there was a minimum volume, at least 20 µl for a sample1. 
This is to ensure that the aqueous phase created a significant layer above the oil phase 
within the bottomless PCR vial in the robotic droplet generator. Consequently, a balance 
needed to be achieved in the sample preparation, where the protein sample concentration, 
the viscosity of samples and the sample volume all had to be within a specific range to 
permit the experiment to work. The commercial protein ladder was diluted to decrease the 
viscosity of the sample. Dilution was achieved by the addition of a very dilute fluorescein 
solution. Fluorescein was also used as a marker. Dilution reduces the viscosity but also 
has the effect of reducing protein sample concentration and consequently the intensity of 
the fluorescence signal.  
 
Consistency of droplet size was required to ensure the same behavior of droplet injection 
during the entire experiment and additionally, so that the injection volume is consistent 
and results may be compared. Droplet size was mostly affected by the pressure in the 
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system during droplet generation. The three parameters that control droplet size and 
necessary to achieve stable pressure were the size of the tube for droplet collection, the 
number of generated droplets and the stabilized pressure prior to droplet generation. The 
size of the tube (i.e. small diameter and long tube) and the large amount of number of 
generated droplets could cause the backpressure leading to inconsistency of both droplet 
size and interdroplet spacing. The optimum size of the tube and the number of droplets, 
which minimized backpressure, were 100 µm I.D. and 30-cm long tube and 100-150 
droplets. The last factor for achieving consistent droplet size was to stabilize the pressure 
by running the syringe pump at the required refilled flow rate for 5-10 minutes before 
starting droplet generation. 
 
6.3.2 Assembly of the interfacing droplet-based separation unit 
The interfacing droplet-based microdevice, a droplet delivery tube, a prepared glass 
capillary and a PTFE membrane were assembled for droplet-based separations on a 
platform as described in detail in Section 5.2.6.2. The set-up is tedious and requires all 
components to be ready and stable prior to interfacing. Furthermore, the assembly process 
can be time-consuming. Each aspect of the assembled platform and the challenges in 
hyphenating and solutions to these challenges are described below. 
 
6.3.2.1 One-piece and two-piece droplet delivery tubes  
It was found that the utilization of the two-piece droplet delivery tubes resulted in two 
advantages. First, the droplet collecting tube could be reused several times since the 
length of the tube remained the same (uncut). The mouth of the 2-cm long tube cut at 30° 
angle, which was aligned underneath the open channel of the microdevice, did not have to 
be removed when a new droplet collecting tube was changed. However, a significant 
disadvantage was the leakage of droplets at the junction between two tubes and between 
the tubes and the sleeve. This occurred when the two tubes were imperfectly joined as 
illustrated in Figure 6.4a. From the observation, there were two circumstances of 
leakage. First, a whole droplet leaked. Second, a part of a droplet leaked resulting in the 
deformed shape of the droplet (Figure 6.4b). Furthermore, it was time-consuming to join 
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the two tubes with a perfect connection that prevent droplets from leaking. Consequently, 
one-piece droplet delivery tube was employed instead although the tube needed to be 
changed more frequently. 
 
 
 
 
 
 
 
 
  
 
Figure 6.4: Images showing the leakage of a droplet due to the imperfect joining of two tubes (a) The 
leakage of a whole droplet (i) A droplet reaches the connection between two tubes, (ii) The droplet starts to 
leak into the sleeve, (iii) The rest of the droplet is leaking out; (b) The leakage of a part of a droplet. The 
droplet designated as “1” has the normal shape, while the shape of droplets designated as “2” and “3” is 
deformed after they pass the connection between two tubes. 
 
6.3.2.2 Alignment between the droplet delivery tube and the open channel of the 
microdevice 
The open channel of the microdevice (100 µm width and 100 µm depth) was aligned onto 
the mouth of the tube (100 µm I.D.), which was placed onto the PTFE membrane situated 
on the platform. The alignment of the microdevice and the tube was always done prior to 
fixing the platform to the microscope stage for the detection. This means that every time 
any component on the platform (i.e. the microdevice, the capillary, the PTFE membrane 
and the droplet delivery tube) needs replacement, the platform has to be detached from 
the microscope stage and the microdevice along with the capillary is removed from its 
well-aligned position and will be realigned after the replacement of any component is 
accomplished. Due to the extremely small size of the microchannel and the tube, it was 
(a) ii. iii. i. 
(b) 
1	
2	
3	
Connection between two tubes 
 Chapter VI  
 
 239 
found to be difficult to achieve the precise alignment that allowed successful droplet 
injection. 
 
6.3.3 Droplet injection and separation in single and parallel separation channel 
6.3.3.1 Injection of fluorescein droplets in single separation channel 
The mechanism of droplet injection using the interfacing microdevice “Design 6” was as 
the same as that of “Design 2”, which was described in detail in Section 5.3.2.3. Figure 
6.5a shows an electropherogram of injections of nine fluorescein droplets in which each 
droplet was injected as a whole droplet (single injection). The volume of successfully 
injected droplets in this experiment was 2.13 ± 0.15 nl (n = 30). The average 
electrophoretic mobility of nine fluorescein peaks was found to be 7.29 × 10-9 m2/Vs. In 
this experiment, the droplet was injected every ~ 22 seconds and detected at around 1 cm 
measured from the injection point to the detection point.  
 
 
Figure 6.5: The injection of nine fluorescein droplets using “Design 6” interfacing microdevice. (a) An 
electropherogram of nine injected fluorescein droplets (designated from 1 to 9). In this experiment, the 
droplets were delivered to the mouth of the tube at the flow rate of 0.3 µl/min and injected to the open 
channel containing 0.1% SDS. Fluorescein released from droplets migrated into the 5-cm long glass 
capillary containing 6% PEO 100 kDa in 0.05 M TRIS-CHES, 0.1% SDS, pH 8.5. The applied electric field 
during this experiment was 333.33 V/cm. The detection was performed at 1 cm from the injection point; (b) 
A scatterplot between the droplet volume and the fluorescence intensity of nine injected droplets with the 
correlation coefficient (r) of 0.9752 and the p-value of 7.7×10-6. 
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It was also found that the decrease in the fluorescence intensity of the injected droplets 
(Figure 6.5a) was as a result of the systematic decrease of the droplet volume during 
droplet generation using the robotic droplet generator. This could be due to the fact that 
the optical detection volume is larger than the droplets probed. Figure 6.5b shows the 
scatter plot and the data analyzed using Pearson’s product-moment correlation, which 
indicated that the fluorescence intensity was significantly positively correlated with the 
droplet volume, r = 0.9752 and p = 7.7×10-6 (p < 0.05). 
 
6.3.3.2 Injection of BSA-FITC droplets and the investigation of the buffer used in 
the interfacing PDMS microdevice 
The injection of BSA-FITC droplets was also investigated. It was found that once BSA-
FITC denatured in 0.2% SDS was released from a droplet into 0.1% SDS buffer in the 
interfacing PDMS microdevice, BSA-FITC migrated towards an anode for a short 
distance before it migrated backward to a cathode. This might be due to high EOF in the 
PDMS part of the channel. Therefore, the buffer in the PDMS part that could be used in 
conjunction with the glass capillary filled with 6% PEO buffer was investigated by testing 
various buffers using a cross-piece PDMS microdevice coupled to a glass capillary as 
described in Section 6.2.2. From the experiment, turbulence was observed and BSA-
FITC was not accumulated in the cross piece filled with 0.1% SDS or 0.1x TBE when an 
electric field was applied during injection step. This indicated the presence of EOF. In 
case 6% PEO buffer was filled up both the cross-piece PDMS microdevice and the glass 
capillary, BSA-FITC could be successfully injected into the glass capillary. However, 6% 
PEO buffer could not be filled up the interfacing PDMS microdevice since this buffer 
was viscous and would leak from the open channel. Only base buffer (0.05 M TRIS-
CHES, 0.1% SDS, pH 8.5) of 6% PEO buffer was therefore tested in the cross-piece 
PDMS part. Although EOF was not observed, the current was too high (> 100 µA) 
leading to buffer boiling. When 10x dilution of the base buffer (0.005 M TRIS-CHES, 
0.1% SDS, pH 8.5) was employed, BSA-FITC could be successfully injected and the 
current was not high. Consequently, 0.005 M TRIS-CHES, 0.1% SDS, pH 8.5 buffer was 
chosen for the interfacing PDMS microdevice.  
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The injection and detection of BSA-FITC droplets using the interfacing microdevice 
“Design 6”, which filled with 0.005 M TRIS-CHES, 0.1% SDS, pH 8.5 in the PDMS 
part, was shown in the electropherogram (Figure 6.6). Seven BSA-FITC droplets having 
an average volume of 2.05 ± 0.07 nl (n = 10) were injected every ~ 33 seconds and 
detected at 1 cm. The average electrophoretic mobility of seven BSA-FITC peaks was 
found to be 3.11 × 10-9 m2/Vs. According to the electropherogram (Figure 6.6), there 
was an intense band at the tail of each BSA-FITC peak. The bright band was as a result of 
a stacking effect. When the analyte migrated from the dilute to the concentrated 
background electrolyte (~10x difference in concentration)1, the velocity of the analyte 
decreased resulting in more concentrated analyte and hence shorter analyte zone2.  
 
  
  
 
 
 
  
 
 
 
Figure 6.6: An electropherogram obtained from the injection of BSA-FITC droplets using “Design 6” 
interfacing microdevice. In this experiment, the droplets were delivered to the mouth of the tube at the flow 
rate of 0.3 µl/min and injected to the open channel containing 0.005 M TRIS-CHES, 0.1% SDS, pH 8.5. 
BSA-FITC released from droplets migrated into the 5-cm long glass capillary containing 6% PEO 100 kDa 
in 0.05 M TRIS-CHES, 0.1% SDS, pH 8.5. The applied electric field during this experiment was 333.33 
V/cm. The detection was performed at 1 cm from the injection point. 
 
6.3.3.3 Injection and separation of benchmark fluorescent protein standard (11-155 
kDa) 
Droplets of fluorescent protein standard (11-155 kDa) mixed with fluorescein were 
injected into the interfacing microdevice containing 0.005 M TRIS-CHES, 0.1% SDS, pH 
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8.5, separated and detected in the glass capillary containing 6% PEO buffer. It was found 
that proteins in the ladder were not separated. Although the detection was placed at longer 
distance varied from 0.5 to 5.0 cm, no separation of proteins was observed (data not 
shown).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.7: Electropherograms showing fluorescent protein standard (11-155 kDa) mixed with 0.18 µM 
fluorescein separated in 6% PEO 100 kDa in 0.05 M TRIS-CHES, 0.1% SDS, pH 8.5 using the interfacing 
droplet-based microdevice “Design 6”. The droplets were delivered to the interfacing PDMS microdevice 
containing 0.005 M TRIS-CHES, 0.1% SDS, pH 8.5 at the flow rate of 0.08 µl/min. The detection was 
around 2.5 cm from the injection point, while the total length of the system was 8.0 cm. The applied 
separation fields were (a) 81.25 V/cm; (b) 118.75 V/cm; (c) 125 V/cm and (d) 150 V/cm. Fluorescein peak 
was designated as (1) and protein ladder was designated as (2).  
 
 
• It was also found that too long of a detecting distance caused band broadening and 
required longer analysis time, as a result, the detecting distance was limited to be 
between 2.0-3.0 cm.  
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• Another reason might be that the frequency of droplet injection was so high that 
there was not enough time for proteins from each droplet to be separated properly. 
The frequency of droplet injection was therefore decreased by increasing the 
interdroplet spacing and decreasing the flow rate of droplet delivery to the 
interfacing microdevice. The interdroplet spacing could be increased by 
decreasing the frequency of droplet generation or by increasing the refilled flow 
rate during droplet generation. Although droplets were injected at lower frequency 
and the time between each injected droplet was longer (~170 seconds), proteins 
were still not separated (Figure 6.7a).  
• The other parameter that was varied was the separation field strength. It was 
found that fluorescein was separated from protein ladder; however, proteins in the 
ladder were not separated as shown in Figure 6.7.  
• Another reason behind this might be due to the loss of resolving power of the gel 
buffer when several droplets pass through. The gel buffer in the glass capillary 
was not frequently replaced during the experiment since it required the 
detachment of the whole setup, i.e. the detachment of the platform from the stage 
and the capillary from the interfacing PDMS microdevice, which was time-
consuming. 
Although there were many attempts, droplet-based separations of proteins were not 
achieved. 
 
6.3.4 Platform improvement to hold the chip and capillary 
According to the problems mentioned in Section 6.3.2, a new platform was fabricated as 
described in Section 2.2 to facilitate the assembly of the interfacing droplet-based 
separation unit. The new platform consisted of the main acrylic plate as the base, the 
microdevice holding plate and the microdevice cover plate as illustrated in Figure 6.8. A 
PTFE membrane was placed on the main plate and was properly secured in place by the 
microdevice holding plate, while the membrane was secured using only adhesive tape in 
the previous platform. A droplet delivery tube already cut a 30° angle at one end was 
inserted into an aluminium tube used to hold the droplet delivery tube more tightly. The 
mouth of the tube was placed in the middle of the microdevice holding plate (~ 0.6 cm 
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measured from the inner edge of the holding plate), which would be the same place where 
the open channel would be situated. The interfacing PDMS microdevice along with the 
inserted glass capillary was then placed onto the mouth of the tube without significant 
alignment since the PDMS microdevice was cut to fit the holding space (1.2 cm width 
and 1.8 cm length). Consequently, whenever the microdevice was placed into the holding 
space, the open channel would always align onto the mouth of the tube. The microdevice 
was secured by the cover plate, which was also used to determine the distance between 
the open channel and the mouth of the tube by loosening or tightening the screws. This 
cover plate was cut open to allow an electrode to be immersed into the buffer reservoir. 
The entire platform was then fixed to the microscope stage. 
 
There were four major advantages of the new platform over the previous one. First, the 
oil depletion unit (PTFE membrane) was properly secured in place; while still being 
easily replaced. Second, the alignment between the open channel and the mouth of the 
droplet delivery tube was more convenient leading to the third advantage was that the gel 
buffer could be replaced more often. Finally, the overall experimental setup was less 
time-consuming. 
 
 
 
 
 
 
 
 
 
 
Figure 6.8: A photograph showing the new platform to facilitate the assembly of interfacing droplet-based 
separation unit. Note: the PDMS microdevice shown in the photo was not the actual size used in the 
experiment. 
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6.3.5 Injection of fluorescein droplets in parallel separation channel 
The interfacing droplet-based microdevice “Design 6” could also be parallelized to 
achieve high-throughput separation. This was demonstrated by the injection of 
fluorescein droplets into two-parallel channels of the interfacing microdevice “Design 6” 
in which the experiment was performed using the new platform described in Section 
6.3.4 and the results were shown in the electropherograms (Figure 6.9). The volume of 
successfully injected droplets in the above channel was 2.02 ± 0.11 nl (n = 10) and in the 
below channel was 1.97 ± 0.05 nl (n = 10). The average electrophoretic mobilities of 
fluorescein peaks were found to be 1.35× 10-8 m2/Vs and 2.21× 10-8 m2/Vs for the above 
and below channel, respectively. The difference in the mobilities is most likely due to 
differences in the surface chemistry of the parallel channels resulting in difference in the 
driving EOF.  
 
 
 
 
 
 
  
 
 
 
Figure 6.9: The overlay of electropherograms of fluorescein droplets injected in parallel channels of the 
interfacing droplet-based microdevice “Design 6”. Fluorescein peaks obtained from the above channel and 
from the below channel were illustrated as black line and red line, respectively. The droplets were delivered 
to the interfacing PDMS microdevice containing 0.005 M TRIS-CHES, 0.1% SDS, pH 8.5 at the flow rate 
of 0.1 µl/min. The detection was around 1.3 cm from the injection point, while the total length of the system 
was 6.0 cm. The applied electric field was ~ 217 V/cm. The detection was performed at 1.3 cm from the 
injection point. 
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6.4 Conclusion 
Here, both the fluorescent dye and protein droplets were successfully injected into the 
interfacing microdevice “Design 6” and were detected in the glass capillary during gel 
electrophoresis. To achieve this separation using the droplet injection format required that 
all three main parts of this experiment - droplet generation, device assembly and droplet 
injection and separation had to be independently and seamlessly prepared for and 
interfaced.  
 
For each experimental part, challenges were met and addressed. For droplet generation, 
protein samples and the pressure changing in the system caused problems. SDS-protein 
samples used in this work, especially the commercial fluorescent protein ladder, were 
viscous and expensive. High viscosity protein samples limited the use of “low refilled” 
flow rate, which affected the control of droplet size. Therefore, the protein samples were 
diluted to reduce the effect of viscosity and to allow the small volume of expensive 
protein samples to be used. In addition to these complications, the SDS necessary for in 
protein sample preparation could easily cause bubble formation in the presence of 
vibration; hence, very careful handling was required. To prevent pressure changing 
during droplet generation, the size of the droplet collecting tube (100 µm I.D. and 30 cm 
long), the number of droplets (100-150 droplets) and the stabilized pressure prior to 
droplet generation (running the pump at the required flow rate for 5-10 min) were 
optimized.  
 
Two foremost challenges that inconvenienced experimental setup making them time-
consuming were the connection between the droplet collecting tube and the droplet 
transferring tube and the alignment between the droplet delivery tube and the open 
channel of the microdevice. The imperfect joining of the two tubes resulted in the leakage 
of droplets at the tubing connection. This challenge was addressed by replacing the two-
piece delivery tubing with a one-piece droplet delivery tube. The other problem required 
the redesign of the chip-holder platform. 
 
Additionally, maintaining stable injection conditions was difficult and although single 
injection of droplets was achieved, often droplets merged or split causing multiple 
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injections. This problem has been discussed in detail in Section 5.3.2.3. Furthermore, 
another problem that occurred during protein droplet injection was the presence of high 
EOF. This prevented proteins from migrating to the anode and therefore be detected. 
Several buffers were then tested to determine the most suitable buffer to be used in the 
PDMS section of the device to minimize the EOF in this section. Here, a cross-piece 
PDMS microdevice coupled to a glass capillary was used to perform the tests, where the 
capillary was filled with 6% PEO buffer. Following the screen, a 0.005 M TRIS-CHES, 
0.1% SDS, pH 8.5 buffer (10x dilution of the base buffer of 6% PEO buffer) was 
employed. However, even with this buffer a stacking effect was observed when used in 
conjunction with the 6% PEO buffer in the glass capillary. Although droplet contents 
were successfully transferred into the capillary and several parameters (e.g. detecting 
distance, frequency of droplet injection and separation field strength) were varied, protein 
separation was not achieved. This might be due to the loss of resolving power of the gel 
buffer. 
 
Finally, a new platform was designed and fabricated to alleviate the problems in the 
experimental setup. The new platform was tested in the injection of fluorescein droplets 
into a parallel separation channel using the adapted interfacing microdevice “Design 6”. 
Not only did this experiment show the ability of “Design 6” to be parallelized, but also 
the advantages of the new platform. The oil depletion unit was properly secured when the 
new platform was utilized. Furthermore, the alignment between the droplet delivery tube 
and the open channel of the microdevice was more convenient. This allowed the gel 
buffer in the capillary to be replaced more often, which might improve the separation of 
proteins. Future experiments should explore the use of this optimized platform for the 
droplet injection and separation of proteins.  
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7.1 Conclusions and Future work 
 
Protein separation is a key process in proteomics, having undoubted importance in 
medical and pharmaceutical research. Proteins are normally separated using multiple 
dimensional separation methods, which provide for high-resolution analysis of complex 
protein mixtures. Unfortunately, during the transfer of proteins between dimensions, 
issues related to dead volumes, analytes dispersion (and loss) and resolution degradation 
are common. 
 
In this work, a droplet-based microfluidic device was employed as an interface for 
transferring separated proteins between dimensions, with the aim of alleviating the 
aforementioned problems. Briefly, a fluorescently labeled protein mixture was used to 
represent proteins separated within a first separation dimension. This sample was 
compartmentalised into droplets (as a segmented flow) using a robotic droplet generator. 
The formed droplets were then transferred to the developed interfacing microdevice and 
subsequently separated via capillary gel electrophoresis, which was chosen as a 
representative second separation dimension. The buffer used for protein separation, the 
reaction between proteins and fluorescent labels and the nature of the interfacing 
microdevice, were considered to be crucial in the overall process, and as such were 
investigated in detail. 
 
A novel buffer for protein separations using the droplet-based microfluidic system was 
developed to allow for high-speed and high-resolution separations of proteins and to 
ensure compatibility with the microfluidic substrates (i.e. PDMS and glass capillaries). 
Initially, both commercial and laboratory-made buffers were screened using a commercial 
CE instrument prior to testing within PDMS microdevices. Interestingly, it was found that 
the commercial “Beckman buffer” provided for high-resolution separation of protein 
mixtures using the commercial CE instrument. However, it was incompatible with the 
PDMS microdevice due to excessive Joule heating occurred and poor heat dissipation 
within the PDMS. Since the recipe of Beckman buffer remains proprietry, it was difficult 
to modify Beckman buffer to allow compatibility with the PDMS microdevice. 
Accordingly, in-house buffers based on PEO and dextran were assessed. Extensive 
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experimentation demonstrated that a 5% PEO 100 kDa in 0.1 M TRIS-CHES, 0.1% SDS, 
pH 8.7 buffer provided for compromised resolution and analysis time. By decreasing the 
concentration of background electrolyte and the pH was successful in reducing Joule 
heating and EOF. Although a 5% PEO 100 kDa in 0.05 M TRIS-CHES, 0.1% SDS, pH 
8.5 buffer allowed the successful separation of protein ladders (11-155 kDa) within the 
PDMS microdevice, an increase in PEO concentration to 6% was found to provide for 
similar resolution over shorter separation lengths and using lower separation fields. 
Additionally, proteins could be separated using the 6% PEO buffer in a cross-piece 
PDMS microdevice coupled to a glass capillary. As a result, the 6% PEO 100 kDa in 0.05 
M TRIS-CHES, 0.1% SDS, pH 8.5 buffer was used for subsequent protein separations in 
the interfacing droplet-based microfluidic format. 
 
To avoid the necessity of using expensive (commercially) fluorescently labeled protein 
mixtures and improve operational flexibility, three fluorescent dyes were investigated 
with respect to protein labeling. FITC and NHS-Fluorescein exhibited similar problems 
related to inefficient labeling chemistry. This included the incomplete removal of 
unbound dye, which could further react with components in the separation buffer, 
reduced labeling efficiencies and unbound dye in the conjugate samples compromising 
absorbance measurements. Accordingly, NanoOrange was employed to address such 
problems. Unfortunately, the use of NanoOrange raised other problems including the 
binding of NanoOrange with SDS micelles, the precipitation of protein samples in the 
presence of NanoOrange and low fluorescence intensities from droplets containing 
protein conjugates. Related problems were observed for all laboratory-conjugated 
proteins studied, and as a result, it was decided that commercially labeled proteins 
samples were best suited to act as benchmarks for the droplet-based separation of 
proteins. 
 
Six interfacing microdevice constructs were designed, fabricated and evaluated for use in 
the droplet-based separation of proteins. All designs employed a PTFE membrane as an 
oil depletion unit in which oil removal occurred passively. Herein, the ease of fabrication, 
robustness, stability of separation currents, uniformity of the electric field distribution, 
compatibility with buffer solutions, ease of manipulation and successful droplet injection 
were evaluated as key figures of merit. Based on these metrics, “Design 6”, consisting of 
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an interfacing PDMS microdevice coupled to a glass capillary, was chosen as the most 
appropriate design as it provided for superior performance despite its more involved 
operation. Accordingly, further investigations and refinement of “Design 6” were 
performed and described in Chapter 6. 
 
The developed buffer, the commercial protein mixture and the chosen interfacing 
microdevice were then integrated to perform droplet-based separations of proteins. 
Several challenges were observed from each part of the experiment and were in the large 
part successfully addressed. For droplet generation, protein samples and unstable pressure 
were the major issues. Protein samples used in gel electrophoresis (unlike nucleic acid 
samples) contained SDS for denaturation, which could often cause bubble formation; the 
handling of protein samples during droplet generation was therefore critical. In addition, 
the commercially sourced fluorescent protein ladder was diluted to reduce the viscosity, 
which allowed the use of lower refill flow rates and in turn allowed generation of smaller 
droplets. Pressure variations during droplet generation were addressed by optimizing the 
size of the droplet collection tubing (100 µm I.D. and 30 cm long), the number of droplets 
(100-150 droplets) and the stabilized pressure prior to droplet generation (i.e. by running 
the pump at the required flow rate for 5-10 minutes prior to use). For the assembly of the 
interfacing droplet-based separation unit, a one-piece droplet delivery tube was employed 
to address the imperfect join between two tubes. During protein droplet injection, 
significant EOF was present, which prevented proteins from migrating to the anode for 
detection. Accordingly, 0.005 M TRIS-CHES, 0.1% SDS, pH 8.5 was employed in the 
PDMS part instead of 0.1% SDS to minimize EOF. However, when using this buffer in 
conjunction with the 6% PEO buffer in the capillary, stacking effects were observed. The 
successful single injection of each protein droplet was achieved; however, protein ladder 
was still not perfectly separated. This is likely to be a result of the loss of resolving power 
of the gel buffer.  
 
Finally, the new platform was fabricated and used to perform the injections of fluorescein 
droplets into parallel channels. The new platform allowed the oil depletion unit and the 
droplet delivery tube to be properly secured. In addition, the alignment between the open 
channel of the interfacing microdevice and the droplet delivery tube could be achieved 
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quickly and easily, which allowed for more frequent changes of the gel buffer in the glass 
capillary.  
 
It is expected that future studies will assess the use of this optimized platform for droplet 
injection and the separation of protein mixtures. Moreover, droplet docking could be 
added between droplet generation and the interface to store droplets containing separated 
analytes from the first dimension in a sequential manner prior to further analysis. By 
doing so, droplets entering the interface microdevice could be better controlled. In 
addition, the developed interfacing microdevice could be integrated to several 
downstream processes such as other separation dimensions (based on IEF, CZE, MEKC 
and nano LC for example), on-chip sample preparation or microreactors. The developed 
interfacing microdevice along with the optimized platform has also demonstrated 
potential for parallelization, which would undoubtedly afford high-throughput analysis of 
more complex biological samples. This would save much time in the study of real-world 
protein samples. 
 
 
 
 
 
 
 
 
 
